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ABSTRACT  
 
Laura R. Loehr, MD MS:  The association of overweight and obesity with incident  
heart failure 
(under the direction of Wayne D. Rosamond, PhD MS) 
 
 
    Obesity has been identified as a risk factor for heart failure.  The importance of a measure 
of central adiposity (waist-hip ratio) as compared to BMI has not been extensively studied.  
The increasing prevalence of both obesity and heart failure (HF) make this association an 
important topic for prevention.   
    The Atherosclerosis Risk in Communities (ARIC) study is an ongoing bi-racial 
population-based cohort (45-65 years) from 4 U.S. communities with 14 years median 
follow-up for incident hospitalized or fatal heart failure.  Waist-hip ratio (WHR), waist 
circumference and BMI were measured at the baseline visit (1987-1989).  After exclusion of 
prevalent HF, missing anthropometry measures, and poorly represented race groups, there 
were N=8,031 women and N=6,659 men at baseline.  BMI was categorized as normal weight 
(BMI <25 kg/m2), overweight (BMI 25-30 kg/m2), and obese (BMI ≥ 30 kg/m2).  WHR and 
waist circumference were divided into gender-specific tertiles.  Models were adjusted for 
demographics, alcohol use, smoking, age, and educational level using Cox proportional 
hazards modeling.  Because HF is a syndrome without clear objective diagnostic criteria, we  
evaluated the effect of outcome misclassification with Monte Carlo sensitivity analysis.  The 
impact of a hypothetical reduction in obesity and overweight on heart failure incidence was 
estimated by calculation of the generalized impact fraction.
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    With stratification by race and gender, the adjusted hazard ratios for the comparison of the 
highest category of each anthropometric measure (obese) to the lowest were similar and ≥ 
1.0.  Results from the sensitivity analysis estimated the effect of outcome misclassification 
was to bias our findings toward the null.  Calculation of the generalized impact fraction 
estimated that a hypothetical 30 % reduction in the prevalence of obesity would reduce 
incident HF by 6.7 % in the population. 
    Our findings do not support the superiority of a measure of central adiposity (WHR) over 
BMI for the prediction of incident HF.  A 6.7 % reduction in heart failure, the estimated 
impact of a 30 % reduction in obesity, would result in 44,220 fewer incident heart failure 
cases per year.  Such evaluations are vital to prioritize and inform future prevention programs 
regarding the possible impact of their efforts.    
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CHAPTER I 
SPECIFIC AIMS 
 
     This study aims to fulfill the following objectives:  1) quantify the association between 
overweight and obesity as measured by waist/hip ratio, waist circumference, and BMI with 
incident hospitalized heart failure; 2) compare the magnitude of association for these three 
anthropometrical measures as to their ability to predict heart failure; 3) assess the probable 
magnitude and direction of systematic error due to outcome misclassification; 4) determine 
the effect of outcome misclassification on the association between obesity and heart failure 
using a semi-automated probabilistic sensitivity analysis; 5) determine the population burden 
of incident heart failure that could be prevented if there were a hypothetical reduction in the 
distribution of obesity and overweight. 
 
Specific Aim 1   
Assess obesity/overweight as risk factors for the development of incident hospitalized heart 
failure.  This aim will be achieved by the following sub-aims: 
1.1:  Determine the hazard ratio for the association of obesity (as measured by BMI, 
waist/hip ratio, and waist circumference) with incident heart failure, while controlling 
for potential effect modifiers and confounders. Assess race as a potential effect 
modifier.   
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1.2:  Compare three anthropometrical measures (e.g. BMI, waist circumference, and 
waist/hip ratio) as to their ability to predict incident hospitalized heart failure. 
 
Specific Aim 2   
Assess the probable magnitude and direction of systematic error due to misclassification of 
the outcome of heart failure for the association of obesity with incident heart failure.  This 
aim will be achieved by the following sub-aims:   
2.1:  Determine a distribution for sensitivity and specificity as estimated from the 
literature for the definition of the outcome (incident HF) as defined by hospital 
discharge and death codes. 
2.2:  Perform a semi-automated probabilistic sensitivity analysis to estimate the degree 
of bias due to disease misclassification based on the chosen distribution of sensitivity 
and specificity.  Separate multivariable estimates of the odds ratio and its distribution 
will be obtained that include systematic error (from disease misclassification), random 
error and both. 
 
Specific Aim 3 
Assess the burden of incident heart failure that could be prevented if there were a reduction 
in the proportion of obesity and/or overweight.  This aim will be accomplished through the 
use of generalized impact fractions, a generalization of the attributable fraction.  We will 
assume several hypothetical changes to BMI distribution to determine the effect on the 
burden of heart failure.  
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3.1 Determine a range for the feasible reduction in the prevalence of obesity and 
overweight (as measured by BMI), based on the findings from the literature.   
3.2 Given several hypothetical scenarios based on the literature for the reduction in 
prevalence of obesity and overweight, and the magnitude of association between BMI 
and incident heart failure (as determined from the previous aims), the generalized 
impact fraction will be determined, overall and stratified race, gender, and age.  This 
will estimate the potential population-level impact of weight reduction on the incidence 
of heart failure.  
3.3 Determine the population attributable fraction for overweight/obese for the outcome 
of incident hospitalized heart failure. Compare this more commonly used measure to 
that of the generalized impact fraction.  
 
Rationale 
     This study adds to the existing literature on obesity and heart failure in several ways.  
First, the ARIC study will be the largest population-based cohort study to evaluate the 
association of waist/hip ratio and waist circumference with incident heart failure.  Also, since 
the ARIC cohort is a large biracial study, we will be able to evaluate race and gender as 
potential effect modifiers of these associations.  Second, to address the limitation of disease 
misclassification, we will use a novel approach to evaluate the effect of systematic error from 
disease misclassification.  Third, we will use the generalized impact fraction as an important 
tool to predict the population burden of disease due to obesity and overweight that could be 
prevented given an effective weight reduction intervention program. 
  
 
 
 
CHAPTER II 
 
BACKGROUND AND SIGNIFICANCE 
 
A. Public Health Burden of Heart Failure and Obesity 
     Heart failure is responsible for more hospitalizations than any other condition in those 65 
and older.  The temporal trend of heart failure (HF) indicates a steadily increasing population 
burden (Masoudi, Havranek et al. 2002).  Furthermore, the prevalence of heart failure is 
higher in U.S. blacks than in any other race group in the United States(Brown, Haldeman et 
al. 2005).  The primary risk factor for heart failure is coronary heart disease (CHD).  
Advances in medical care for CHD has resulted in longer survival time with CHD.  
Therefore, this emerging heart failure epidemic may partially be the result of the enlarging 
population with a history of CHD, in addition to the aging of the population in 
general(Braunwald 1997).  Unfortunately, there is a high rate of hospital re-
admission(Krumholz, Parent et al. 1997), and a poor prognosis associated with HF, such that 
between 25-33 % die within the first year following an incident HF hospitalization (Croft, 
Giles et al. 1999; Schellenbaum, Rea et al. 2004).   In 2006, the estimated cost of HF in the 
United States is projected to be $29.6 billion(Thom, Haase et al. 2006). 
     Study of the epidemiology of heart failure has been hindered by the lack of a standard 
definition to define it(Goldberg and Konstam 1999).  When present, the symptoms of heart 
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failure may include shortness of breath, fatigue and lower extremity edema which are not 
specific to heart failure.  Signs of heart failure include reduced left ventricular function which 
can be assessed in most hospitals by echocardiography; however, the cut-point at which one 
defines HF is not well standardized.  Originally, reduced LV function was thought to be a 
key component of the definition of HF, now it is understood that many people have HF with 
preserved LV function(Gottdiener, McClelland et al. 2002).     
     Risk factors for HF include advancing age, history of coronary heart disease, 
hypertension, male gender, and valvular heart disease(He, Ogden et al. 2001).  Overweight 
and obesity and its associated conditions, diabetes and even insulin resistance, have also 
recently been implicated as risk factors for HF(He, Ogden et al. 2001; Kenchaiah, Evans et 
al. 2002; Ingelsson, Sundstrom et al. 2005; Murphy, Macintyre et al. 2005).  This is alarming 
considering the rapidly increasing prevalence of obesity(2005).  Over the last few decades, 
the prevalence of obesity (BMI ≥ 30) in the United States has doubled.  Diabetes has shown a 
similar increase in prevalence which is largely attributed to the obesity trends(Ford, 
Williamson et al. 1997; Mokdad, Ford et al. 2000).  Current estimates from the National 
Health and Nutrition examination survey (NHANES) show that 31 % of U.S. adults are 
obese and 65 % are overweight; however these estimates vary across race-gender groups.  
The prevalence of obesity is highest (49.6 %) in African-American women, followed by 31.3 
% in white women, 28.9 % in black men and 28.7 % in white men(2005).         
     Obesity and overweight as measured by BMI have been identified as risk factors for heart 
failure from the Framingham Heart Study and other studies (Kenchaiah, Evans et al. 2002; 
Murphy, Macintyre et al. 2005).  Further support for the association of obesity with HF 
comes from echocardiographic studies in which obesity is an even stronger predictor of left 
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ventricular mass, a known HF predictor, than hypertension (Drazner, Rame et al. 2004).   
BMI is the only ponderosity metric to date to be assessed as a HF risk factor in a large 
population based study; the importance of measures of central adiposity (such as waist 
circumference and waist-hip ratio) as compared to BMI has yet to be studied in this setting.  
The increasing prevalence of both obesity and heart failure make this association an 
important topic for further investigation.   
 
B. Risk Factors for Heart Failure 
     Heart failure is a chronic disease with multiple co-morbid conditions and underlying risk 
factors.  Many of the risk factors associated with HF are preventable.  Risk factors identified 
in the Framingham Heart Study include advanced age, CHD, left ventricular hypertrophy, 
hypertension, valvular heart disease, diabetes and obesity; with hypertension having the 
strongest influence on the development of HF(Kannel, D'Agostino et al. 1999; Kenchaiah, 
Evans et al. 2002).  Heart failure risk factors identified from the New Haven, Connecticut 
cohort for the Established Population for Epidemiologic Studies of the Elderly program were 
previous myocardial infarction, male gender, older age, diabetes, pulse pressure and BMI ≥ 
28(Chen, Vaccarino et al. 1999).  More recent studies have found that insulin resistance, and 
retinopathy increase the risk of HF(Ingelsson, Sundstrom et al. 2005; Wong, Rosamond et al. 
2005).  The First National Health and Nutrition Examination Survey Epidemiologic Follow-
up Study (NHANES) estimated the population attributable fraction for the following heart 
failure risk factors: CHD 61.1 %, smoking 17.1 %, hypertension 10.1 %, low physical 
activity 9.2 %, male gender 8.9 %, less than high school education 8.9, overweight 8.0, 
diabetes 3.1 % and valvular heart disease 2.2%(He, Ogden et al. 2001).  Studies have been 
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consistent in finding that many of the HF risk factors are also risk factor for atherosclerotic 
disease.   It is likely that risk factor profiles differ depending on whether the etiology is 
ischemic or non-ischemic, although there is little data to support this.   Furthermore, the 
distribution of risk factors for HF is believed to vary by race.  Results from the National 
Heart Failure Project found that hypertension and diabetes were more common co-morbid 
conditions in blacks hospitalized with HF than whites, whereas CHD was a more common 
co-morbidity in whites(Rathore, Foody et al. 2003).      
 
C. Obesity as a Risk Factor for Heart Failure 
     Obesity may cause heart failure through both direct and indirect mechanisms.  These are 
displayed in Figure 1 below by Vasan(Vasan 2003).  The indirect mechanisms are those in 
which obesity causes other diseases, i.e. diabetes, hypertension, hyperlipidemia, and renal 
disease that then result in atherosclerotic disease, ie myocardial infarction or neurohormonal 
changes thus leading to heart failure.  The direct pathway refers to the direct effects of 
increased adipose tissue on vascular structures and is described in the figure as lipoendocrine 
changes.  Both direct and indirect mechanisms will be discussed below.  
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Figure 1.  Direct and indirect mechanisms through which obesity can lead to heart failure, adapted from 
RS Vasan(2003)(Vasan 2003) 
  
 
Direct effects of excess adipose tissue  
     Independent of co-existing CHD risk factors, cardiac adaptation to excess body fat may 
result in decreased cardiac function(Poirier, Giles et al. 2006).  This has been termed obesity 
cardiomyopathy.  Possibly the first case study of obesity cardiomyopathy was in 1847 by 
William Harvey; he describes fatty adherences to the heart in an obese man with symptoms 
of orthopnea before his death(Ford 1950).  In 1933, Smith and Willius described the 
association between obesity and increased heart weight(Smith and Willius 1933).  This led to 
the next discovery that a mechanism through which obesity causes HF is via the development 
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of pulmonary hypertension, and right heart failure(Auchincloss, Cook et al. 1955).  The 
combination of obesity, right heart failure, and sleep apnea was termed the Pickwickian 
syndrome(Burwell, Robin et al. 1956).  For many years, pulmonary hypertension and right 
heart failure (cor pulmonale) was believed the only mechanism by which obesity causes 
HF(Alexander 1998); however in 1965 Amad et al found increased heart weight in morbid 
obesity was primarily due to left ventricular hypertrophy(Amad, Brennan et al. 1965).  
Hemodynamic studies followed in which obesity was linked to increased plasma volume, 
increased cardiac output(Alexander, Dennis et al. 1962), increased LV filling pressures and 
decreased LV compliance (de Divitiis, Fazio et al. 1981); furthermore, improvements in 
these hemodynamic changes were noted after weight loss(Alexander and Peterson 1972). 
These findings were then confirmed in echocardiographic studies(Alpert, Terry et al. 1985; 
Alaud-din, Meterissian et al. 1990; Lauer, Anderson et al. 1991).  Specifically, results from 
the Framingham Heart Study found a positive correlation between left ventricular chamber 
size as measured by echocardiography and severity of obesity as measured by BMI.  Another 
study reported positive correlations of left ventricular mass with waist/hip ratio and waist 
circumference (Rasooly, Sasson et al. 1993).   
     More recently, research from animal models have lent support to the cardiotoxic effects of 
fat cells(Zhou, Grayburn et al. 2000).  A process termed lipotoxicity has been described; it is 
the disruption of the usual mechanism that regulates triglyceride storage.  Normally 
triglycerides are stored in adipose cells, however when this process is disrupted then 
triglycerides may deposit in non-adipose cells causing cell death or dysfunction(McGavock, 
Victor et al. 2006).  This process, depicted below in Error! Reference source not found., is 
also theorized to also cause type 2 diabetes mellitus and nonalcoholic hepatic steatosis.  
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Another novel hypothesis is that an increase in inflammatory cytokines from excess 
adipocytes may increase risk of HF(Vasan, Sullivan et al. 2003; McGavock, Victor et al. 
2006). 
      Clinical manifestations of true obesity cardiomyopathy are not that common.  It is 
thought to occur most frequently amongst those with extreme obesity (BMI ≥ 40 kg/m2) of 
greater than 10 years duration(Kaltman and Goldring 1976).  Amongst this population, it is 
estimated that approximately 10 % develop circulatory congestion(Alexander, Amad et al. 
1962).  Therefore, the majority of heart failure associated with pre-existing obesity may be 
through indirect pathways.   
 
Figure 2.  Depiction of lipotoxicity, adapted from McGavock JM (2006)(McGavock, Victor et al. 2006) 
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Indirect effects of excess adipose tissue  
     More commonly, however, obesity leads to co-morbid conditions such as diabetes and 
hypertension that are also risk factors for heart failure.  These co-morbid conditions are also 
known CVD risk factors; therefore, it is likely that a common pathway from obesity to heart 
failure is through these intermediary diseases which then cause coronary heart disease and 
ischemic heart failure.  However, several of these secondary diseases have been found to 
cause heart failure independent of CHD.  For example, obstructive sleep apnea causes 
pulmonary hypertension and resulting right heart disease which can lead to heart failure.  
Also, diabetes mellitus, insulin resistance and the metabolic syndrome have all been 
identified as independent causes of heart failure.  Hypertension is known to cause left 
ventricular hypertrophy which can lead to heart failure.   
 
D. Studies of Obesity as a Risk Factor for Heart Failure  
     Studies investigating the association of obesity with HF are reviewed in the following 
section.  See Table 1, for a summary of these studies.  Most of these studies are in primarily 
white populations, or specific populations (ie, clinical trial participants with specific 
exclusion criteria), and BMI is the most commonly used anthropometric measure.    
 
The Framingham Heart Study 
     In a study from the Framingham Heart Study, Kenchaiah et al found that overweight and 
obesity was associated with an increased risk for the development of HF(Kenchaiah, Evans et 
al. 2002).  Weight was measured at the baseline visit by BMI.  Diagnosis of heart failure 
during follow-up was based on continuous surveillance for cardiovascular events followed by 
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committee adjudication using the Framingham Heart Study criteria for HF.  There were 
5,881 participants with a median follow-up of 14 years (mean age 55 years) and 496 cases of 
incident HF.  BMI was analyzed as both continuous and categorical.  After adjustment for 
potential confounders, the hazard ratio for incident heart failure was 1.06 (1.04-1.09 kg/m2) 
for a one unit change in BMI.  The multi-variable adjusted HR for HF for overweight (BMI 
25 – 29.9 kg/m2) and obese (BMI ≥30 kg/m2) as compared to normal weight (BMI 18.5 – 
24.9 kg/m2) were 1.34 (1.08-1.67 kg/m2) and 2.04 (1.59-2.63 kg/m2), respectively.  The 
results were similar for models with BMI and covariates treated as time-varying variables. 
     Effect measure modification was observed for both hypertension and myocardial 
infarction at baseline.  They found that the HR for the trend across categories of BMI was 
lower in those with hypertension (HR = 1.30, 1.11-1.52) than in those without hypertension, 
(HR = 1.66, 1.33-2.07).  For those with myocardial infarction at baseline (N=148), there was 
no effect across categories of BMI (0.80, 0.5-1.30) for incident HF, although they were 
underpowered to detect a HR of 1.5 or less.  For those without myocardial infarction, the HR 
was 1.5 (95 % CI of 1.31- 1.71).  No effect measure modification was found for the 
following variables:  age, smoking status, gender, alcohol use, diabetes mellitus, or valvular 
heart disease.   
     The strength of this study is that it is extremely well characterized; such that the definition 
of heart failure is as close to a gold standard as there exists.  This cohort is almost exclusively 
white and upper class.  The size of the study is large, however may not be large enough for 
the inferences regarding effect modification.  Effect modification was observed for 
hypertension and myocardial infarction.  Unfortunately, BMI was the only metric of 
adiposity in this study.     
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First National Health and Nutrition Examination Survey (NHANES I) Epidemiologic 
Follow-up Study 
     The First National Health and Nutrition Examination Survey (NHANES I) studied the 
association of overweight as measured by BMI and incident heart failure(He, Ogden et al. 
2001).  There were 1,382 heart failure cases from 13,643 participants, age 25 to 74 years, 
followed for a mean of 19 years.  Heart failure was defined by the presence of an ICD-9 code 
‘428.0’ or ‘428.9’ from a hospitalization or death certificate.  Overweight was defined as 
BMI ≥ 27.8 for men and ≥ 27.3 for women.  The adjusted HR for overweight was 1.23 (1.00-
1.52) in men and 1.34 (1.10 – 1.64) in women.  These models were adjusted for age, race and 
time-dependent history of CHD.  They determined that the population attributable fraction of 
HF due to overweight is 8 % (5.6 % for men and 9.6 % for women).   
     This strength of this study is the large size; however, it is limited by the single type of 
anthropometric measurement and the definition of heart failure by ICD codes.  Potential 
effect modification by gender is an important finding.   
 
Health, Aging and Body Composition Study 
     The Health, Aging and Body Composition Study (Health ABC) is a longitudinal cohort 
study of those aged 70-79 without CHD(Nicklas, Cesari et al. 2006).  The association of 
multiple metrics of overweight/obesity and body composition with future HF events was 
studied.  Of 2,435 participants with 6.1 years of follow-up, there were 166 cases of HF.  A 
diagnosis of heart failure was based on surveillance for heart failure followed by physician 
adjudication based on specific HF criteria.  Criteria for HF were met if any of the following 
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were present:  1) physician diagnosis of HF and treatment with diuretics and digoxin or a 
vasodilator, 2) pulmonary edema and cardiomegaly on chest x-ray, or 3) decreased systolic 
function by echocardiography or ventriculography.  This study had multiple measures of 
body composition with dual-energy x-ray absorptiometry and computed tomography to 
measure visceral adipose tissue; in addition to traditional anthropometric measures of BMI, 
waist circumference and waist/thigh ratio were measured.  All of the adiposity measures were 
significant predictors of heart failure in adjusted Cox models.  In addition, models for waist 
circumference included BMI and fat mass still found waist circumference an independent 
predictor of HF.   They also found a significant interaction for gender in terms of the waist to 
thigh ratio.  In men the waist to thigh ratio was significantly associated with HF (HR = 1.33, 
1.11-1.60), whereas in women it was not (HR = 1.06, 0.86-1.30).   
     Additional adjusted models considered both overweight/obese (BMI ≥ 25 kg/m2 or not) 
and high waist circumference (≥ 102 cm for men, ≥ 88 cm for women) as dichotomous 
variables.  There was no significant association of overweight/obese with heart failure with 
BMI measured with this cut-point, however there was a significant association of high waist 
circumference with heart failure (HR = 1.91, 95 % CI = 1.32 – 2.75).  This relationship 
remained significant after adjustment for obesity status.  The authors concluded that it is the 
location of fat tissue that is important in predicting future HF; specifically, waist 
circumference was the most robust predictor of HF.   
     This is a very well characterized cohort in terms of the variety of anthropometric and body 
fat distribution measurements, however this study is not generalizable to those with coronary 
heart disease, as they were excluded at baseline.  Unfortunately, a large proportion of those 
who develop heart failure have pre-existing CHD; this may be one reason for the limited 
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sample size (N = 166).  Although approximately 50 % of the participants were black, it is 
unlikely that the study was adequately powered to make inferences by race and gender.  
Also, this study only included those between 70-79 years of age, therefore these associations 
may not be generalizable to a younger age group. 
   
The Renfrew-Paisley Study 
     A community based study from Renfrew and Paisley, Scotland observed 15,402 
participants aged 45-64 years beginning in 1972(Murphy, Macintyre et al. 2005).  Heart 
failure was defined by ICD codes (ICD 425.4, 425.5, 428, 402) from hospital and death 
records, and was not necessarily incident.  BMI was the only anthropometric measure. They 
found 641 HF cases over 20 years of follow-up.  The crude HR for a one unit increase in 
BMI is 1.06 (1.04-1.08).  In an adjusted model including diabetes, cholesterol level, and 
hypertension, obesity (BMI ≥ 30 kg/m2 as compared to BMI 18.5-24.9 kg/m2) was an 
independent risk factor for men 2.16 (1.57-2.57) and less so for women 1.37 (1.00-1.88).   
     This study is limited by the single type of anthropometric measurement, and the 
homogeneity of this Scottish population.  In addition, HF was necessarily incident.  As in the 
NHANES study above, they found effect modification by gender.   
 
Uppsala Longitudinal Study of Adult Men  
     This community based cohort from Uppsala, Sweden investigated both insulin resistance 
and obesity as predictors of incident HF(Ingelsson, Sundstrom et al. 2005).  There were 104 
incident hospitalized heart failure cases from 1,187 elderly men (70 years and older) over a 
median follow-up of 8.9 years.  Heart failure cases were initially identified by an ICD code 
 16 
 
(‘428’, ‘I50’ or ‘111.0’) and then validated with physician adjudication using the 
classification scheme from the European Society of Cardiology(1995).  Insulin sensitivity 
was measured with the euglycemic insulin clamp technique and anthropometric variables 
were BMI and waist circumference.  Hazard ratios were estimated for a one standard 
deviation change.  Multivariable models were adjusted for diabetes, prior acute MI, 
hypertension, smoking, left ventricular hypertrophy by electrocardiography, and serum 
cholesterol.  They found that BMI (HR 1. 37, 95 % CI = 1.12-1.68) and waist circumference 
(HR 1.40, 95 % CI = 1.13-1.74) were important predictors of HF in a multivariable model, 
however this relationship was no longer significant when clamp glucose disposal rate was 
included in the model (HR for BMI = 1.17, 95 % CI = 0.92-1.50) and (HR for waist 
circumference = 1.18, 95 % CI = 0.88-1.53).  They found similar results sub-samples without 
diabetes and without obesity and in models that included interim MI. 
     This study was in a very specific population, elderly Swedish men, therefore it is 
uncertain if these results are generalizable to women, younger age groups or other ethnic 
groups.  This is the largest study to date to report on insulin sensitivity as measured by a 
euglycemic clamp and heart failure.  The results of this study imply that the relationship 
between obesity and heart failure is largely mediated by insulin resistance.   
 
Other studies 
     The New Haven, Connecticut cohort of the Established Population for Epidemiologic 
Studies of the Elderly program reported on the association of obesity in 173 heart failure 
cases from 1,749 participants free of CHD; however BMI was based on self-report of height 
and weight(Chen, Vaccarino et al. 1999).  Heart failure was based on applying specific 
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criteria to the review of medical records with HF code.  The HR for categorized BMI with 
baseline risk factors in the model was of borderline significance.  This study is limited by the 
self-reported BMI.   
     Predictors of HF were studied amongst women (N =2,391) participating in the Heart and 
Estrogen/Progestin Replacement Study (HERS)(Bibbins-Domingo, Lin et al.).  The HERS is 
a randomized controlled trial of hormone therapy in women with known CHD.  HF was 
defined by hospitalization or death as discovered from routine surveillance and then validated 
by committee adjudication.  There were 237 cases over a mean follow-up of 6.3 years.  The 
adjusted HR for obese participants (BMI >35 kg/m2) compared to those of normal weight 
(BMI 18.5 - 25 kg/m2) was 1.9 (95 % CI = 1.1-3.0).  This study is small and includes only 
women with known CHD.  Also, this is a population participating in a randomized controlled 
trial which is likely healthier than the general population.   
     The Heart Outcomes Prevention Evaluation (HOPE) study is a randomized controlled trial 
assessing the use of an angiotensin-converting enzyme inhibitor (ramipril), vitamin E, or 
their combination in reducing CVD events(Dagenais, Yi et al. 2005).  This study only 
included high risk patients for CVD events; participants must have had CVD or diabetes plus 
one other CVD risk factor.  The population (N=8,802) was 75 % male.  There were 297 HF 
cases over a median follow-up of 4.5 years.  HF defined as a hospitalization with clinical or 
radiographic signs of congestion.  They did not find that BMI or waist/hip ratio were 
significant predictors of heart failure in a fully adjusted model; however when stratified by 
gender, waist hip ratio was a significant predictor of heart failure in women only (HR = 2.30, 
95 % CI = 1.25-4.21).  Also, the hazard ratio for the highest tertile of waist circumference 
compared to the lowest tertile was 1.38 (95 % CI = 1.03- 1.85); however when BMI was 
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added to the model these findings were no longer significant.  There are two main limitations 
of this study which reduce it’s generalizability:  1) the use of tertiles to define cut-points for 
the main exposures are not recommended especially when recommended category 
boundaries are available(Greenland and Rothman 1998), and 2) the population is high-risk 
male participants in an randomized controlled trial (RCT).   
 
Summary 
     Nearly all of these studies find a significant association between obesity and heart failure.  
Only three studies have waist circumference in addition to BMI; however, these particular 
studies are not population-based(Dagenais, Yi et al. 2005; Ingelsson, Sundstrom et al. 2005; 
Nicklas, Cesari et al. 2006), and instead are in very specifically defined populations.  
Waist/hip ratio was an anthropometric measure in only one study(Dagenais, Yi et al. 2005), 
although a similar measure of waist/thigh ratio was used in another study(Nicklas, Cesari et 
al. 2006).  Future studies should assess BMI and WHR and compare their predictive ability.  
Also, most of these populations are primarily white, such that inferences by race were not 
possible. Gender (He, Ogden et al. 2001; Murphy, Macintyre et al. 2005; Nicklas, Cesari et 
al. 2006) was found to be an effect modifier; therefore, we have stratified by gender in this 
dissertation.  
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Table 1.  Summary table of studies of obesity as a predictor of heart failure 
 
Author, year Study Population Anthropometric 
Measures 
Outcome Definition Limitations 
Kenchaiah, 2002 491 cases from 5,881 participants, cohort study from 
Framingham, Mass., mostly white, mean age 55 
BMI Adjudicated incident heart 
failure 
BMI only metric, 
largely white 
cohort 
Chen, 1999 173 cases from 1,749 participants from the New Haven, 
Connecticut cohort in the Established Population for 
Epidemiologic Studies of the Elderly, community based 
cohort, aged 65 years and older, free of CHD, 18 % 
black participants 
BMI, based on self 
report of height and 
weight 
Incident hospitalized heart 
failure based on chart 
review  
Self reported 
BMI, mostly 
white cohort 
Nicklas, 2006 166 cases from 2,435 participants in the Health ABC 
(Aging and Body Composition) study, cohort study of 
those 70-79 years without CHD, biracial (black/white) 
BMI, waist 
circumference, 
waist/thigh ratio, 
dual-energy x-ray 
absorptiometry, 
CT scans  
Adjudicated incident heart 
failure 
Limited sample 
size, free of CHD 
at baseline 
He, 2001 1,382 cases from13,643 participants in First National 
Health and Nutrition Examination Survey (NHANES), 
25 to 74 years of age 
BMI First listing of ICD-9 code 
‘428’ from a hospitalization 
or UCOD on death 
certificate 
BMI only metric, 
non-adjudicated 
definition for HF  
Murphy, 2005 641 cases from 15,402 participants in the Renfrew-
Paisley study, 45-64 years of age from Scotland 
BMI Heart failure ICD codes 
from a hospitalization or 
death certificate 
BMI only metric, 
non-adjudicated 
definition for HF 
Bibbins-
Domingo, 2004 
237 cases from 2,391 women with known CHD 
participating in the Heart and Estrogen Replacement 
Study (HERS), randomized controlled trial of estrogen 
replacement therapy 
BMI Adjudicated incident heart 
failure 
BMI only metric, 
only women, 
RCT, small 
sample 
Dagenais, 2005 297 cases from 8,802 participants in the Heart Outcomes 
Prevention Evaluation (HOPE) study, high risk patients 
for CVD events, 75 % male, randomized controlled trial 
of ACE inhibitor (ramipril) and vitamin E 
BMI, waist 
circumference, 
waist/hip ratio 
Adjudicated incident heart 
failure 
RCT, included 
only high risk 
patients 
Ingelsson, 2005 104 cases from 1,187 participants in the Uppsala 
longitudinal study of adult men, a community based 
observational cohort from Sweden, 70 years and older 
BMI, waist 
circumference 
First hospitalized heart 
failure, adjudicated 
All men, largely 
white cohort 
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E. Validation Studies of ICD codes to Define Heart Failure 
 
     Hospital discharge codes are based on the International Classification of Diseases (ICD) 
system which was created primarily for administrative rather than epidemiologic purposes.  
Despite this, ICD codes are often used in large epidemiologic studies to define disease, when 
the gold standard may not be feasible(He, Ogden et al. 2001; Murphy, Macintyre et al. 2005).  
Unfortunately, the gold standard of committee adjudication is expensive and time 
consuming; also, there are not clearly agreed upon criteria to define heart failure(Goldberg 
and Konstam 1999).  One reason for misclassification from the use of ICD codes are their 
linkage to hospital reimbursement.  In particular, heart failure as a complication during a 
hospitalization can significantly increase the Medicare reimbursement associated with that 
hospitalization(Psaty, Boineau et al. 1999).  Therefore, there is a financial incentive for 
hospitals to “up-code” or to list a heart failure ICD codes.  As a result, studies have tried to 
determine the amount of misclassification of heart failure when diagnosed by ICD codes.  
These validation studies are reviewed below (see summary in Table 2). 
 
Corpus Christi Heart Project  
     The Corpus Christi Heart Project is a population-based study with the main goal of 
surveillance for hospitalized coronary heart disease; therefore, these hospitalizations included 
those for definite and possible myocardial infarction, aortocoronary bypass surgery, and 
transluminal coronary angioplasty(Goff, Pandey et al. 2000).  This data was used to 
determine the frequency and validity of ICD codes for heart failure.  Surveillance took place 
in Nueces County, Texas with a population of 291,145 in 1990 for which there were 5,083 
hospitalizations with possible heart failure.  Heart failure cases were validated based on 
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criteria of a physician diagnosis of acute heart failure or evidence of pulmonary edema on 
chest x-ray.   
     The overall prevalence of a heart failure ICD code was (1197/5083) 23.5 %, whereas the 
most frequent heart failure ICD code was ‘428’ with a prevalence of 20.4 % (1,035/5,083), 
this was followed by 402.x1 (hypertensive heart disease with congestive heart failure) with a 
prevalence of 2.6 %.  All other heart failure ICD codes had a prevalence of less than 1 %.  
The test characteristics of code ‘428’ were as follows:  sensitivity = 62.8 % (864/1376), 
specificity = 95.4 % (3536/3707), positive predictive value = 83.5 % and negative predictive 
value = 87.4 %; whereas, the test characteristics for any HF ICD code were:  sensitivity = 
67.1 % (923/1376), specificity = 92.6 % (3433/3707), positive predictive value = 77.1 %, and 
a negative predictive value = 88.3%.  The sensitivity was higher, but the specificity was 
lower when all of heart failure ICD codes were used. 
     This study is a large population-based validation study of ICD codes for heart failure in 
those with a co-existing ICD code for coronary heart disease; therefore, it is likely that the 
resulting test characteristics are not generalizable those without CHD.  It is notable that ICD 
code ‘428’ is the most frequently used HF code and it is more specific than when combined 
with all other HF codes.   
 
The Cardiovascular Health Study  
     In the Cardiovascular Health Study (CHS) 5,888 adults 65 years and older were followed 
from 1989 to 2000 during which there were 1,209 incident heart failure hospitalizations 
(1,072 had an ICD-9 diagnostic code for HF)(Schellenbaum, Heckbert et al. 2006).  They 
used the following ICD-9 discharge codes to identify potential cases:  428 (heart failure), 
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398.91 (rheumatic heart failure), 425 (cardiomyopathy), 402.01, 402.11, 402.91 
(hypertension with heart failure), and 997.1 (cardiac failure postoperatively).  They only 
included those that survived hospitalization.  Of these discharge codes, code ‘428’ was the 
most frequent at 70.6 percent of the events followed by code 997.1 for “cardiac failure 
postoperatively” (11.6 %).  These potential cases were then validated with committee 
adjudication using criteria created by the CHS.  The CHS criteria required a physician 
diagnosis of heart failure in addition to supporting evidence of any of the following:  heart 
failure signs and symptoms, pulmonary edema on chest x-ray or evidence of treatment for 
heart failure.   
     Using only the ICD-9 code ‘428’, there were 523 cases that were adjudicated as heart 
failure, leaving 364 individuals with a code ‘428’ that were not considered heart failure after 
adjudication.  The test characteristics of a code ‘428’ by the CHS criteria are as follows:  
sensitivity = 0.71, specificity = 0.925, positive predictive value = 0.59 and negative 
predictive value = 0.96.  Mortality was selected as a surrogate endpoint for predictive validity 
of these HF identification methods.  Mortality was not significantly different across these two 
methods of HF event definition.  Also notable considering the proposed dissertation, BMI did 
not vary across the type of event definition (ie adjudication vs. discharge diagnosis).  
     This is a well done validation study from a large population-based cohort.  The only 
issues that decrease generalizability to other population-based studies are the older age group 
(65 years and older) and the exclusion of those who died during hospitalization.  It is 
interesting that mortality did not vary by method of case definition.  This implies that the 
distinction between validated and non-validated groups is not clinically relevant.   
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Olmsted County, Minnesota 
     A study from Olmsted County, Minnesota primarily on incidence and survival also tested 
the accuracy of ICD codes for a heart failure by validation with 2 sets of criteria, 
Framingham and specific clinical criteria.(Roger, Weston et al. 2004)  This is community-
based open cohort with 22 years of follow-up.  There were a large proportion of potential 
cases (26 %) that were outpatient only.  They found 7,298 (80%) of those identified as 
potential cases had an ICD code ‘428’, whereas only 1,877 potential cases were identified by 
other HF codes without an accompanying ‘428’ (these other codes were 402.01, 
‘hypertensive heart disease malignant with congestive heart failure’, 402.11, ‘hypertensive 
heart disease benign with congestive heart failure’, 425, ‘cardiomyopathy’, 429.3, 
‘cardiomegaly’, and 514, ‘pulmonary congestion’).  First, they validated these potential cases 
by applying the Framingham criteria using committee adjudication.  They found that 82 % of 
potential cases with a ‘428’ code met Framingham criteria, whereas only 14-30 % of the 
other HF ICD codes (without an associated ‘428’) met Framingham HF criteria.  Next, they 
validated with clinical criteria of a physician diagnosis of heart failure.  In this case, 90% of 
code ‘428’ had a physician diagnosis of heart failure, whereas only 14-36 % of the other 
codes (without a ‘428’) met clinical criteria.   They found that secular trends for incidence 
and survival were similar between the Framingham and clinical criteria.   
     This study provided estimates of the positive predictive value for two sets of criteria from 
an open cohort.  The Framingham criteria identified fewer cases than the clinical criteria.  
Positive predictive value was estimated for code ‘428’ and all codes combined.  The 
inclusion of outpatient cases is unique amongst these validation studies.   
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Women’s Health Initiative (WHI) 
     A study from the observational cohort of the Women’s Health Initiative (WHI) tested the 
accuracy of diagnostic codes to local adjudication(Heckbert, Kooperberg et al.).  Heart 
failure was defined by the following criteria:  symptoms and signs of HF and either 
pulmonary edema by chest x-ray, documented dilated ventricle or decreased ventricular 
function, or physician diagnosis of HF and receiving medical treatment(Curb, McTiernan et 
al. 2003).  There were 93,676 post-menopausal women in the observational cohort of which 
1,241 were hospitalized with an ICD 9 code ‘428’; of these codes, only 603 were validated as 
HF by local adjudication using a standard definition developed by the WHI.  The positive 
predictive value of an ICD code 428 was estimated as 48.6 %.  They also validated ICD code 
425 (N = 134) and found the PPV was a little lower at 45 %.   The main limitation of this 
study was that participants were all female; in addition, participants were mostly upper class 
and from urban areas.  Compared to other validation studies, this one was not population-
based. 
 
National Registry for Atrial Fibrillation 
     A study from the National Registry for Atrial Fibrillation II evaluated the accuracy of ICD 
codes for co-morbid conditions including HF(Birman-Deych, Waterman et al. 2005).  This 
registry includes patient information from 23,657 Medicare beneficiaries representing 3,586 
hospitals in all 50 states.  Mean age was 79 years of age.  There were 11,014 heart failure 
cases based on medical record review for both chronic and current heart failure.  They 
included any of the following ICD-9 codes in any position in the hospital claims data:  428.x, 
398.91, 402.01, 402.11, 402.91, 404.01, 404.11, 404.91, 404.03, 404.13, and 404.93.  They 
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estimated the following test characteristics based on current or past HF events:  sensitivity = 
0.76, specificity = 0.97, positive predictive value = 0.97 and negative predictive value = 0.74.  
When past HF was excluded, then the specificity (0.86) and PPV (0.85) were lower, and the 
sensitivity was higher (0.83).   
     One would expect a higher positive predictive value for a heart failure ICD code in a 
population with atrial fibrillation, since this arrhythmia is even a component of some HF 
diagnostic criteria(Eriksson, Caidhal et al. 1987).   Unfortunately, test characteristics were 
not presented for ICD code ‘428’ only.      
 
Summary 
     These five validation studies provide insight into misclassification rates of ICD codes for 
heart failure.  Unfortunately, there is no gold standard to define heart failure; therefore, the 
diagnostic criteria vary by study.  In the proposed dissertation, there are no internal validation 
studies from which to develop these estimates.  Four of the above studies found that ICD 
code ‘428’ was by far the most frequently documented ICD code for heart failure(Goff, 
Pandey et al. 2000; Heckbert, Kooperberg et al. 2004; Roger, Weston et al. 2004; 
Schellenbaum, Rea et al. 2004; Schellenbaum, Heckbert et al. 2006).  In fact, most of the 
other heart failure ICD codes occurred with a co-existing ‘428’.  In addition, an ICD code 
‘428’ was more specific than when all of the ICD codes were included; therefore, the 
proposed study only included ICD code ‘428’ as diagnostic criteria for heart failure.  
Estimates of sensitivity and specificity from these validation studies will be used in a 
sensitivity analysis for disease misclassification.   
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     The proposed study will use the ARIC population, which is a large population based 
cohort of men and women between 45 and 64 years of age.  The above validation studies 
differ from the ARIC cohort in the following ways:  1) the Corpus Christi Heart Study and 
the National Registry for Atrial Fibrillation are high-risk populations; 2) the WHI include 
only women; 3) Olmsted County includes a proportion of outpatient cases; and 4) the CHS is 
an older population.  The CHS followed by the Corpus Christi Heart Study has the most 
similarities to the ARIC study, and provides estimates of sensitivity and specificity for an 
ICD code ‘428’; therefore, the results of this studies would receive the highest priority in 
selecting estimates for a sensitivity analysis.   
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Table 2. Summary table of validation studies of ICD codes to define heart failure 
First author, year Study Population Validation criteria Results 
Goff, 2000 Corpus Christi Heart Project, included 
hospitalizations for definite or possible MI, 
aortocoronary bypass surgery, and transluminal 
coronary angioplasty, population-based, 5,083 
hospitalizations with possible heart failure 
Physician diagnosis of acute 
HF or pulmonary edema on 
chest x-ray 
For ICD code ‘428’: 
Sensitivity: 62.8 % (864/1376) 
Specificity: 95.4 % (3536/3707) 
PPV: 83.5 % (1035) 
NPV: 87.4 % (4048) 
Schellenbaum, 2005 Cardiovascular Health Study, population-based 
study, 65 years and older, 1,209 with possible 
incident heart failure 
Physician diagnosis of HF, in 
addition to any of the 
following:  HF signs or 
symptoms, pulmonary edema 
on chest x-ray or evidence of 
treatment for HF 
For ICD code ‘428’: 
Sensitivity:  71 % 
Specificity:  93 % 
PPV:  59 % 
NPV:  96 % 
Roger, 2004 Olmsted county, Minnesota, population-based 
open cohort, included 26 % outpatient only cases, 
4,537 possible incident heart failure cases 
Tested 2 criteria 
Framingham and  
Physician diagnosis of HF 
For ICD code ‘428’: 
Framingham criteria: 
PPV: 82% 
Clinical criteria: 
PPV: 90% 
Heckbert, 2004 Women’s Health Initiative, 93,657 post-
menopausal women in the observational cohort, 
1,241 participants with a code ‘428’ 
Symptoms/signs of HF and 
either pulmonary edema by 
chest x-ray, documented dilated 
ventricle/decreased ventricular 
function, or physician diagnosis 
of HF and receiving medical 
treatment 
For ICD code ‘428’: 
PPV:  49 % 
For all ICD codes: 
Sensitivity:  79 % 
PPV:  45 % 
Birman-Deych, 2005 National Registry for Atrial Fibrillation II,  
23,657 Medicare beneficiaries with an ICD code 
for atrial fibrillation, incident and recurrent HF 
Chart review for mention of 
current or history of heart 
failure 
For all HF ICD codes: 
Sensitivity:  76 % 
Specificity:  97 % 
PPV:  97 % 
NPV:  74 % 
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F. Methods to Adjust for Bias  
     Some degree of misclassification is common in observational studies; however, bias due 
to misclassification is rarely quantified.  The conventional approach to the presentation of 
uncertainty in the scientific literature is the 95 % confidence interval; although, confidence 
intervals only quantify residual random error(Poole 2001).  Unfortunately, the confidence 
interval is often misinterpreted to represent all sources of error (Greenland 2001).  Currently, 
the standards for publishing in most journals do not include the need to go beyond the 
uncertainty of random error.  Sensitivity analyses attempt to quantify the effect of bias on the 
results of a study.  These techniques have not yet reached the mainstream; however, several 
epidemiologists have called for a more thorough presentation of the uncertainty inherent in 
scientific research(Maclure and Schneeweiss 2001; Greenland 2005).  In fact, a journal 
named ‘Epidemiologic Perspectives & Innovations’ was created in 2004 inviting the 
exploration of such issues(Phillips, Goodman et al. 2004).  The editors request submission of 
research that expresses “full and proper disclosure of uncertainty in study results” and 
explores “decision making in the face of this full disclosure”(Maldonado and Phillips 2004). 
     A simple sensitivity analysis for misclassification is to back-calculate the expected results 
given a plausible set of specific estimates for sensitivity and specificity(Greenland 1998).  
This method does not consider the likelihood of each set of values(Phillips 2003).  In 
addition, the presentation of such results requires a table rather than a more succinct 
summary.  Recently computer intensive methods have been created using Monte Carlo type 
sensitivity analyses (Lash and Fink 2003; Fox, Lash et al. 2005).  One such software program 
uses SAS software to iteratively change individual level data for the biased parameter, while 
maintaining covariate data such the conventional regression analysis can be performed.  This 
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type of incorporation of uncertainty into regression analysis is called a Monte Carlo Risk 
Assessment (MCRA) or Monte Carlo uncertainty analysis.  Such an analysis requires the 
statement of a prior distribution for each sensitivity parameter which should include an 
explicit rationale for the priors(Greenland 2001).  More specifically, an MCRA can 
iteratively sample for multiple pairs of sensitivity parameters from the input distribution, then 
create modified datasets for each set of parameters, and then re-run the conventional 
regression for each modified dataset.  A summary of the distribution of the effect estimates 
obtained from each modified dataset can be presented graphically, or with 95 % “uncertainty 
intervals” by taking the 2.5th and 97.5th percentiles from this distribution.     
     This is an improvement over older sensitivity analysis methods for the following reasons:  
1) a distribution of sensitivities and specificities can be specified, such that the likelihood of 
each set of values is taken into account; 2) the distribution of sensitivities and specificities 
are used to create modified datasets for analysis with conventional regression, such that a 
summary distribution of effect estimates is created; 3) concise summarization of results can 
be presented that account for random error, systematic error and both; 3) the magnitude of 
multiple sources of bias (i.e., from the exposure, outcome or covariates) can be considered in 
one analysis that still results in concise summary statistics and graphs.  This technique is 
useful for the proposed study as we would like to consider the effect of misclassification of 
the outcome (incident heart failure).  After specifying a distribution for the bias due to 
outcome misclassification, then we will have a new summary statistics to compare with the 
conventional analysis.   
      In an article by Lash and Fink(Lash and Fink 2003) entitled, ‘semi-automatic 
probabilistic sensitivity analysis to assess systematic errors in observational studies’, the 
authors introduce a methodology for sensitivity analysis.  An example is given in which the 
conventional survival analysis results are compared with the results of sensitivity analyses of 
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multiple biases.  They evaluated 3 types of systematic error (selection bias, misclassification, 
and confounding).  These three types of systematic error are analyzed independently and all 
together; next random error is incorporated into each analysis (See below).  The end result is 
the inclusion of all sources of error in the bottom right three columns such that the simulated 
median is 1.52 with 95 % uncertainty intervals of 0.81-2.81; which can be compared to the 
conventional hazard ratio of 2.0 with 95 % CI of 1.2-3.4.  The relative impact of each source 
of error can be visualized in the below in Error! Reference source not found..  In this 
figure, the dotted/dashed line represents the results from the sensitivity analysis including all 
3 sources of systematic error, the dotted line represents the results of the conventional 
analysis, and the solid line represents the combination of systematic and random error from 
the bootstrapped samples.  The availability of high performance software has facilitated this 
advancement in multiple bias modeling, however such techniques are not often used.  We 
suggest the use of this methodology for the analysis of systematic error in the proposed 
study.  From Error! Reference source not found. and  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3, one can envision how the results of such an analysis might appear.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. An example of the succinct summarization of results from a semi-automated  
probabilistic sensitivity analysis, from Lash and Fink(Lash and Fink 2003)  
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Figure 3.  Graphic representation of the results summarized in  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. An example of the succinct summarization of results from a semi-automated, From Lash and 
Fink(Lash and Fink 2003) 
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G. Impact measures of risk factor-disease associations 
     In epidemiology we most often study the association of a given exposure with a disease.  
Once a potentially causative association is found with a modifiable exposure then we want to 
determine the burden of disease that could be prevented given the implementation of 
available interventions to modify the exposure.  This latter part allows prediction of the 
possible public health impact of programs to reduce or eliminate a given exposure.  The 
primary impact measure used in practice is the population attributable fraction (also known 
as, attributable risk).  The attributable fraction, introduced by Levin in 1953(Levin 1953), is 
often misused and/or misinterpreted(Rockhill, Newman et al. 1998). It estimates the 
proportional reduction in disease given complete elimination of an exposure.  For many 
exposures complete elimination is impossible or highly unlikely(Benichou 2007).  Obesity 
and overweight is an exposure that is unlikely to be eliminated.  Despite this, the attributable 
fraction has been used extensively in the recent articles attempting to estimate the burden of 
deaths attributable to overweight and obesity(Flegal, Graubard et al. 2004; Flegal, Graubard 
et al. 2005).  A more useful calculation for risk factors such as obesity is the generalized 
impact fraction, also known as the potential impact fraction and the generalized attributable 
fraction(Benichou 2001; Rodgers, Ezzati et al. 2004).  It is a generalization of the attributable 
fraction which estimates the proportional reduction in disease incidence given a reduction in 
prevalence of a given risk factor.  These calculations are often stratified by important 
confounders, allowing the identification of subgroups with particularly high impact that can 
be targeted for intervention.   For common risk factors such as obesity and overweight, the 
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impact of intervention will likely reveal important changes in the burden of disease even 
when risk factor-disease associations are relatively weak(Morgenstern and Bursic 1982).   
   
Generalized impact fraction 
     The generalized impact fraction was originally described by Walter in 1980(Walter 1980), 
then further elucidated and coined by Morgenstern and Bursic in 1982(Morgenstern and 
Bursic 1982).  It is “the proportional reduction in the total number of new (incident) cases of 
a certain disease, resulting from a specific change in the distribution of a risk factor in the 
population at risk.”(Morgenstern and Bursic 1982).  Despite its introduction over 25 years 
ago, it hasn’t caught on as either a replacement for or as an additional measure to report with 
the attributable fraction.   
     Morgenstern and Bursic (1982) illustrate the use of the generalized impact fraction with 
an example of the impact of a hypothetical weight loss programs on the incidence of 
coronary heart disease(Morgenstern and Bursic 1982).  Here they reveal the above mentioned 
advantages of the identification of high risk subgroups and the likely unexpected impact of 
modest changes in the prevalence of obesity and overweight.  Morgenstern and Bursic 
discuss several key assumptions of the potential impact fraction.  A relative risk of the 
relationship under study will be needed to calculate the GIF.  It is assumed that it is a valid 
estimate of the relationship between exposure and disease for the desired target population, 
and is therefore, not biased by confounding or misclassification.  Also, we assume that those 
who are hypothetically shifted to a different risk group post-intervention, now have the same 
risk that this group had pre-intervention.  When this condition is not met then the potential 
impact fraction may overestimate the impact of the intervention.  Also, it is assumed there 
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are not secular trends in risk of disease that are not due to the intervention; and there are not 
secular trends in intermediary diseases, such as diabetes for obesity, that would effect the 
relationship between the exposure and disease.   
     Inherent in estimating the GIF, one must consider a counterfactual approach(Rodgers 
2002).  The theoretical minimum risk distribution would be the complete elimination of 
obesity, or for a continuous measure it would be the point of lowest risk on the distribution.  
However, it is more likely that there could be partial eradication of obesity.  There are 
multiple counterfactual situations that could be considered between the current and minimum 
distributions and these are called distributional transitions by the World Health Organization. 
Most likely to occur are small distributional shifts, such as 10 % or 20 % change.  Murray 
and Lopez introduce four types of counterfactual exposure distributions:  theoretical 
minimum risk, plausible minimum risk, cost-effective minimum risk, and feasible minimum 
risk.  In our case, we are interested in feasible minimum risk(Murray and Lopez 1999).  
Feasible means that the distribution change has been achieved in some population and is also 
possible for the current population.  A plausible distribution is imaginable, but rather may be 
possible for some society during some time period.    
 
Feasible goals for weight reduction  
     To determine feasible goals for weight reduction, we will consider results from previous 
weight-loss intervention studies and the goals set by the US Department Health and Human 
services in the Healthy People 2010 report.  Healthy People 2010 are a set of recommended 
health objectives to be achieved by the year 2010(2000).  Obesity and overweight are listed 
as high priority public health issues.  These goals are meant to serve as a basis from which to 
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develop US national, state and community plans for health improvement.  Specifically, their 
objective is to reduce the proportion of obese adults aged 20 years and older to 15 % from 
23% (25 % in females and 20 % in males, data from 1988-1994, age adjusted to year 2000).  
A second objective is to increase the proportion of adults at a healthy weight to 60 % from 42 
% (45 % in women, 38 % in men, data from 1988-1994, age-adjusted to year 2000).   
     Obesity and overweight are unfortunately increasing rather than decreasing(Rosamond, 
Flegal et al. 2007).  Many strategies for weight reduction exist, however all have limited 
effectiveness.  A meta-analysis by Franz et al categorized weight loss clinical trials into 8 
types of intervention:  diet and exercise, exercise alone, advice alone, meal replacements, 
very-low-energy diets, and weight-loss medications (orlistat and sibutramine)(Franz, 
VanWormer et al. 2007).  Results from this meta-analysis, which includes clinical trial 
completers with at least one year of follow-up, found that the mean weight loss was 5-8.5 kg 
(5-9%) at 6 months and stabilized at 4.5-7.5 kg (4.8-8 %) at 12 months.  A diet and exercise 
intervention would be most applicable for a population wide strategy.  Those in the diet and 
exercise group lost 7.6 kg at 12 months, whereas those in the diet-alone group lost 4.6 kg.  A 
systematic review of diet and exercise trials reported that a mean of 6.7 kg of weight loss was 
maintained after one year(Curioni and Lourenco 2005).  Based on these findings of those 
who completed one year of follow-up, it is apparent that at best only a modest weight 
reduction could be expected from a population wide intervention.    
 
H. Summary and public health significance 
     Heart failure and obesity are important healthcare issues that have increasing prevalence.  
Previous studies have found an association between obesity and heart failure; although most 
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of these studies used BMI as the sole metric of adiposity and were in primarily white 
populations, specific clinical trial populations or isolated community populations.  Insulin 
resistance is likely an important intermediary factor in the association between obesity and 
HF.  Waist hip ratio, a metric of central adiposity, is more closely associated with insulin 
resistance than BMI.  Selecting the best anthropometric for the prediction of HF could have 
public health implications for the screening and prevention of HF.  Currently, screening for 
obesity and overweight is primarily assessed with BMI, rather than waist circumference or 
WHR.  Further evidence supporting measures of central adiposity, rather than BMI, could 
eventually result in a shift in current practice patterns.   
     The magnitude of misclassification of heart failure due to the use of ICD codes has been 
quantified in several studies.  For large observational studies without committee validation, 
one method to adjust for disease misclassification is to perform a sensitivity analysis to show 
the effect of misclassification.  Approaches called multiple bias modeling allow the 
incorporation of various types of bias, either from the main exposure, outcome or covariates, 
into multivariate modeling using Monte Carlo techniques.  This study provides further 
example of how Monte Carlo Risk Assessment techniques can be used to succinctly 
summarize the possible effects of systematic error.  The application of this method has public 
health importance in providing further example of how the interpretation of results can easily 
include a sensitivity analysis which incorporates systematic error in addition to random error.  
For studies in which results will potentially change policy or alter patient care, it is vital that 
such estimates of uncertainty be considered in the interpretation of results.   
     We estimated the public health impact on the incidence of heart failure given a 
hypothetical and feasible reduction in the prevalence of obesity and/or overweight.  This will 
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provide further example of how this important measure, the generalized impact fraction, 
should be routinely used in practice for risk factors that are unlikely to be completely 
eradicated.  For common risk factors such as obesity and overweight, the impact of 
intervention will likely reveal important changes in the burden of disease even when risk 
factor-disease associations are relatively weak.  Such evaluations are vital to prioritize and 
inform future prevention programs regarding the possible impact of their efforts. 
 
  
 
 
 
 
 
 
 
 
 
CHAPTER III 
 
 
METHODS 
 
 
A. Study population 
     The ARIC cohort was recruited using probability sampling of those aged 45-64 from the 
following four US communities:  Forsyth County, North Carolina (includes Winston-Salem); 
the city of Jackson, Mississippi; the northwestern suburbs of Minneapolis, Minnesota; and 
Washington County, Maryland (includes Hagerstown).  The distribution of blacks and whites 
from each county is representative of the area (mostly white in Minneapolis and Washington 
County), except for Forsyth County in which blacks were over-sampled (15 %) and in 
Jackson where only blacks were sampled.  Response rates were 46 % in Jackson and between 
65-67 % for the other communities.  The design and rationale of the ARIC study 
(Investigators 1989) and the comparison between responders and non-responders (Jackson, 
Chambless et al. 1996) have been previously published.  The institutional review boards from 
each site approved the ARIC study; also, the institutional review board at UNC-Chapel Hill 
approved this dissertation.  All participants provided written informed consent.  
     Initially, a home interview was administered to all potential cohort members.  Those 
meeting criteria and interested in participating were provided an ARIC brochure and 
scheduled for their first examination.  Informed consent was obtained on the arrival of 
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participants to the local field center.  Staff members were certified in the appropriate method 
for obtaining consent.  The first portion of the examination was performed following a 12 
hour fast.  Cohort examinations took place every 3 years for 4 visits, beginning with the 
baseline visit in 1987-1989.  Between cohort examinations, a telephone questionnaire was 
administered yearly to identify intervening hospitalizations and deaths.  In addition, 
community-wide surveillance was performed to identify all cohort hospitalizations and 
deaths(Investigators 1989). 
 
B. Exclusion criteria  
     Racial groups not classified as white or black (N=48) and those missing anthropometry 
(N=33) were excluded.  In addition, those with prevalent heart failure at baseline were 
excluded from this analysis by the following criteria:  1) those answering “yes” to the 
following question:  “Were any of the medications you took during the last two weeks for 
heart failure?” (N = 83), or else 2) those with stage 3 or ‘manifest heart failure’ by applying 
Gothenburg criteria (N= 699), or 3) those who did not meet one of these 2 criteria, but were 
unresponsive to the HF medication question or any component of the Gothenburg criteria (N 
= 289).  The Gothenburg criteria are based on a study from Gothenburg, Sweden of men born 
in 1913(Eriksson, Caidahl et al. 1987).  It is composed of three scores:  1) cardiac, 2) 
pulmonary, and 3) therapy.  In order to have stage 3 heart failure, one must have a point from 
each category.  See Table 4, for a description of the Gothenburg criteria.  All current 
medications (taken within the last two weeks) were brought into the clinic and documented.  
Use of digoxin and diuretics was determined from these medication lists.  Atrial fibrillation 
was diagnosed by visual inspection of a 2 minute rhythm strip from leads V1, II and V5 using 
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standardized methodology(Vitelli, Crow et al. 1998).  All other components were determined 
by participant self-report.  After these exclusions, the total sample size was 14,690.   
Table 4.  Description of Gothenburg score 
 Gothenburg components 
Cardiac Coronary Heart Disease -1 point if ever, 2 points if within the last year 
Angina -  1 point if ever, 2 points if within the last year 
Leg edema – 1 point 
Shortness of breath at night – 1 point 
Rales on lung exam – 1 point 
Atrial fibrillation on ECG – 1 point 
Pulmonary History of bronchitis – 1 point 
History of asthma – 1 point 
Cough, phlegm or wheezing – 1 point 
Rhonchi on lung exam – 1 point 
Therapy Treatment with digoxin – 1 point 
Treatment with diuretics – 1 point 
 
 
C. Ascertainment of heart failure events     
     The following three methods were used for ascertainment of events during the follow-up 
period:  1) Participants were contacted annually by phone and interviewed about interim 
hospitalizations; 2) local hospitals provided lists of discharges with cardiovascular diagnoses 
and these were reviewed to identify cohort hospitalizations; and 3) health department death 
certificate files were continuously surveyed.  All discharge codes for cohort hospitalizations 
and listed causes of death from death certificates were recorded.  We used any listing of an 
ICD code for HF on a death certificate rather than HF listed as an underlying cause of death, 
because usually the cause of HF is listed as the underlying cause of death, rather than just 
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HF.  Therefore, many deaths due to HF would be missed using only a definition of HF as 
underlying cause of death.   
 
D. Incident heart failure event criteria 
 
     Incident HF was defined as the first occurrence of either:  1) a hospitalization which 
included an ICD-9-CM (International Classification of Diseases, 9th revision, clinical 
modification) discharge code beginning with ‘428’ in any position (N = 1,329) or else 2) a 
death certificate with an ICD-9 code beginning with ‘428’ (HF) or ICD-10 code ‘I50’ (HF) in 
any position (N = 76).  Follow-up time for those with an incident HF event was defined as 
the time from the date of their baseline examination (1987-1989) until the incident event 
(follow-up through Dec. 31st, 2003).  The end of follow-up time for those without HF was the 
first occurrence of either:  1) December 31st, 2003, 2) date of last contact for those lost to 
follow-up, or 3) date of death.   
 
E. Anthropometric measures  
     Anthropometric indices were measured with participants in standard scrub suits and 
lightweight non-constricting underwear.  Participants had been instructed to fast overnight 
and to empty their bladder prior to these measures.  Measures were taken by either two 
technicians or one technician with a full length mirror for assistance.  Technicians measured 
height with participants barefoot using a wall mounted ruler.  An anthropometric measuring 
tape was applied horizontally to measure hip and waist girth; participants stood upright with 
weight evenly distributed between both feet and breathing quietly.  Waist girth was measured 
at level of the umbilicus and hip girth at the level of maximal protrusion of the gluteal 
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muscles.  Values were rounded down and were recorded to the centimeter.  Weight 
measurements were performed using a scale (Detecto model 437) that was zeroed daily and 
calibrated quarterly.  Body mass index (BMI) was calculated as weight divided by height 
squared (kilograms/meters2), whereas waist/hip ratio is the waist girth divided by the hip 
girth.  Inter-technician reliability coefficients for waist and hip girth and WHR were > 
0.91.(Ferrario, Carpenter et al. 1995) 
 
F. Baseline covariate definitions  
     All covariates were collected from the baseline visit.  Race, gender, educational level, 
current alcohol use, and smoking status were obtained by participant self-report.  Race 
categories included white, black, American Indian, Asian/Pacific Islander, and Hispanic; 
however, as mentioned earlier, racial groups not classified as white or black were excluded 
due to their limited numbers (N= 48).  Prior history of myocardial infarction (MI) was 
defined as a reported history of physician-diagnosed MI or silent MI as identified by 
electrocardiography.  History of coronary heart disease includes those with a history of MI, 
and those with a prior coronary revascularization procedure or coronary artery bypass 
surgery.  History of stroke was defined by self-report of physician diagnosis of stroke.        
     Blood pressure (BP) measurements were taken using a standardized protocol.  The last 
two of three sitting BP measurements were averaged.  Hypertension was defined by either a 
diastolic blood pressure ≥ 90 mm Hg or a systolic blood pressure ≥ 140 mm Hg, or anti-
hypertensive medication use during the previous 2 weeks.  Left ventricular hypertrophy was 
identified by electrocardiography using Cornell criteria (Crow, Prineas et al. 1995).  Diabetes 
mellitus was defined as any of the following: self-reported history of physician diagnosed 
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diabetes, medication use for diabetes over the last 2 weeks, a blood glucose ≥ 126 mg/dl 
fasting or a blood glucose ≥ 200 mg/dl non-fasting.  Forced expiratory volume (FEV1) was 
obtained from pulmonary spirometry performed by trained technicians with computer 
assistance.  The FEV1 measurements have been adjusted for age, race, gender and 
height(Shahar, Boland et al.).  Methods for the measurement of blood levels of albumin, 
creatinine, and glucose have been previously described (Eckfeldt, Chambless et al. 1994).  
Low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), 
triglycerides, and total cholesterol were measured in fasting state using standardized methods 
(Investigators 1989). 
 
G. Data quality 
      Data was directly entered into a computer-assisted data collection system.  Suspicious 
values were immediately detected while the participant was onsite, such that the value could 
be confirmed or corrected.  The main study data was held at the coordinating center; the main 
data was updated weekly by diskettes of study data mailed from the centers.  Reports on data 
were generated routinely for review by all study sites.  Quality control measures were 
undertaken to assure uniform data collection across time and between centers.  All staff 
received training and certification in data collection procedures.  Staff performance was 
monitored by supervisors, both directly and indirectly with video-recordings of participant 
interviews.  When deemed necessary, re-training and re-certification was performed.  Also as 
part of their training, staff was instructed on the ethical conduct of research involving human 
subjects, with an emphasis on confidentiality of the study data and its protection.  All ARIC 
staff signed a pledge of confidentiality.  Other data monitoring steps were undertaken with 
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included:  1) assessment of participant effort during spirometry; 2) assessment for digit 
preference in blood pressure data; 3) measurement of blood flow rate during venipuncture; 4) 
repeat anthropometric measures by the same and different technicians; and 5) blind analysis 
of duplicate blood samples and electrocardiograms(Investigators 1989).       
 
H. Statistical power analysis 
     Since there are accepted cut-points for BMI, we used BMI as the main exposure for the 
statistical power analysis.  The data for this study has already been collected and therefore 
the numbers per groups has already been defined.  Power analyses for incident HF were 
estimated stratified by gender for the comparison between the highest category of BMI (BMI 
>30) as compared to the referent group (BMI < 25).  Power analysis assumes no 
confounding, no missing values, and no bias.  Preliminary data from the ARIC study was 
used to determine the exponential survival parameters for each BMI group, whereas we 
assumed a dropout rate of 5 % per year.  The group with the smallest number was provided 
as “n per group” and was held constant across the table.  The highlighted numbers were 
estimated by the software.    
Table 5 provides an estimate of power given different hazard ratios for men.  The proportion 
used for the exponential parameter for λ
 1 was based on the proportion of men in group BMI 
> 30 with HF by the end of follow-up.  In the first column, λ
 2 is the proportion of men in the 
BMI <25 group, with HF by the end of follow-up.  However, for columns 2-4, the HR varies 
and therefore λ
 2 varies depending on the HR that was input.  The power based on a HR of 2.1 
is 99 % if there were 133 cases (example 1), whereas when the hazard ratio is decreased to 
1.5, the power decreases to 89 % if there were 248 cases (example 2).  As for the women (see 
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power Error! Reference source not found.) based on a HR of 2.9 is 99 % if there were 66 
cases (example 1), whereas as when the HR decreases to 1.5, the power decreases to 91 % if 
there were 275 cases (example 3).   The actual total number of events for these two BMI 
categories combined is 372 for men and 383 for women.  Since we have over 350 cases for 
both men and women, this tables shows that we have adequate power even after stratification 
by gender.  Power estimates and tables were created using NQuery Advisor 5.0.   
 
Table 5. Two group test of equal exponential survival, with exponential dropout, only men included 
1 2 3 4
  Test significance level, α   0.050   0.050   0.050   0.050
  1 or 2 sided test?    2    2    2    2
  Length of accrual period    3.00    3.00    3.00    3.00
  Maximum length of follow-up   16.00   16.00   16.00   16.00
  Common exponential dropout rate, d    0.0500    0.0500   0.0500   0.0500
      BMI >30, exponential parameter, λ
 1    0.0101    0.0101   0.0101   0.0101
      BMI <25, exponential parameter, λ
 2    0.0048    0.0067   0.0078   0.0072
  Hazard ratio, h= λ
 1 / λ 2     2.104     1.500     1.300     1.400
  Power ( % )      99      89      57      77
  n per group  1567  1567  1567  1567
  Total number of events required, E       133       248       268       258
 
Table 6.  Two group test of equal exponential survival, with exponential dropout, women only 
1 2 3 4
  Test significance level, α   0.050   0.050   0.050   0.050
  1 or 2 sided test?    2    2    2    2
  Length of accrual period    3.00    3.00    3.00    3.00
  Maximum length of follow-up   16.00   16.00   16.00   16.00
  Common exponential dropout rate, d    0.0500    0.0500   0.0500   0.0500
      BMI >30, exponential parameter, λ1    0.0072    0.0072   0.0072   0.0072
      BMI <25, exponential parameter, λ
 2    0.0025    0.0036   0.0048   0.0055
  Hazard ratio, h= λ
 1 / λ 2     2.880     2.000     1.500     1.300
  Power ( % )      99      99      91      62
  n per group  2405  2405  2405  2405
  Total number of events required, E        66       153       275       298
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     In addition, a power analysis was performed to determine the power to assess for effect 
modification by race, hypertension, diabetes, and CHD using Power Program v.3.0.0 
(downloaded from http://dceg.cancer.gov/POWER/).  Given that the analysis is already 
stratified by gender, there is inadequate power to detect effect modification for any of the 
potential effect modifiers, given a theta of 1.5 (See Table 7).  All of these effect modifiers 
except race could be considered causal intermediates, therefore we will only further consider 
race as a potential effect modifier.  There are no race- and gender-stratified estimates in the 
literature for the association of obesity with HF.  Despite the estimated lack of power to find 
a significant difference between these groups, we will investigate these stratified estimates to 
gain some insight as to how this association might vary across these race and gender groups.   
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Table 7.  Estimate of power* to assess for multiplicative effect measure modification by the 
following variables, given probabilities and sample size in the ARIC 
 Power in Men Power in Women 
Age 0.31 0.34 
Race 0.49 0.35 
Hypertension 0.40 0.32 
Diabetes 0.25 0.16 
CHD 0.19 0.07 
 
I. Statistical Analysis  
     The distributions of all three exposures (BMI, WHR, and WC) were inspected for outliers.  
The distribution of men and women were compared for each exposure.  Pearson correlation 
coefficients were estimated to determine the correlation between BMI, waist-hip ratio and 
waist circumference.  Categorization of BMI was defined as established in the literature(NIH 
1998):  1) BMI < 25 kg/m2 (normal weight); 2) BMI between 25-30 kg/m2 (overweight); and 
3) BMI >30 kg/m2 (obese).  No well accepted epidemiologic standard exists for the 
categorization of WHR and WC, therefore both of these measures were categorized into 
approximate tertiles by gender.  Although a sex-specific dichotomous cut-point has been 
suggested for WC (obese defined as men > 102 cm and women > 88 cm)(NIH 1998), we 
preferred approximate sex-specific tertiles of WC for better specification.  Categorized 
variables were represented as indicator variables with comparison to the lowest group 
(normal weight) as referent.  We evaluated BMI in classes of weight as represented in the 
clinical guidelines from the National Institutes of Health(1998).  In addition, we 
characterized obesity within BMI category by low or high waist circumference as seen in the 
NIH’s clinical guidelines on the identification, evaluation, and treatment of overweight and 
obesity in adults(NIH 1998).  The cut-point for low and high waist circumference is 102 cm. 
in men and 88 cm. women are recommended to further define those at high risk among 
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individuals with a BMI between 25 kg/m2 and 34.9 kg/m2.  Furthermore, BMI categories of 
normal weight, overweight and obese, were stratified by low and high waist-hip ratio using 
gender-specific cutpoints from the U.S. Department of Agriculture (WHR cutpoints:  women, 
0.88; men, 0.95)(US Department of Agriculture 1990). 
     Univariate associations by gender were determined across categories of the three 
exposures for each categorical covariate using chi-square and for each continuous covariate 
using analysis of variance (ANOVA).  Poisson models were used to age-adjust (to the mean 
age at baseline, 54 years) incidence rates for heart failure for each weight category, stratified 
by race-gender.   
 
Analysis to address aim 1.1 
1.1:  Determine the hazard ratio for the association of obesity (as measured by BMI, 
waist/hip ratio, and waist circumference) with incident heart failure, while 
controlling for potential effect modifiers and confounders. Assess race as a potential 
effect modifier.   
    Multivariable Cox proportional hazard regression was used to model the association 
between each anthropometric variable (BMI, WHR and waist circumference) and time to 
incident HF.  Log (- log) survival curves and time interaction terms for the main exposures 
and all covariates were performed to validate the proportional hazards assumption.  In the 
multivariable model, ties were handled with the method suggested by Efron.  All statistical 
analyses were performed using SAS software v 9.1 (Cary, NC).  Multivariable hazard ratios 
were estimated for the main exposure variables (BMI, WHR, and waist circumference) in 
both continuous (per one standard deviation change) and categorized form.   
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Assessment of confounding 
     A directed acyclic graph (DAG) was drawn representing a conceptual framework of the 
relationship between obesity and HF (Weinberg 1993; Greenland, Pearl et al. 1999), see 
Figure 4.  This technique has been recommended as a formal method to assess whether 
possible confounders truly meet the definition of a confounder.  There are three 
characteristics that define a covariate as a confounder:  1) the covariate should be associated 
with the disease, 2) and the exposure, and 3) not affected by the exposure(Rothman and 
Greenland 1998).  These relationships are based on findings from the literature and on 
biologic plausibility.  Possible causal relationships are represented by arrows.  Since a 
confounder should not be affected by the exposure, then all arrows emanating from the 
exposure (obesity) are removed (see Figure 5.  Same as Figure 4, except all arrows 
emanating from the main exposure (obesity); therefore, now there are unblocked backdoor 
paths between age, gender, education, race, center, smoking and alcohol use.  These 
unblocked backdoor paths indicate potential confounders.  All the other factors, such as CVD 
risk factors and CHD, are along the causal pathway between obesity and HF.  These factors 
are caused by the exposure and adjustment for or stratification by any of these intermediates 
can create bias(Weinberg 1993).  Therefore, only these factors with unblocked backdoor 
paths were considered as potential confounders.       
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Figure 4.  A Directed Acyclic Graph (DAG) for the association between obesity and incident heart failure 
 
Figure 5.  Same as Figure 4, except all arrows emanating from the main exposure (obesity) have been 
removed   
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     As an alternative to the full model, a change in estimate approach was used to further 
select confounders to be in a more parsimonious model.  The following formula was used in 
which the full model was compared to the reduced model:   
Change in estimate = | ln( HRfull /HRreduced) |, 
Where, HRfull = the hazard ratio for obesity or overweight with all covariates in the model, 
and HRreduced = the hazard ratio for obesity or overweight with all covariates except the 
covariate of interest. 
The cut-point for inclusion in the model was a change in estimate of > 0.1.  In addition, 
precision was assessed for all models with the confidence limit ratio (upper confidence 
limit/lower confidence limit).  Furthermore, in order to quantify the trade-off between 
precision and validity for the inclusion versus exclusion of a given covariate, the following 
variation on the estimate of mean square error (“MSE”) was calculated:   
“MSE”full = variance(lnHR) 
“MSE”reduced = variance(lnHRreduced) + (lnHRfull – lnHRreduced)2 
If “MSE” for the full model is < the “MSE” for the reduced model then the assessment of the 
precision/validity trade-off favors adjustment for the covariate of interest.  These same 
methods, change in estimate, confidence limit ratio and “MSE” where used to assess the 
different forms of certain covariates.   
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 Covariate specification 
         The appropriate form of each covariate (age, education, race, center, smoking, alcohol 
use) was investigated.  For the continuous covariate (age in years) linearity was assessed, 
separately for men and women:  1) Age groups were created by dividing age into 3 year 
categories and then creating indicator variables with the youngest group as referent, 2) The 
HR for the association of age with HF was plotted to assess for linearity.  Age in continuous 
form was re-centered to an age of 45 years.  All other variables were considered as indicator 
variables.  Specifically, the form of alcohol use and smoking status were evaluated as never, 
current and former and also in more detailed categories of never, former, current occasional, 
current moderate, and current heavy.  Race and center were considered jointly with indicator 
variables because the distribution race and center were dependent.  One center (Jackson, MS) 
was all black, two centers (Minneapolis, MN and Washington County, MD) were almost 
exclusively white, and the other center (Forsyth County, NC) contained both race groups; 
therefore, blacks not from Jackson or Forsyth (N= 22 women, N=26 men) were excluded 
from all models.  To control for both race and center, indicator variables were created for 
blacks from Jackson, whites form Minnesota, whites from Washington County, blacks from 
Forsyth, and whites from Forsyth that compared each with a referent group of whites from 
Minnesota.  The Minnesota group was selected as referent because it was the largest group.   
Furthermore, a complete case analysis was performed, therefore, participants missing values 
for any covariates were excluded from modeling (N = 7967 for women, N = 6,603 for men, 
after deletion of 120 participants that were either missing values for any of these 6 covariates 
or were blacks not from Jackson or Forsyth centers).  Complete case analysis is a good 
choice since there is relatively little missing information on covariates.    
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Assessment for effect measure modification 
     To assess for additive effect measure modification by race, interaction contrast ratios 
(ICR) with 95 % CI were calculated.  Specifically, ICR’s were calculated separately for men 
and women for the comparison of obese (BMI ≥ 30) with normal weight (BMI < 25).  The 
formula for the ICR is as follows: 
ICR = HR11 – HR10 - HR01 +1 
Where, HR11 = hazard for those obese and black/ hazard for those normal weight and  
white, jointly exposed,  
HR10  = hazard for those obese and black/ hazard for those normal weight and white,  
single exposure to black race, and  
HR01 = hazard for those normal weight and black/ hazard for those normal weight  
and white, single exposure to obesity 
 
The formula for 95 % CI for ICR is as follows: 
(-HR01)2 X Variance(β1) + (-HR10)2 X Variance(β2) + (HR11)2 X Variance(β3) + 
( (-HR01) X (-HR10) X 2(Covariance(β1 β2))+ ((-HR01) X (HR11)X 2(Covariance(β1 β3))+ 
((HR21) X (-HR01) X 2(Covariance(β2 β3)) 
   Where β1 = βnormalweight/black, β2 = βobese/white, and β3 = βobese/black 
A value for the interactive contrast ratio (and it’s 95 % CI) different from zero suggests an 
additive interaction.   
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     Multivariable models assume constancy of effect between covariates.  To assess whether 
there were statistical interactions between covariates, we calculated likelihood ratio tests by 
gender for models with and without interaction terms (p value < 0.05 considered significant).  
The final model with significant interaction terms were compared with the reduced model 
using the above mentioned calculations of change in estimate, confidence limit ratio and 
“MSE”.     
 
Analysis to address aim 1.2 
1.2 Compare three anthropometrical measures (e.g. BMI, waist circumference, and 
waist/hip ratio) as to their ability to predict incident hospitalized heart failure. 
    The predictive ability of each anthropometric variable for incident heart failure was 
compared using time-dependent receiver operating curves (ROC) for estimation of area 
under the curve at 10 years (AUC(10)), as described by Chambless and Diao(Chambless and 
Diao 2006).  We determined the AUC (10) for each categorized anthropometric measure 
based on predicted probabilities estimated from gender-stratified Cox proportional hazards 
model with adjustment for age, educational level, race, smoking status, and alcohol use.  
Predicted probabilities at 10 years were divided into deciles and each compared to the lowest 
group.  Goodness of fit was assessed using Hosmer-Lemeshow tests.  To test for the 
differences in AUC(10) between waist-hip ratio, waist circumference, BMI, and BMI 
stratified by high and low waist circumference, bootstrapping (sampling with replacement) 
was used to estimate a distribution of AUC(10) differences such that 95 % confidence 
intervals were determined.  Furthermore, we adjusted for optimism due to use of the same 
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dataset for determination of AUC(10) for both models being compared(Harrell, Lee et al. 
1996).  
 
Analysis to address aim 2.1 
2.1 Determine a distribution for sensitivity and specificity as estimated from the 
literature for the definition of the outcome (incident HF) as defined by hospital 
discharge and death codes.   
     Estimates of the range of values for sensitivity (62.8 %) and specificity (95.4 %) of ‘428.0 
– 428.9’ ICD code to define HF were based on findings from Goff et. al.(Goff, Pandey et al. 
2000).  Although there are other studies which validate HF when defined by ICD codes, 
these other studies used additional codes besides ‘428.0 – 428.9’.      
      
Analysis to address aim 2.2 
2.2   Perform a semi-automated probabilistic sensitivity analysis to estimate the 
degree of bias due to disease misclassification based on the chosen distribution of 
sensitivity and specificity.  Separate multivariable estimates of the odds ratio and  its 
distribution will be obtained that incorporate systematic error (from disease 
misclassification), random error and both. 
     A sensitivity analysis was performed to assess the impact of systematic error due to 
misclassification of the outcome (heart failure).  The SAS software macro developed by Lash 
and Fink(Lash and Fink 2003) was used.  Since this macro is written for use with logistic 
regression, the odds ratios for the association of obesity with HF from  multivariable logistic 
regression models were compared to the hazard ratios from multivariable Cox proportional 
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hazards regression models.  Since the results were similar then logistic regression was used 
for the sensitivity analysis, to avoid reclassifying survival time for those with reclassified 
outcomes. 
     A distribution of values of sensitivity and specificity were input based on the finding from 
aim 2.1 for non-differential outcome misclassification.  The program deleted all iterations 
that are not plausible combinations of sensitivity and specificity.  Initial parameters for the 
trapezoidal distribution of sensitivity (minimum = 0.75, maximum = 1) and specificity 
(minimum = 0.75, maximum = 1) resulted in multiple deleted iterations (>25,000), therefore 
a broader range of sensitivity and specificity values (0.25 – 1 with modes of 0.5 and 0.75) 
were entered, such that the plausible range of values from the non-deleted iterations could be 
determined.  The plausible range of values for the trapezoidal distribution of sensitivity were:  
minimum =0.6, mode 1 = 0.7, mode 2 = 0.85, maximum = 1, and for specificity: minimum = 
0.94, mode 1 = 0.96, mode 2=0.96, maximum = 1.  Therefore, this was the range used for the 
analysis.    
 
Analysis to address aim 3.1 
3.1 Determine a range for the feasible reduction in the prevalence of obesity and 
overweight (as measured by BMI categories), based on findings from weight 
reduction studies. 
    Based on above review of the literature on weight-loss reduction intervention studies only 
modest weight-loss (about 5-7 kgs) was achieved.  However, these studies do not tell us the 
population-level impact of an intervention in terms of the reduced proportion obese or 
overweight.  Instead we relied on goals set by the US Department Health and Human 
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services in the Healthy People 2010 report.  Healthy People 2010 are a set of recommended 
health objectives meant to serve as a basis from which to develop US national, state and 
community plans for health improvement by the year 2010(2000) .  Obesity and overweight 
are listed as high priority public health issues.  Specifically, their objective is to reduce the 
proportion of obese adults aged 20 years and older to 15 % from 23% (25 % in females and 
20 % in males, data from 1988-1994, age adjusted to year 2000), which is approximately a 
35 % reduction in the proportion of obese.    We chose several scenarios for the reduction in 
the proportion of obese and overweight, for which the maximum achievable goal selected 
was a 30 % reduction in both obesity and overweight.   
 
Analysis to address aim 3.2 
3.2 Given several estimates for the reduction in prevalence of obesity and overweight, 
and the magnitude of association between BMI and incident heart failure, the 
generalized impact fraction will be determined, stratified by gender.  This will 
estimate the potential impact of weight reduction on the incidence of heart failure. 
     The generalized impact fraction (GIF) for the association of overweight/obesity with the 
incidence of HF will be estimated using the following equation: 
 
 
 
      
     The generalized impact fraction (GIF) for heart failure given a reduction in overweight 
and or obesity was estimated using equations 1 and 3 (see box, below).  Specifically, for this 
GIF = (Pr(D) – Pr (D/E*)) / Pr (D) 
Where Pr (D) = probability of disease, and  
Pr (D/E*) = probability of disease given modified exposure distribution. 
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study, the GIF was calculated for each age-, race- and gender- stratified group (see equation 
1) and then combined using a case-load weighted-sum method to obtain an overall GIF (see 
equation 3).  For each stratum, the components of GIF equation were defined as follows: 1) 
Pi is the prevalence of the exposure (obesity, overweight and normal weight) in the ARIC 
population at baseline (1987-1989); 2) Pi* is the reduced prevalence of obesity, overweight 
and normal weight (reduced as compared to Pi) after a hypothetical change in the distribution 
of BMI; and 3) RRi, in this case HRi, is the crude hazard ratio of incident heart failure for 
those overweight, obese or normal weight as compared to the referent group (normal weight), 
for that stratum.  Cox proportional hazard regression was used to model the association 
between obesity (BMI ≥ 30 kg/m2), overweight (BMI ≥ 25 and ≤ 30, kg/m2) with normal 
weight (BMI < 25 kg/m2) and time to incident HF.  BMI was categorized as represented in 
the clinical guidelines from the National Institutes of Health(NIH 1998).  In the multivariable 
model, ties were handled with the method suggested by Efron.  All statistical analyses were 
performed using SAS software v 9.1 (Cary, NC).   
     Since calculation of the GIF is based on a single study population (the ARIC cohort), we 
added further uncertainty to these calculations by bootstrapping to obtain 95 % simulation 
intervals for the GIF and attributable fraction (see Figure 6)(Greenland 2004).  Ten thousand 
bootstrapped samples (with replacement) were performed for each subgroup of race, gender 
and age (therefore, there were 8 subgroups each with 10,000 bootstrapped datasets).  Each 
sampled dataset was the same size as the subgroup in the original dataset.  The unadjusted 
hazard ratios (HRi) for obesity and overweight (the HR for normal weight is always 1), and 
the prevalence (Pi) of normal weight, overweight and obesity were determined within each 
stratum for each of the 10,000 bootstrapped dataset.  The GIF for each stratum was 
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calculated given these values and a specified alternative distribution for the reduced 
prevalence of obesity, overweight and normal weight (Pi*).   
     The overall GIF for each hypothetical scenario of weight reduction was determined using 
the case-load weighted-sum approach for each bootstrapped sample using equation 2 
(Benichou 2001).  From the distribution of the 10,000 overall generalized impact fractions, 
the median (along with 2.5 % and 97.5 % simulation intervals) were calculated for each 
hypothetical scenario.   
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(Equation 1) 
GIF for a given bootstrap sample, and stratum a,b,c =Σ Pi, abc(RRi, abc) – Σ Pi*,abc (RRi, abc)             
       Σ Pi, abc(RRi,abc) 
Where, 
GIF = generalized attributable fraction for one bootstrap sample, from a given stratum of 
abc,  
Pi = proportion of the population in exposure category, i, 
Pi*= proportion of the population in exposure category i after an intervention or other 
change, 
RRi = Relative risk at exposure category i compared to the reference level, 
i = normal weight, overweight, or obese categories as defined by BMI, 
abc = stratum of age (age < 55 years, age ≥ 55 years), race (black or white) and gender 
(male or female) 
Specifically, 
Numerator GIFa,b,c  =  [Poverwt, abc(RRoverwt, abc) + Pobese, abc(RRobese, abc) + Pnormal wt, abc(1)]  –  
[(P*overwt, abc)(RRoverwt, abc) + (P*obese, abc)(RRobese, abc) + (P*normal wt, abc)(1)]    
Denominator GIFa,b,c=[(Poverwt, abc)(RRoverwt, abc)+(Pobese, abc)(RRobese, abc)+(Pnormal wt, abc)(1)] 
(Equation 2) 
AF (or maximum GIF) for a given bootstrap sample from stratum a, b, c = 
 [∑(pdi(RRi) – 1)] / [∑(pdi(RRi)] 
  
where pdi = proportion of total cases arising from the ith exposure category   
 RRi = the unadjusted RR (in this case HR) for the ith exposure category  
 compared to referent (i = overweight, or obese categories compared to normal) 
 
(Equation 3) 
Case-load weighted sum method for GIFoverall  
Numerator GIFoverall (or AFoverall) for a one bootstrap sample =  
(#casesa1b1c1)(GIFa1b1c1) + (#casesa1b1c0)(GIFa1b1c0) +  
(#casesa0b1c1)(GIFa0b1c1) + (#casesa0b1c0)(GIFa0b1c0) +  
(#casesa0b1c1)(GIFa0b1c1) + (#casesa0b1c0)(GIFa0b1c0) +     
(#casesa1b0c1)(GIFa1b0c1) + (#casesa1b0c0)( GIFa1b0c0) +  
(#casesa1b0c1)(GIFa0b0c1) + (#casesa0b0c0)( GIFa0b0c0) +  
(#casesa0b0c1)( GIFa0b0c1) + (#casesa0b0c0)(GIFa0b0c0) 
   
Denominator GIFoverall (or AFoverall) for a given boostrap sample = 
(#casesa1b1c1) + (#casesa1b1c0) + (#casesa0b1c1) + (#casesa0b1c0) + (#casesa0b1c1)  
+ (#casesa0b1c0) + (#casesa1b0c1) + (#casesa1b0c0) + (#casesa1b0c1) + (#casesa0b0c0) + 
(#casesa0b0c1) + (#casesa0b0c0) 
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Stratum A, White women, <55 years 
Dataset x from 10,000 (N = 3,079) 
for stratum A 
 
Stratum B, White women, ≥ 55 yrs 
Dataset x (N = 2,580) from 10,000 
bootstrapped datasets for stratum B 
Stratum C, Black women, < 55 yrs 
Dataset x (N = 1,423) from 10,000 
bootstrapped datasets for stratum C 
Stratum D, Black women, ≥ 55 yrs 
Dataset x (N = 927) from 10,000 
bootstrapped datasets for stratum D 
Stratum E, White men, < 55 years 
Dataset x (N = 2,476) from 10,000 
bootstrapped datasets for stratum E 
 
Stratum F, White men, ≥ 55 years 
Dataset x (N = 2,659) from 10,000 
bootstrapped datasets for stratum F 
Stratum G, Black men, < 55 years 
Dataset x (N = 830) from 10,000 
bootstrapped datasets for stratum G 
Stratum H, Black women, ≥ 55 yrs 
Dataset x (N = 668) from 10,000 
bootstrapped datasets for stratum H 
 Stratum A, White women, < 55 years 
From dataset x, the following were obtained: 
Poverwt,A,x, Pobese,A,x, HRoverwt,A,x, HRobese,A,x, Ncases,A,x 
 
GIFA,x = GIF for dataset x 
from stratum A for a given 
scenario of weight reduction 
 
 Stratum B, White women, ≥ 55 years 
From dataset x, the following were obtained:  
Poverwt,B,x, Pobese,B,x, HRoverwt,B,x, HRobese,B,x, Ncases,B,x 
 
Stratum C, Black women, < 55 years 
From dataset x, the following were obtained:  
Poverwt,C,x, Pobese,C,x, HRoverwt,C,x, HRobese,C,x, Ncases,C,x 
 
Stratum D, Black women, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,D,x, Pobese,D,x, HRoverwt,D,x, HRobese,D,x, Ncases,D,x 
 
Stratum E, White men, < 55 years 
From dataset x, the following were obtained:  
Poverwt,E,,x, Pobese,E,x, HRoverwt,E,x, HRobese,E,,Ncases,E,x 
Stratum F, White men, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,F,,x, Pobese,F,x, HRoverwt,F,x, HRobese,F,,Ncases,F,x 
Stratum G, Black men, < 55 years  
From dataset x, the following were obtained: 
Poverwt,G,,x, Pobese,G,x, HRoverwt,G,x, HRobese,G,,Ncases,G,x 
Stratum H, Black men, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,H,,x, Pobese,H,x, HRoverwt,H,x, HRobese,H,,Ncases,H,x 
GIFB,x = GIF for dataset x 
from stratum B for a given 
scenario of weight reduction 
 
GIFC,x = GIF for dataset x 
from stratum C for a given 
scenario of weight reduction 
 
GIFD,x = GIF for dataset x 
from stratum D for a given 
scenario of weight reduction 
 
GIFE,x = GIF for dataset x 
from stratum E for a given 
scenario of weight reduction 
 
GIFF,x = GIF for dataset x 
from stratum F for a given 
scenario of weight reduction  
GIFG,x = GIF for dataset x 
from stratum G for a given 
scenario of weight reduction 
 
GIFH,x = GIF for dataset x 
from stratum H for a given 
scenario of weight reduction 
 
Figure 6.  Diagram of intermediate steps in the estimation of the distribution of the generalized impact fraction (GIF) using bootstrapped 
datasets (sampled with replacement), x = dataset number out of 10,000 bootstrapped datasets.  Each dataset contains the same name number 
(N) in each stratum as found in the original data.  Poverwt= proportion overweight, Pobese = proportion obese, HRoverwt = unadjusted hazard ratio 
for obese, HRobese = unadjusted hazard ratio for overweight, and Ncases = number of incident heart failure cases 
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Analysis to address aim 3.3 
3.3 Determine the population attributable fraction for overweight/obese for the 
outcome of incident hospitalized heart failure. Compare this more commonly used 
measure to that of the generalized impact fraction. 
    The attributable fraction, or in this case the maximum GIF, was calculated with the same 
case-load weight-sum method using equation 2(Morgenstern and Bursic 1982).  Based on the 
distribution of values from the bootstrapped samples, the median attributable fraction along 
with 2.5 and 97.5 percentiles were reported.     
 
J. Methodological strengths and limitations  
     Strengths of the analysis for manuscript 1 included the large sample size of this well 
characterized cohort and the extended period of follow-up. Measures were obtained using 
standardized techniques.  Anthropometric variables were analyzed in both continuous form 
and using cut-points.  Since there are three anthropometric measures available from the 
baseline visit, we were able to compare the predictive ability of the three measures using a 
newly described method for time-dependent ROC analysis.   
    The main limitation of this analysis is the misclassification of the outcome measure, 
however the uncertainty due to this bias was evaluated with the sensitivity analysis from the 
second aim in which we show the estimated effect of outcome misclassification on our 
results.  In this aim we will use a novel technique called multiple bias modeling to allow the 
incorporation of this bias, into multivariate modeling using Monte Carlo techniques.  This 
study will provide further example of how Monte Carlo Risk Assessment techniques can be 
used to succinctly summarize the effect of systematic error.  
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     Strengths of the analysis for manuscript 2 are that we re-introduced the generalized impact 
fraction, as an alternative to the attributable fraction, for exposures that are unlikely to be 
eliminated, such as obesity.  We show how confidence intervals can be obtained from 
bootstrapped datasets.  In addition, we use these findings to extrapolate the public health 
impact in terms of the predicted decrease in heart failure hospitalizations and healthcare 
costs.  Limitations of the analysis for manuscript 2 include the basic assumptions of the GIF, 
which are the same as for the attributable fraction, and the need to stratify on important 
confounders, unlike the attributable fraction.   
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
CHAPTER IV 
 
RESULTS 
 
 
A. Manuscript 1:  The Association of Overweight and Obesity with Incident Heart 
Failure:  the Atherosclerosis Risk in Communities (ARIC) Study 
 
ABSTRACT 
Introduction:  Obesity, as measured by BMI, has been identified as a risk factor for heart 
failure.  This association has not been studied in non-white racial groups.  Furthermore, the 
importance of a measure of central adiposity (waist-hip ratio) as compared to BMI has yet to 
be studied in a large population-based study.  Methods: The Atherosclerosis Risk in 
Communities (ARIC) study is an ongoing bi-racial population-based cohort of those aged 45-
65 years from 4 U.S. communities with 14 years median follow-up for incident, hospitalized 
or fatal heart failure.  Waist-hip ratio, waist circumference and BMI were measured at the 
baseline visit (1987-1989).  After exclusion of prevalent heart failure, missing anthropometry 
measures, and poorly represented race groups, the sample size was 14,642.  BMI was 
categorized as normal weight (BMI <25 kg/m2), overweight (BMI 25-30 kg/m2), and obese 
(BMI ≥ 30 kg/m2).  WHR and waist circumference were divided into gender-specific tertiles.  
A first occurrence of ICD-9-CM codes of heart failure, either hospital discharge (428.0-
428.9, N=1,329), or on a death certificate (428.0-428.9 or I50.0-I50.9, N=76) was considered 
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an incident case.  Analyses were adjusted for alcohol use, smoking, age, and educational 
level using Cox proportional hazards modeling.  Results:  Even with stratification by race 
and gender, the adjusted hazard ratios for the comparison of the highest category of each 
measure (obese) to the lowest were similar and well above 1.0 for all three anthropometric 
measures (HR with 95 % CI for 3rd vs. 1st tertile of waist-hip ratio:  2.55 (1.88, 3.44) for 
white women; 3.10 (2.13, 4.51) for black women, 2.69 (2.10, 3.45) for white men, and 2.45 
(1.75, 3.43) for black men.  Hazard ratios for the middle category for all three anthropometric 
measures tended to be intermediate, thus suggesting a graded response between body size 
and heart failure.  
Conclusion:  Generalized obesity, overweight, and central adiposity, as measured by three 
different anthropometric measures, were associated with incident heart failure over 14 years 
median follow-up of the ARIC cohort.  The current study does not support the superiority of 
waist-hip ratio and waist circumference over BMI for the prediction of incident heart failure.   
 
1. Introduction 
     Obesity, as measured by body mass index (BMI), has been identified as a risk factor for 
heart failure from the Framingham Heart Study(Kenchaiah, Evans et al. 2002) and other 
studies(He, Ogden et al. 2001; Murphy, Macintyre et al. 2005).  The increasing prevalence of 
both obesity and heart failure (HF) in the U.S. make this association an important topic for 
prevention(Rosamond, Flegal et al. 2007).  Replication of the association of obesity with 
heart failure in non-white racial groups has been mentioned as an important area for future 
research.(Kenchaiah, Gaziano et al. 2004).     
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     Furthermore, research on the association of measures of central adiposity with heart 
failure as has been mentioned as a priority research area(O'brien G 2002).  Because diabetes 
and insulin resistance are risk factors for heart failure(Bertoni, Hundley et al. 2004; 
Ingelsson, Sundstrom et al. 2005), one would expect that a measure of central adiposity, a 
correlate of impaired insulin sensitivity, would have a stronger association with incident 
heart failure than a measure of generalized adiposity.  Waist circumference is highly 
correlated with BMI and is therefore considered a measure of both central and generalized 
adiposity, whereas waist-hip ratio is a measure of central adiposity only(Folsom, Kushi et al. 
2000).  Existing studies imply that waist circumference and waist-hip ratio are also 
associated with incident heart failure(Dagenais, Yi et al. 2005; Ingelsson, Sundstrom et al. 
2005; Nicklas, Cesari et al. 2006), however results vary depending on the population under 
study.     
     The Atherosclerosis Risk in Communities (ARIC) study is a bi-racial longitudinal cohort 
study of cardiovascular disease and its risk factors in those aged 45-65 years.  It has 
anthropometric measures of BMI, waist-hip ratio, and waist circumference from the baseline 
visit along with 14 years median follow-up for incident heart failure.  In this study, we 
evaluated the race- and gender-specific associations of overweight and obesity with incident 
heart failure.  Furthermore, we determined whether a measure of central adiposity (waist-hip 
ratio) would be more closely associated with incident heart failure than BMI.   
 
2. Methods 
Study Population 
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     The ARIC cohort (N=15,792) was recruited between 1987-1989 using probability 
sampling of those aged 45-64 years from the following four US communities:  Forsyth 
County, North Carolina; Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and 
Washington County, Maryland.  The distribution of blacks and whites from each field center 
was representative of the area (mostly white in Minneapolis and Washington County, 15 % 
black in Forsyth County), except in Jackson where only blacks were sampled.  Response 
rates at baseline were 46 % in Jackson and between 65-67 % for the other communities.  
Three subsequent visits were conducted at approximately three-year intervals through 1996-
98.  The design and rationale of the ARIC study (The ARIC Investigators 1989) and a 
comparison of responders and nonresponders (Jackson, Chambless et al. 1996) have been 
previously published.  The institutional review boards from each site approved the ARIC 
study.  All participants provided written informed consent.  
     Racial groups not classified as white or black (N = 48), and blacks not from Jackson or 
Forsyth County (N = 120) were excluded in this study due to their limited numbers.  In 
addition, those with missing anthropometry (N = 33), prevalent heart failure at baseline 
(N=751), or missing criteria used to define prevalent heart failure (N=289) were excluded 
from this analysis.  Criteria to define prevalent heart failure were as follows:  1) those 
answering “yes” to the following question:  “Were any of the medications you took during 
the last two weeks for heart failure?” (N = 83), or 2) those with stage 3 heart failure by 
applying Gothenburg criteria (N = 699)(Eriksson, Caidahl et al. 1987).  Gothenburg criteria 
were defined by self-reported medical history, medication lists and 
electrocardiography(Loehr, Rosamond et al. 2008).  After these exclusions, the total sample 
size was 14,642. 
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Anthropometric Measures 
     Anthropometric indices were measured after an overnight fast with participants in 
standard scrub attire.  Technicians measured height with participants barefoot using a wall 
mounted ruler.  An anthropometric measuring tape was applied horizontally to measure hip 
and abdominal girth; participants stood upright with weight evenly distributed between both 
feet and breathing quietly.  Abdominal girth was measured at the level of the umbilicus and 
hip girth at the level of maximal protrusion of the gluteal muscles.  Weight was measured 
using a scale (Detecto model 437) that was zeroed daily and calibrated quarterly.  Body mass 
index (BMI) was calculated as weight divided by height squared (kilograms/meters2), 
whereas waist/hip ratio (WHR) was the waist girth divided by the hip girth.  Inter-technician 
reliability coefficients for waist and hip girth and waist-hip ratio were >0.91(Ferrario, 
Carpenter et al. 1995) 
 
Ascertainment of heart failure events     
     The following methods were used for ascertainment of heart failure events:  1) 
participants were contacted annually by phone and interviewed about interim hospitalizations 
(93-96 % response); 2) local hospitals provided lists of hospital discharges with 
cardiovascular diagnoses and these were reviewed to identify cohort hospitalizations; and 3) 
health department death certificate files were continuously surveyed.  All discharge diagnosis 
codes for cohort hospitalizations and underlying or contributory causes of death from death 
certificates were recorded.  
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Incident heart failure event criteria 
     Incident heart failure was defined as the first occurrence of either:  1) a hospitalization 
which included an ICD-9-CM (International Classification of Diseases, 9th revision, clinical 
modification) discharge diagnosis code for heart failure beginning with ‘428’ (i.e. 428.0 to 
428.9) in any position (N = 1,329) or else 2) a death certificate ICD-9 code beginning with 
‘428’ (heart failure) or ICD-10 code ‘I50’ (heart failure or I50.0 to I50.9) in any position (N 
= 76).  Follow-up time for those with an incident heart failure event was defined as the time 
from the date of their baseline examination until the incident event.  The end of follow-up 
time for those without heart failure was the first occurrence of either:  1) December 31st, 
2003, 2) date of last contact for those lost to follow-up, or 3) date of death.   
 
Baseline covariate definitions 
     All covariates were collected from the baseline visit.  Race was self-reported; educational 
level, alcohol use, and smoking status were obtained with interviewer-administered 
questionnaires.  Prior history of myocardial infarction (MI) was defined as a reported history 
of physician-diagnosed MI or silent MI as identified by electrocardiography.  History of 
coronary heart disease included those with a history of MI, and those with a prior coronary 
revascularization procedure or coronary artery bypass surgery.   
     Hypertension was defined by either a diastolic blood pressure ≥ 90 mm Hg or a systolic 
blood pressure ≥ 140 mm Hg measured with random-zero mercury manometers, or anti-
hypertensive medication use during the previous 2 weeks.  Left ventricular hypertrophy was 
identified by electrocardiography using Cornell criteria (Crow, Prineas et al. 1995).  Diabetes 
mellitus was defined as any of the following: self-reported history of physician diagnosed 
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diabetes, medication use for diabetes over the last 2 weeks, a blood glucose ≥ 126 mg/dl 
fasting or a blood glucose ≥ 200 mg/dl non-fasting.  Low-density lipoprotein cholesterol 
(LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides, and total cholesterol 
were measured in fasting state using standardized methods(The ARIC Investigators 1989). 
 
Statistical Analysis 
     Pearson correlation coefficients were estimated to determine the correlation between BMI, 
waist-hip ratio and waist circumference.  Multivariable Cox proportional hazard regression 
was used to model the association between each anthropometric variable (BMI, waist-hip 
ratio and waist circumference) and time to incident heart failure, after stratification by race 
and gender.  Waist circumference, BMI and waist-hip ratio were analyzed as both continuous 
and categorized variables.  BMI was categorized as normal weight (< 25 kg/m2), overweight 
(25 – 30 kg/m2) and obese (≥ 30 kg/m2), as represented in the clinical guidelines from the 
National Institutes of Health(NIH 1998).  Waist-hip ratio and waist circumference were 
categorized into approximate gender-specific tertiles (Table 9 (MS. 1, Table 2)) details the 
specific cutpoints used)(Dagenais, Yi et al. 2005).  Furthermore, BMI categories of normal 
weight, overweight and obese, were stratified by low and high waist-hip ratio using gender-
specific cutpoints from the U.S. Department of Agriculture (WHR cutpoints:  women, 0.88; 
men, 0.95)(US Department of Agriculture 1990).  Poisson models were used to age-adjust 
incidence rates for heart failure to the mean age at baseline (54 years).  Log (- log) survival 
curves and time interaction terms for the main exposures and all covariates were used to 
evaluate the proportional hazards assumption.  In the multivariable model, ties were handled 
with the method suggested by Efron(Efron 1977).  A directed acyclic graph (DAG) was 
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drawn (DAG not shown) for the identification of confounders which represents our 
conceptual framework of the relationship between obesity and heart failure, distinguishing 
confounders from causal intermediates(Weinberg 1993; Greenland, Pearl et al. 1999).  In 
addition, a backward selection change-in-estimate approach was used to further reduce 
confounders.   
     The predictive ability of each anthropometric variable for incident heart failure was 
compared using time-dependent receiver operating curves (ROC) for estimation of area 
under the curve at 10 years (AUC(10)), as described by Chambless and Diao(Chambless and 
Diao 2006).  We determined the AUC (10) for each anthropometric measure (using 
categories shown in (Table 8 (MS. 1, Table 2) and Table 11 (MS. 1, Table 4)) based on 
predicted probabilities estimated from gender-stratified Cox proportional hazards model with 
adjustment for age, educational level, race, smoking status, and alcohol use.  Predicted 
probabilities at 10 years were divided into deciles and each compared to the lowest group.  
Goodness of fit was assessed using Hosmer-Lemeshow tests.  To test for the differences in 
AUC(10) between waist-hip ratio, waist circumference and BMI, bootstrapping (sampling 
with replacement) was used to estimate a distribution of AUC(10) differences such that 95 % 
confidence intervals were determined.  Furthermore, we adjusted for optimism due to use of 
the same dataset for determination of AUC(10) for both models being compared(Harrell, Lee 
et al. 1996).  
     To assess for additive effect measure modification by race, interaction contrast 
ratios(Rothman and Greenland 1998) (ICR) with 95 % CI’s were calculated.  To assess for 
improved model fit, alternative models with covariate interactions were tested using 
likelihood ratio tests.   
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     A sensitivity analysis was performed to assess the impact of systematic error due to 
misclassification of the outcome (heart failure) on our results.  A SAS macro (available at 
http://sph.bu.edu/index.php?option=com_content&task=view&id=405&Itemid=508#epidemi
ologic) developed by Lash and Fink(Lash and Fink 2003) was used to incorporate 
uncertainty due to systematic bias from outcome misclassification into traditional regression 
using Monte Carlo uncertainty analysis.  All statistical analyses were performed using SAS 
software v 9.1 (Cary, NC).  
 
3. Results 
     Those who developed heart failure were older at baseline, less well educated, and were 
more likely to be Black and male (Table 8 (MS. 1, Table 1)).  As would be expected, there 
was a higher percentage of coronary heart disease and cardiovascular risk factors, such as 
diabetes and hypertension, among heart failure cases.  Waist circumference and waist-hip 
ratio cutpoints for men were higher than they were for women (Table 9 (MS. 1, Table 2)).  
The mean value for each anthropometric measure for each category was surprisingly similar 
by gender and across race.  Unlike the other race and gender groups, black women had a 
consistently higher percentage of person-time in the highest group (obese) of each measure 
compared to the lowest.  For all race and gender groups, age-adjusted heart failure incidence 
rates were two to three fold higher when comparing the lowest group to the highest for all 
three anthropometric measures (Table 9 (MS. 1, Table 2)).  Across all three anthropometric 
exposures, heart failure incidence rates were higher in blacks compared to whites for both 
men and women.  The heart failure incidence rates in black women compared to white 
women were nearly two-fold higher for all exposures categories.                 
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     Potential confounders available from the ARIC study and identified using the directed 
acyclic graph (DAG) were educational level, alcohol use, age, center, and smoking status.  
The following were identified as causal intermediates and therefore were not considered as 
confounders:  coronary heart disease, hypertension, diabetes mellitus, and kidney disease.  
For all three anthropometric exposures, reduced models (data not shown) determined using a 
backward selection change-in-estimate approach (with 10 % change as criteria) resulted in 
hazard ratios of similar magnitude and precision to the models including all identified 
confounders.  For comparability across the three exposures, models with all identified 
confounders are reported here.  In addition, there was no observed improvement in model fit 
with the inclusion of significant (P < 0.05) covariate interactions.   
     Adjusted hazard ratios for the comparison of the highest anthropometric category (obese) 
to the lowest for all three measures were well above 1.0 for all race and gender groups (Table 
10 (MS. 1, Table 3) and Figure 7 (MS. 1, Figure 1), Panel B).  In fact, when combined across 
race, the adjusted hazard ratios for heart failure with obesity by all three measures were well 
above 2.0.  Hazard ratios for the middle category (overweight) for all three anthropometric 
measures tended to be intermediate, thus suggesting a graded response between body size 
and heart failure (Table 10 (MS. 1, Table 3) and Figure 7 (MS. 1, Figure 1), Panel A).  
Calculation of interaction contrast ratios and interaction term analysis (P < 0.05) did not 
provide evidence for additive or multiplicative effect measure modification by race.  
Although we did not find such support for differences by race, for completeness, we present 
race- and gender- stratified estimates of the association of heart failure and adiposity.   
     Multivariable models for a standard deviation (gender-specific) change in the three 
exposures showed positive associations for all race and gender groups ( (MS. 1, Table 3)).  
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After adjustment for confounding factors, women with a 1 SD (0.08) higher waist-hip ratio 
were 62 % more likely to develop incident heart failure over the next 14 years, whereas men 
with a 1 SD higher waist-hip ratio (0.05) were 50 % more likely to develop incident heart 
failure.  Results were similar for BMI and waist circumference.  In addition, to refute the 
hypothesis that obesity at baseline was due to fluid retention from heart failure, we excluded 
the first three years of follow-up time from the analysis; there was little change in the 
associations examined here (data not shown).  
     BMI and waist circumference were highly correlated (r = 0.88), waist-hip ratio and waist 
circumference were moderately correlated (r= 0.73), and BMI and waist-hip ratio were 
poorly correlated (r = 0.43).  Stratification of BMI by waist circumference resulted in small 
sample sizes for certain categories, such as those with normal BMI and high waist 
circumference; therefore, we describe heart failure incidence rates for BMI categories, 
stratified by high and low waist hip ratio.  Age-adjusted heart failure incidence rates for BMI 
(normal weight, overweight and obese), stratified by high and low waist-hip ratio show an 
increasing trend across these categories, with particularly a high heart failure incident rate 
(10.1 per 1,000 person-years) in those who have a high BMI and waist-hip ratio (Table 11 
(MS. 1, Table 4) and Figure 8 (MS. 1, Figure 2)).       
     Estimation of AUC (10) from predicted probabilities from multivariable models for each 
anthropometric were as follows:  BMI (0.73 for men, 0.79 for women); waist-hip ratio (0.74 
for men, 0.79 for women); waist circumference (0.73 for men, 0.79 for women); and BMI 
stratified by high and low waist-hip ratio (0.74 for men, 0.79 for women).  By gender, there 
were no significant differences in AUC (10) between the three measures, or when compared 
to models with cross-classified categories of BMI and waist-hip ratio (P > 0.05 for all 
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comparisons).  The inferences were the same from this analysis when stratified by race and 
gender groups.  Of note, in some cases, the Hosmer-Lemeshow tests did not support good 
model fit.   
     The sensitivity analysis assessed the effect of misclassification of the outcome (incident 
heart failure) on the multivariable association of obesity (BMI ≥ 30) and incident heart 
failure.  The distribution of sensitivity parameters selected were based on findings from the 
literature (sensitivity:  minimum =0.6, mode 1 =0.7, mode 2 =0.85, maximum =1; for 
specificity, minimum =0.94, mode 1 =0.96, maximum =1)(Goff, Pandey et al. 2000).  The 
results of the sensitivity analysis show the median odds ratio with 2.5th and 97.5th percentiles 
was higher (OR = 4.54, 95 %  CI = 2.93, 14.83) after incorporating uncertainty due to 
outcome misclassification compared to the conventional analysis, incorporating only random 
error (OR = 2.89, 95 % CI =2.47, 3.42).  As would be expected, this suggests that the effect 
of outcome misclassification on our findings, given the chosen distribution of sensitivity and 
specificity, was to bias them towards the null.              
 
4. Discussion 
     Generalized obesity and central adiposity, as measured by three different anthropometric 
measures, were associated with incident heart failure over 14 years median follow-up of the 
ARIC cohort.  The magnitudes and patterns of the associations were similar for all three 
measures and there was evidence of a graded relation for all race, gender groups.  
Furthermore, an adverse association existed between adiposity and incident heart failure even 
for those who were overweight compared to normal weight, although less consistent across 
race- and gender-stratified analyses.  Analyses of receiver operating curves found no 
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significant differences in the prediction of incident heart failure for the three measures.  This 
implies that measures of waist-hip ratio and waist circumference are not superior to BMI in 
the prediction of heart failure.  This is contrary to our hypothesis that measures of central 
adiposity will be more closely associated with heart failure due to their closer association 
with diabetes, a known heart failure risk factor.       
     Several previous studies have found similar associations to those observed here between 
obesity as measured by BMI and incident heart failure.  The Framingham Heart Study found 
that overweight (BMI 25 – 29.9 kg/m2) and obesity (BMI ≥30 kg/m2) as measured by BMI 
were associated with an increased risk for the development of heart failure over 14 years 
median follow-up; multivariable adjusted hazard ratios were 1.34 (95 % CI = 1.08-1.67) and 
2.04 (95 % CI = 1.59-2.63), respectively (Kenchaiah, Evans et al. 2002).  In these models, 
the Framingham study adjusted for diseases, such as diabetes, which are considered along the 
causal pathway between obesity to heart failure.  As they note, adjustment for factors along 
the causal pathway may underestimate the effect of overweight or obesity with heart failure.  
The Framingham Heart Study is a primarily white population from a single community that 
is approximately a third the size of the ARIC study.  Since the ARIC study included blacks 
and whites from 4 US communities, one might expect to find more heterogeneity in the 
findings between these two studies.  Instead the robustness of these findings supports a lack 
of differences in this association by race.  Further study differences between the Framingham 
study and ours include that the outcome of heart failure from the Framingham study was 
validated using Framingham criteria.  Heart failure was not one of the original main 
outcomes of the ARIC cohort and therefore validation of heart failure events was not 
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performed.  Again despite these study differences, the findings are strikingly similar for the 
association of obesity with heart failure.     
     A community based study from Scotland, the Renfrew-Paisley study, observed a stronger 
association of heart failure with obesity, as defined by BMI, in men (HR = 2.16, 95 % CI = 
1.57-2.57) than in women ( HR = 1.37, 95 % CI = 1.00-1.88)(Murphy, Macintyre et al. 
2005).  In contrast, we observed a similar magnitude of association between BMI and heart 
failure for men and women, even after additional stratification by race.  The First National 
Health and Nutrition Examination Survey (NHANES I) studied the association of excess 
BMI and incident heart failure(He, Ogden et al. 2001), using a dichotomous cut-point for 
BMI (27.8 kg/m2 in men and 27.3 kg/m2 in women).  The adjusted hazard ratio was 1.23 (95 
% CI =1.00-1.52) in men and 1.34 (95 % CI = 1.10 – 1.64) in women.  This dichotomous 
cutpoint was based on the 85th percentile from NHANES I(Must, Spadano et al. 1999), and it 
occurs in the middle of the overweight group by the current classification scheme.  Yet, their 
findings are very similar to the hazard ratios observed for our overweight group.   
     To date, studies of central obesity and heart failure have involved less generalizable 
populations.  For example, the Health, Aging and Body Composition Study (Health ABC) is 
a longitudinal cohort study of those aged 70-79 without CHD, in which multiple metrics of 
overweight/obesity and body composition were measured(Nicklas, Cesari et al. 2006).   This 
study had a limited number of heart failure events (N = 166), in part due to the exclusion of 
those with CHD, a common heart failure precursor(Kannel, D'Agostino et al. 1999).  Despite 
the small sample size, BMI, waist circumference, and waist/thigh ratio were all positively 
associated with heart failure incidence in adjusted multivariable models.  In contrast, a study 
of participants with CVD from the Heart Outcomes Prevention Evaluation (HOPE) study did 
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not find an association between obesity and incident heart failure (N=297 HF events) for 
BMI or waist/hip ratio; however when stratified by gender, waist-hip ratio was a significant 
predictor of heart failure in women only (HR = 2.30, 95 % CI = 1.25-4.21) (Dagenais, Yi et 
al. 2005).   
     We also describe risk groups using the cross-classification of two anthropometric 
measures, BMI and waist-hip ratio.  Unlike waist circumference which is highly correlated 
with BMI, waist hip ratio seems a distinct measure of central adiposity.   
We find that incidence rates increase across categories of BMI stratified by waist-hip ratio, 
however the ROC analysis does not support better prediction of incident heart failure with 
this cross-classification of BMI and waist-hip ratio as compared to these measures alone. 
     Further support for the association of obesity with heart failure comes from 
echocardiographic studies.  Specifically, results from the Framingham Heart Study found 
positive correlations between obesity (BMI > 30 kg/m2) and echocardiographic measures of 
left ventricular mass, which were also associated with increase in left ventricular internal 
dimensions, and wall thickness(Lauer, Anderson et al. 1991).  A small study in normotensive 
men reported stronger positive correlations of left ventricular mass with waist/hip ratio and 
waist circumference as compared to BMI (Rasooly, Sasson et al. 1993).  Recently, 
McGavock et. al. found that cardiac steatosis as seen with magnetic resonance spectroscopy 
occurs with impaired glucose tolerance even before the development of type 2 diabetes 
mellitus and/or left ventricular dysfunction(McGavock, Lingvay et al. 2007). 
     Obesity’s role in the development of heart failure may be through either direct and/or 
indirect mechanisms.  The indirect mechanisms are those in which obesity causes other 
diseases, such as diabetes(Ford, Williamson et al. 1997), hypertension(Stamler 1991) or 
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coronary heart disease, which are themselves risk factors for heart failure(Kannel, 
D'Agostino et al. 1999).  A direct mechanism might be that cardiac adaptation to excess body 
fat can result in decreased cardiac function(Poirier, Giles et al. 2006).  This has been termed 
obesity cardiomyopathy.  Several mechanisms have been proposed for the cardiotoxic effect 
of fat cells.  Research from animal models has lent support to a process termed lipotoxicity, 
which is the disruption of the usual mechanism that regulates triglyceride storage(Zhou, 
Grayburn et al. 2000) (McGavock, Victor et al. 2006).  Another novel hypothesis is that an 
increase in inflammatory cytokines from excess adipocytes may increase risk of heart 
failure(Vasan, Sullivan et al. 2003; McGavock, Victor et al. 2006).  The incidence of true 
obesity cardiomyopathy is low.  Obesity cardiomyopathy is thought to occur most frequently 
amongst those with extreme obesity (BMI ≥ 40 kg/m2) of greater than 10 years 
duration(Kaltman and Goldring 1976).  In any given case of heart failure preceded by 
obesity, multiple mechanisms may be contributing factors.     
     The main limitation of this study is our definition of heart failure.  We included 
hospitalized and fatal heart failure, as we did not have data on outpatient heart failure; 
however, community surveillance reports have indicated that 74 % of outpatient heart failure 
cases are hospitalized within 1.7 years(Roger, Weston et al. 2004).  To address this 
limitation, we performed a sensitivity analysis to explore the effect of outcome 
misclassification on our findings.  As would be expected with outcome misclassification, we 
found it should bias our findings toward the null.       
     This study is relevant and important to the understanding of the etiology of heart failure 
for three reasons.  First, the ARIC study is the largest population-based cohort study to 
evaluate the association between waist/hip ratio and waist circumference and incident heart 
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failure.  Furthermore, this is a well characterized cohort with a long period of follow-up for 
which standardized methodology was used for the measurement of BMI, waist-hip ratio and 
waist circumference.  Because it is a large biracial study, we were able to describe this 
association stratified by race and gender.   
     In conclusion, we observed that obesity was associated with incident heart failure and 
there was a graded relation with body size.  This association did not vary by race or gender.  
The consistency of findings for the association of overweight with incident heart failure is in 
striking contrast with the inconsistencies regarding the association for overweight with 
coronary heart disease and mortality (Barrett-Conner 1985; Wilson, D'Agostino et al. 2002; 
Flegal, Graubard et al. 2007).  Selecting the best anthropometric for the prediction of heart 
failure could have implications for the screening and prevention of heart failure.  The current 
study does not support the superiority of waist-hip ratio or waist circumference over BMI for 
the prediction of heart failure.   
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Table 8.  (MS. 1, Table1)  Characteristics at baseline(1987-1989) of those who did or did not develop 
heart failure, ARIC 
Characteristics  Incident Heart Failure  
 (N = 1,405) 
Non-cases 
(N = 13,237) 
Age, mean (SD), years 56.8 (5.4) 53.8 (5.7) 
Men, % 54  44 
Black, % 35 25 
Center, %   
     Jackson, MS 31 23 
     Forsyth County, NC 24 26 
     Minneapolis, MN 17 27 
     Washington County, MD 28 25 
Educational level, %   
     Less than high school 40 21 
     High school graduate 30 33 
     Greater than high school 30 46 
Smoking status, %   
     Never smoker 29 43 
     Former smoker 34 32 
     Current smoker 37 25 
Alcohol use, %   
     Never drinker 27 25 
     Former drinker 29 17 
     Current drinker 44 58 
Diabetes, % 32 9 
Hypertension, % 55 30 
Left ventricular hypertrophy by ECG, % 7 2 
History of coronary heart disease, % 14 3 
     History of myocardial infarction, % 13 2 
Plasma lipids, mean (SD), mg/dl   
     Total cholesterol 220 (45) 214 (41) 
     LDL-C 143 (41) 137 (39) 
     HDL-C  46 (16) 52 (17) 
     Triglycerides 159 (115) 127 (85) 
Anthropometric variables, mean (SD)   
     Body mass index, kg/m2 29.6 (6.1) 27.3 (5.1) 
     Waist circumference, cm 103 (15) 96 (13) 
     Waist/Hip ratio 0.97 (0.07) 0.92 (0.08) 
Abbreviation:  LDL-C, low density lipoprotein cholesterol; HDL-C, High density lipoprotein  
cholesterol  
SI conversion: to convert total cholesterol values to g/L, multiply by 0.01; LDL-C,  
HDL-C to mmol/L, multiply by 0.0259; triglyceride to mmol/L, multiply by 0.113.
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Table 9. (MS. 1, Table 2)  Number of heart failure cases, total person-years of follow-up and age-adjusted* incidence rates (IR) for heart 
failure by category of each anthropometric measure (BMI, waist circumference, and waist-hip ratio), stratified by race and gender, ARIC, 
1987-2003  
 White Women (N = 5,659) Black Women (N = 2,350) 
 Mean 
Value 
Total  
person-years 
N (%) 
Heart failure 
Events (N) 
Age-adjusted*  
heart failure IR  
(95 % CI) per 1,000 
person years 
Mean 
Value 
Total  
person-years 
Heart failure 
events (N) 
Age-adjusted*  
heart failure IR  
(95 % CI) per 1,000 
person years 
BMI, kg/m2         
 < 25 22.2 39,557 (48) 104 2.27 (1.86, 2.77) 22.7 5,742 (18) 39 5.42 (3.99, 7.37) 
 25-30 27.2 25,259 (31) 109 3.96 (3.48, 4.50) 27.5 11,410 (35) 78 7.69 (6.54, 9.03) 
 ≥ 30 34.5 17,788 (21) 146 6.89 (5.77, 8.23) 35.8 15,135 (47) 175 10.91 (9.23, 12.89) 
Waist circumference, cm     
 1st Tertile, < 87 78.9 31,814 (39) 73 1.92 (1.50, 2.46) 79.4 6,762 (21) 31 4.17 (2.96, 5.88) 
 2nd Tertile, 87 ≤ 100   92.6 28,110 (34) 94 3.57 (3.10, 4.13) 93.2 10,667 (33) 68 7.08 (5.92, 8.46) 
 3rd Tertile, ≥ 100   111.2 22,680 (27) 192 6.64 (5.56, 7.93) 113.4 14,857 (46) 193 12.01 (10.15, 14.22) 
Waist-hip ratio          
1st Tertile, < 0.86  0.80 30,449 (37) 58 1.95 (1.57, 2.42) 0.80 10,136 (31) 35 4.28 (3.15, 5.81) 
2nd Tertile, 86 ≤ 0.93  0.89 25,910 (31) 97 3.48 (3.08, 3.94) 0.89 9,353 (29) 79 7.48 (6.35, 8.81) 
3rd Tertile, ≥ 0.93   0.98 26,245 (32) 204 6.22 (5.36, 7.22) 0.98 12,797 (40) 178 13.07 (10.99, 15.53) 
 White Men (N = 5,135 ) Black Men (N = 1,498 ) 
BMI, kg/m2         
 <25 23.1 19,561 (27) 113 3.92 (3.30, 4.67) 22.4 5,787 (30) 49 6.85 (5.23, 8.99) 
 25-30 27.3 36,665 (51) 256 6.12 (5.51, 6.79) 27.4 8,434 (43) 70 9.47 (8.11, 11.05) 
 ≥ 30 33.0 15,010 (21) 190 9.54 (8.25, 11.03) 33.6 5,271 (27) 76 13.07 (10.44, 16.37) 
Waist circumference, cm     
 1st Tertile, <87 88.9 24,020 (34) 108 4.01 (3.36, 4.78) 86.2 8,972 (46) 66 6.84 (5.39, 8.67) 
 2nd Tertile, 87 ≤ 100   98.4 23,715 (33) 193 5.92 (5.30, 6.61) 98.5 5,108 (26) 44 9.81 (8.44, 11.41) 
 3rd Tertile, ≥100   110 23,501 (33) 258 8.75 (7.66, 10.01) 111.8 5,413 (28) 85 14.01 (11.34, 17.46) 
Waist-hip ratio         
1st Tertile, <0.86  0.91 20,995 (29) 78 3.07 92.53, 3.72) 0.90 10,197 (52) 66 6.39 (4.97, 8.21) 
2nd Tertile, 86 ≤ 0.93  0.96 21,479 (30) 131 5.33 (4.77, 5.97) 0.96 4,866 (25) 46 10.20 (8.68, 11.98) 
3rd Tertile, ≥0.93   1.02 28,761 (40) 350 9.28 (8.25, 10.44) 1.01 4,429 (23) 83 16.27 (12.83, 20.6) 
*age-adjusted to mean age at baseline, 54 years
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Table 10.  (MS. 1, Table 3) Unadjusted and adjusted* hazard ratios (with 95 % CI) for incident heart failure by BMI, waist circumference and 
waist-hip ratio, stratified by race and gender, ARIC, 1987-2003 
 Women Men 
 White women  
HR (95 % CI) 
Black women  
HR (95 % CI) 
All women 
HR (95 % CI) 
White men 
HR (95 % CI) 
Black men 
HR (95 % CI) 
All men  
HR (95 % CI) 
BMI       
 Overweight vs. normal, crude 1.62 (1.25, 2.15) 1.00 (0.68, 1.47) 1.62 (1.30, 2.01) 1.21 (0.97, 1.51) 0.97 (0.67, 1.40) 1.13 (0.93, 1.36) 
 Overweight vs. normal, adjusted  1.59 (1.21, 2.09) 1.01 (0.68, 1.49) 1.38 (1.10, 1.72) 1.36 (1.09, 1.71) 1.09 (0.75, 1.59) 1.31 (1.08, 1.58) 
       
 Obese vs. normal, crude 3.15 (2.45, 4.05) 1.70 (1.19, 2.40) 3.13 (2.57, 3.81) 2.22 (1.76, 2.80) 1.69 (1.18, 2.42) 2.07 (1.70, 2.51) 
 Obese vs. normal, adjusted  2.99 (2.30, 3.88) 1.82 (1.27, 2.61) 2.52 (2.03, 3.12) 2.60 (2.04, 3.30) 1.91 (1.31, 2.78) 2.43 (1.98, 2.98) 
       
 Continuous, 1 SD change†, 
adjusted 
1.64 (1.48, 1.81) 1.35 (1.22, 1.49) 1.47 (1.37, 1.57) 1.51 (1.39, 1.63) 1.34 (1.20, 1.49) 1.45 (1.36, 1.54) 
       
Waist Circumference       
 2nd Tertile vs. 1st tertile, crude 1.46 (1.07, 1.98) 1.38 (0.90, 2.10) 1.55 (1.21, 1.98) 1.78 (1.41, 2.25) 1.17 (0.80, 1.71) 1.54 (1.27, 1.87) 
 2nd Tertile vs. 1st tertile, adjusted  1.28 (0.94, 1.74) 1.24 (0.80, 1.91) 1.27 (0.99, 1.63) 1.85 (1.45, 2.34) 1.14 (0.77, 1.70) 1.63 (1.34, 1.99) 
       
 3rd tertile vs. 1st tertile, crude 3.73 (2.85, 4.88) 2.86 (1.95, 4.17) 3.86 (3.11, 4.78) 2.38 (1.90, 2.97) 2.16 (1.56, 2.97) 2.20 (1.84, 2.64) 
 3rd tertile vs. 1st tertile, adjusted  2.89 (2.19, 3.82) 2.51 (1.69, 3.71) 2.70 (2.15, 3.39) 2.37 (1.88, 2.98) 2.07 (1.48, 2.89) 2.26 (1.88, 2.73) 
       
 Continuous, 1 SD change†, 
adjusted  
1.61 (1.46, 1.78) 1.46 (1.32, 1.63) 1.54 (1.43, 1.65) 1.56 (1.44, 1.69) 1.40 (1.26, 1.56) 1.50 (1.40, 1.60) 
       
Waist-hip Ratio       
 2nd Tertile vs. 1st tertile, crude 1.98 (1.43, 2.73) 2.45 (1.65, 3.65) 2.19 (1.70, 2.81) 1.65 (1.25, 2.19) 1.47 (1.01, 2.14) 1.46 (1.17, 1.82) 
 2nd Tertile vs. 1st tertile, adjusted  1.49 (1.08, 2.08) 2.10 (1.40, 3.15) 1.73 (1.34, 2.24) 1.47 (1.11, 1.95) 1.36 (0.92, 2.01) 1.41 (1.13, 1.77) 
       
 3rd tertile vs. 1st tertile, crude 4.12 (3.08, 5.52) 4.08 (2.84, 5.86) 4.32 (3.45, 5.42) 3.34 (2.61, 4.27) 2.98 (2.16, 4.12) 2.88 (2.38, 3.47) 
 3rd tertile vs. 1st tertile, adjusted  2.55 (1.88, 3.44) 3.10 (2.13, 4.51) 2.76 (2.18, 3.49) 2.69 (2.10, 3.45) 2.45 (1.75, 3.43) 2.58 (2.12, 3.14) 
       
 Continuous, 1 SD change†, 
adjusted 
1.57 (1.40, 1.76) 1.67 (1.47, 1.89) 1.62 (1.48, 1.76) 1.51 (1.40, 1.63) 1.47 (1.29, 1.67) 1.50 (1.41, 1.60) 
*Adjusted models included age, alcohol use, educational level, smoking status.  Models of all men and women also adjust for race and center. 
Adjusted models exclude 243 participants with missing covariates:  smoking status (N=9), educational level (N=23), and alcohol use (N=218).   
†1 SD change for BMI = 6 kg/m2 for women, 4.2 kg/m2 for men; 1 SD change for waist circumference = 15.4 cm for women and 10.9 cm for men; 1 SD 
change for waist-hip ratio = 0.08 for women and 0.05 for men. 
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Figure 7. (MS. 1, Figure 1) Adjusted hazard ratios (with 95 % CI) for the association of  body mass index (BMI), waist circumference (WC) and 
waist-hip ratio (WHR) with incident heart failure, stratified by gender and race, ARIC, 1987-2003.  Shown are overweight (Panel A) and obesity 
(panel B) as compared with the lowest category for that respective measure. 
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Table 11.  (MS. 1, Table 4)  Numbers of heart failure events, person-years of follow-up, age-adjusted heart failure incidence rates and 
multivariable adjusted hazard ratios of BMI stratified by high or low waist-hip ratio (WHR)Ω, ARIC 1987-2003 
 Heart failure 
events,  
N 
Person-years 
Of follow-up 
*Age-adjusted heart failure 
incidence rates per 1,000 person-
years  
(95 % CI) 
†Multivariable adjusted  
HR (95 % CI) 
BMI < 25 kg/m2, Low WHR 164 47,838 3.11 (2.77, 3.50) 1.00 
BMI< 25 kg/m2, High WHR 137 21,722 3.94 (3.59, 4.31) 1.48 (1.18, 1.86) 
BMI 25-30 kg/m2, Low WHR 119 30,795 4.98 (4.64, 5.35) 1.14 (0.90, 1.45) 
BMI 25-30 kg/m2, High WHR 382 49,679 6.30 (5.93, 6.70) 1.86 (1.54, 2.23) 
BMI > 30 kg/m2, Low WHR 48 9,169 7.97 (7.46, 8.52)) 1.73 (1.25, 2.41) 
BMI > 30 kg/m2, High WHR 524 43,060 10.08 (9.27, 10.97) 3.18 (2.66, 3.81) 
*Age-adjusted to mean age at baseline, 54 years.     
†Multivariable Cox proportional hazards models adjusted for age, educational level, race and center, gender,  
smoking status and alcohol use:  excludes 243 participants with missing covariates:  smoking status (N=9),  
educational level (N=23), and alcohol use (N=218) 
ΩWaist-hip ratio cutpoints were:  0.88 for women and 0.95 for men 
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Figure 8. (MS. 1, Figure 2) *Age-adjusted heart failure incidence rate (per 1,000) person-years by categories of BMI, stratified 
by category of waist-hip ratio (cutpoints were = 0.88 for women and 0.95 for men), ARIC 1987-2003 
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*Age-adjusted to mean age at baseline, 54 years 
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B. Manuscript 2:  The preventable burden of heart failure due to obesity:  The 
Atherosclerosis Risk in Communities (ARIC) Study 
 
ABSTRACT 
 
Prevention of heart failure is a priority as it is associated with significant personal suffering, 
healthcare utilization and costs.  We estimated the proportion of incident heart failure that 
would be prevented from a range of feasible reductions in obesity and/or overweight, by 
calculation of the generalized impact fractions (GIF).  Methods:  The Atherosclerosis Risk in 
Communities (ARIC) study is an ongoing bi-racial population-based cohort of those aged 45-
65 years from 4 U.S. communities with 14 years median follow-up for incident, hospitalized 
or fatal heart failure.  BMI was measured at the baseline visit (1987-1989) and categorized as 
normal weight (BMI <25 kg/m2), overweight (BMI 25-30 kg/m2), and obese (BMI ≥ 30 
kg/m2).  After exclusion of baseline prevalent heart failure, missing anthropometry measures, 
and poorly represented race groups, the sample size was 14,642.  The GIF was calculated for 
each age-, race- and gender- stratified group and then combined overall groups using a case-
load weighted-sum method.  A 95 % distribution of the GIF was estimated from 10,000 
bootstrapped datasets.  Results:  A 30% hypothetical reduction in both obesity and 
overweight would prevent 8.5 % (95 % intervals = 6.1%, 10.7%) of incident heart failure 
cases, whereas a 30 % reduction in obesity only would prevent 6.7 % (95 % intervals = 5.4 
%, 8.0 %) of incident heart failure.  However, a 6.7 % reduction in heart failure would result 
in 44,220 fewer incident heart failure cases with approximately $477,674,356 cost savings 
per year.  The attributable fraction (28 % [95 % intervals = 20 %, 36 %]), which assumes 
complete elimination of obesity and overweight, is approximately 3 times larger than the 
highest amount of weight reduction (30 % reduction in obesity) assumed feasible here.  
Conclusion:  Calculation of the GIF was enlightening as to the actual impact of an aggressive 
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reduction in obesity and overweight.  The overall GIF number appears small, however when 
applied to the actual impact on healthcare utilization and cost, it has a large impact since HF 
is a common condition that is expensive to manage.  We propose studies should consider 
estimation of the generalized impact fraction in addition to the attributable fraction, in order 
to avoid estimates of population impact based on unachievable goals, such as eradication of 
obesity.   
 
1. Introduction 
     Heart failure (HF) is common, with an estimated 5,300,000 American adults living with 
HF, and it is increasing in prevalence(Rosamond, Flegal et al. 2008).  Hospital discharges for 
heart failure in the U.S. have increased 171 % since 1979, with 660,000 incident heart failure 
cases expected in the U.S. for 2008 with nearly 35 billion in U.S healthcare costs{Rosamond, 
2008 #201}.  Clearly the prevention of heart failure must be a priority.  Obesity is a known 
risk factor for heart failure(Kenchaiah, Narula et al. 2004).  In fact, obesity has been 
recognized as a qualifying risk factor for stage A heart failure, a pre-heart failure stage, in the 
latest staging scheme for heart failure from the American Heart Association (AHA)(Hunt, 
Abraham et al. 2005).  A recent scientific statement from the AHA was released specifically 
on the prevention of heart failure; it recommends maintenance of normal weight as one way 
to prevent heart failure(Schocken, Benjamin et al. 2008).  The actual impact of a population-
level reduction in obesity on the potential prevention of heart failure has been assessed only 
in terms of the attributable fraction, which estimates the proportional reduction in disease 
given complete elimination of an exposure(He, Ogden et al. 2001; Kenchaiah, Narula et al. 
2004).  For many exposures, complete elimination is impossible or highly unlikely, a 
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circumstance applicable to obesity and overweight as exposures that are unlikely to be 
eliminated from society(Benichou 2007).  Despite this, the attributable fraction has been used 
extensively in the obesity literature, including recent articles estimating the burden of all-
cause mortality attributable to overweight and obesity(Flegal, Graubard et al. 2004; Flegal, 
Graubard et al. 2005).   
     A more realistic and meaningful calculation for estimating the impact of weight reduction 
on disease incidence is the generalized impact fraction (GIF), also known as the potential 
impact fraction and the generalized attributable fraction(Benichou 2001; Vander Hoorn, 
Ezzati et al. 2004).  It is a generalization of the attributable fraction which estimates the 
proportional reduction in disease incidence given a graded reduction in the prevalence of a 
risk factor.  For common risk factors and diseases, the impact of a hypothetical reduction in 
the exposure may reveal an important effect on disease incidence even when risk factor-
disease associations are relatively weak(Morgenstern and Bursic 1982).   The GIF was 
originally described by Walter in 1980(Walter 1980), then further elucidated and coined by 
Morgenstern and Bursic in 1982(Morgenstern and Bursic 1982).  Specifically, it is “the 
proportional reduction in the total number of new (incident) cases of a certain disease, 
resulting from a specific change in the distribution of a risk factor in the population at 
risk.”(Morgenstern and Bursic 1982).  Despite its introduction over 25 years ago, it hasn’t 
caught on as either a replacement for, or complement to, the attributable fraction.   Despite 
it’s limited adoption in the literature as compared to the attributable fraction, the generalized 
impact fraction has been adopted recently in the literature on  the global burden of 
disease(Murray and Lopez 1999), health policy(Nilunger, Diderichsen et al. 
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2004),environmental epidemiology(Semenza, Rubin et al. 1996) and nutritional 
epidemiology(Graham 2000).  
     The goal of this study is to estimate the population burden of incident heart failure that 
would be prevented from a feasible reduction in the prevalence of obesity and overweight, by 
calculation of the generalized impact fraction.  Several scenarios of reduced prevalence of 
obesity and overweight are considered.  In addition, we calculate the attributable fraction to 
compare this more commonly used measure with the GIF.   
 
2. Methods 
Study population 
     The ARIC cohort (N=15,792) was recruited between 1987-1989 using probability 
sampling of those aged 45-64 from the following four US communities:  Forsyth County, 
North Carolina; Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington 
County, Maryland.  The distribution of blacks and whites from each field center was 
representative of the area (mostly white in Minneapolis and Washington County, 15 % black 
in Forsyth County) except in Jackson where only blacks were sampled.  Response to the 
baseline examination was 46 % in Jackson and between 65-67 % for the other communities.  
Three subsequent examinations were conducted at approximately three-year intervals 
through 1996-98.  The design and rationale of the ARIC study (The ARIC Investigators 
1989) and the comparison between responders and nonresponders (Jackson, Chambless et al. 
1996) have been previously published.  The institutional review boards from each study site 
approved the ARIC study.  Participants provided written informed consent at each 
examination.  
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     Racial groups not classified as White or Black (N = 48) and Blacks not from the city of 
Jackson or Forsyth County (N = 120) were excluded from analyses due to their limited 
numbers.  In addition, those with missing anthropometry (N = 33) or those with prevalent 
heart failure (HF) at baseline were excluded from this analysis.  Criteria to define prevalent 
HF were as follows:  1) those answering “yes” to the following question:  “Were any of the 
medications you took during the last two weeks for heart failure?” (N = 83), or 2) those with 
stage 3 or ‘manifest HF’ by applying Gothenburg criteria (N = 699)(Eriksson, Caidahl et al. 
1987).  Gothenburg criteria were defined by self-reported medical history, medication lists 
and electrocardiography.  After these exclusions, the total sample size was 14,399. 
 
Anthropometric and covariate measurement  
     Body mass index (BMI) was calculated as weight (kg) divided by height (meters2) 
squared.  Height and weight were measured after an overnight fast with participants in 
standard scrub attire.  Technicians measured height with participants barefoot using a wall 
mounted ruler.  Weight measurements were performed using a scale (Detecto model 437) 
that was zeroed daily and calibrated quarterly.   
     All covariates are drawn from the baseline visit.  Race, gender, educational level, alcohol 
use, and smoking status were obtained by participant self-report.  History of coronary heart 
disease included those with a history of myocardial infarction (MI) (either self-report of 
physician-diagnosed MI or silent MI as identified by electrocardiography), and those with a 
prior coronary revascularization procedure or coronary artery bypass surgery.  Hypertension 
was defined by either a diastolic blood pressure ≥ 90 mm Hg or a systolic blood pressure ≥ 
140 mm Hg measured with random-zero mercury manometers, or anti-hypertensive 
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medication use during the previous 2 weeks.  Diabetes mellitus was defined as any of the 
following: self-reported history of physician diagnosed diabetes, medication use for diabetes 
over the last 2 weeks, a blood glucose ≥ 126 mg/dl fasting or a blood glucose ≥ 200 mg/dl 
non-fasting.  
 
Ascertainment of heart failure events     
 
     The following methods were used for ascertainment of HF events:  1) participants were 
contacted annually by phone and interviewed about interim hospitalizations; 2) local 
hospitals provided lists of hospital discharges with cardiovascular diagnoses and these were 
reviewed to identify cohort hospitalizations; and 3) health department death certificate files 
were continuously surveyed.  All discharge codes for cohort hospitalizations and listed 
causes of death from death certificates were recorded (underlying cause of death or 
contributory causes).   
 
Incident heart failure event criteria 
     Incident HF was defined as the first occurrence of either:  1) a hospitalization which 
included an ICD-9-CM (International Classification of Diseases, 9th revision, clinical 
modification) discharge code for heart failure beginning with ‘428’ (428.0 - 428.9) in any 
position (N = 1,329) or else 2) a death certificate beginning with ICD-9 code ‘428’ or ICD-
10 code ‘I50’ (I50.0 – I50.9) in any position (N = 76).  Follow-up time for those with an 
incident HF event was defined as the time from the date of their baseline examination until 
the incident event with follow-up through December 31st, 2003.  The end of follow-up time 
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for those without HF was the first occurrence of either:  1) December 31st, 2003, 2) date of 
last contact for those lost to follow-up, or 3) date of death.   
 
Estimates for the reduced prevalence of obesity and overweight 
     To determine feasible goals for weight reduction, we considered the goals set by the US 
Department Health and Human services in the Healthy People 2010 report.  Healthy People 
2010 is a set of recommended health objectives meant to serve as a basis from which to 
develop US national, state and community plans for health improvement by the year 
2010(2000) .  Obesity and overweight are listed as high priority public health issues.  
Specifically, Healthy People 2010 aim to reduce the proportion of obese adults aged 20 years 
and older to 15 % from 23% by the year 2010 (25 % in females and 20 % in males, data from 
1988-1994, age adjusted to year 2000), which is approximately a 35 % reduction in the 
proportion of obese.  We chose several scenarios for the reduction in the proportion of obese 
and overweight, for which the maximum achievable goal selected was a 30 % reduction in 
both obesity and overweight.  We chose a 30 % reduction in each subgroup, rather than 
targeting 15 % prevalence of obesity for all subgroups, as certain subgroups, such as Black 
women in which 47-48 % were obese at study baseline, would require an impractical amount 
of widespread weight reduction to meet this goal.    
 
Statistical methods 
     The generalized impact fraction for heart failure given a reduction in overweight and or 
obesity was estimated using equations 1 and 3 (see box).  Specifically, for this study, the GIF 
was calculated for each age-, race- and gender- stratified group (see equation 1) and then 
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combined using a case-load weighted sum method to obtain an overall GIF (see equation 3).  
For each stratum, the components of GIF equation were defined as follows: 1) Pi is the 
prevalence of the exposure (obesity, overweight and normal weight) in the ARIC population 
at baseline (1987-1989); 2) Pi* is the reduced prevalence of obesity, overweight and normal 
weight (reduced as compared to Pi) after a hypothetical change in the distribution of BMI; 
and 3) RRi, in this case, is the crude hazard ratio of incident heart failure for those 
overweight, obese or normal weight as compared to the referent group (normal weight), for 
that stratum.  Cox proportional hazard regression was used to model the association between 
obesity (BMI ≥ 30 kg/m2), overweight (BMI ≥ 25 and ≤ 30, kg/m2) with normal weight (BMI 
< 25 kg/m2) and time to incident HF.  BMI was categorized as represented in the clinical 
guidelines from the National Institutes of Health(NIH 1998).  In the multivariable model, ties 
were handled with the method suggested by Efron.  All statistical analyses were performed 
using SAS software v 9.1 (Cary, NC).   
     Since calculation of the GIF is based on a single study population (the ARIC cohort), we 
added further uncertainty to these calculations by bootstrapping to obtain 95 % simulation 
intervals for the GIF and attributable fraction (see Figure 9 (MS. 2, Figure 1))(Greenland 
2004).  Ten thousand bootstrapped samples (with replacement) were performed for each 
subgroup of race, gender and age (therefore, there were 8 subgroups each with 10,000 
bootstrapped samples).  Each sampled dataset was the same size as the subgroup in the 
original dataset.  The unadjusted hazard ratios (HRi) for obesity and overweight (the HR for 
normal weight is always 1), and the prevalence (Pi) of normal weight, overweight and obesity 
were determined within each stratum for each of the 10,000 bootstrapped dataset.  The GIF 
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for each stratum was calculated given these values and a specified alternative distribution for 
the reduced prevalence of obesity, overweight and normal weight (Pi*).   
     The overall GIF for each hypothetical scenario of weight reduction was determined using 
the case-load weighted-sum approach for each bootstrapped sample using equation 2 
(Benichou 2001).  From the distribution of the 10,000 overall generalized impact fractions, 
the median (along with 2.5 % and 97.5 % simulation intervals) were calculated for each 
hypothetical scenario.  The attributable fraction, or in this case the maximum GIF, was 
calculated using the same case-load weight-sum method using equation 2(Morgenstern and 
Bursic 1982).  Based on the distribution of values from the bootstrapped samples, the median 
attributable fraction along with 2.5 and 97.5 percentiles are reported.     
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(Equation 1) 
GIF for a given bootstrap sample, and stratum a,b,c  =Σ Pi, abc(RRi, abc) – Σ Pi*,abc (RRi, 
abc)                    Σ Pi, abc(RRi,abc) 
Where, 
GIF = generalized attributable fraction for one bootstrap sample, from a given stratum of 
abc,  
Pi = proportion of the population in exposure category, i, 
Pi*= proportion of the population in exposure category i after an intervention or other 
change, 
RRi = Relative risk at exposure category i compared to the reference level, 
i = normal weight, overweight, or obese categories as defined by BMI, 
abc = stratum of age (age < 55 years, age ≥ 55 years), race (black or white) and gender 
(male or female) 
Specifically, 
Numerator GIFa,b,c  =  [Poverwt, abc(RRoverwt, abc) + Pobese, abc(RRobese, abc) + Pnormal wt, abc(1)]  –  
[(P*overwt, abc)(RRoverwt, abc) + (P*obese, abc)(RRobese, abc) + (P*normal wt, abc)(1)]    
Denominator GIFa,b,c =[(Poverwt, abc)(RRoverwt, abc)+(Pobese, abc)(RRobese, abc)+(Pnormal wt, abc)(1)] 
(Equation 2) 
AF (or maximum GIF) for a given bootstrap sample from stratum a, b, c = 
 [∑(pdi(RRi) – 1)] / [∑(pdi(RRi)] 
  
where pdi = proportion of total cases arising from the ith exposure category   
 RRi = the unadjusted RR (in this case HR) for the ith exposure category  
 compared to referent (i = overweight, or obese categories compared to normal) 
 
(Equation 3) 
Case-load weighted sum method for GIFoverall  
Numerator GIFoverall (or AFoverall) for a one bootstrap sample =  
(#casesa1b1c1)(GIFa1b1c1) + (#casesa1b1c0)(GIFa1b1c0) +  
(#casesa0b1c1)(GIFa0b1c1) + (#casesa0b1c0)(GIFa0b1c0) +  
(#casesa0b1c1)(GIFa0b1c1) + (#casesa0b1c0)(GIFa0b1c0) +     
(#casesa1b0c1)(GIFa1b0c1) + (#casesa1b0c0)( GIFa1b0c0) +  
(#casesa1b0c1)(GIFa0b0c1) + (#casesa0b0c0)( GIFa0b0c0) +  
(#casesa0b0c1)( GIFa0b0c1) + (#casesa0b0c0)(GIFa0b0c0) 
   
Denominator GIFoverall (or AFoverall) for a given boostrap sample = 
(#casesa1b1c1) + (#casesa1b1c0) + (#casesa0b1c1) + (#casesa0b1c0) + (#casesa0b1c1) + 
(#casesa0b1c0) + (#casesa1b0c1) + (#casesa1b0c0) + (#casesa1b0c1) + (#casesa0b0c0) + 
(#casesa0b0c1) + (#casesa0b0c0) 
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3. Results 
     There were 3,887 obese and 5,787 overweight participants in the ARIC cohort at baseline 
(Table 12, (MS 2. Table 1).  Obese participants were more often Black, female, with less than 
high school education, and more likely to have diabetes, or hypertension.  Furthermore, they 
were less likely to be smokers, and current drinkers of alcohol.  There were a larger percentage 
of obese participants from Jackson than any other study site; only African-Americans were 
represented from this site.  Prevalent coronary heart disease was less common among normal 
weight participants compared to those overweight or obese.   
     The main components of the GIF formula are shown by subgroup in Table 13 (MS. 2, Table 
2), namely the number of heart failure cases, the proportion of participants in each category of 
the exposure variable (normal weight, overweight, or obese), and the unadjusted hazard ratios for 
the involved comparisons (overweight and obese as compared to referent).  This table also shows 
incidence rates of HF by subgroup.  Across all race and gender groups, the incidence rates of HF 
are at least two times larger for older compared to the younger subgroups.  Older Black women 
and Black men have particularly high HF incidence rates (14.0 and 15.2 per 1,000 person-years, 
for women and men, respectively).  Although there are fewer Blacks than Whites across all age 
and gender groups, the GIF formula weights by the number of heart failure cases in each 
subgroup.  For example, while the number of older Black men (N = 668) is over four times 
smaller  than younger White women (N = 3,079), older Black men have nearly the same weight 
as young White women in the overall GIF formula since they have a similar number of heart 
failure cases (120 and 119, respectively).  Approximately half of White women were in the 
normal weight category whereas only 18 % of Black women were normal weight; nearly half of 
Black women were obese.  There was a higher proportion of overweight among White men (over 
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50 %) compared to Black men, whereas there was a higher proportion obese among Black men 
compared to White men.  For all strata, the unadjusted hazard ratios and their confidence 
intervals for obesity as compared to referent were above 1.0 representing a harmful effect of 
obesity on the incidence of heart failure.  Hazard ratios for heart failure were particularly high 
among young White women (HR = 4.14 (95 % CI = 2.70, 6.36) although the confidence 
intervals overlap for most other subgroups.  The hazard ratios for overweight are lower in 
magnitude with confidence intervals crossing 1.0 in most cases.  In fact, two of the hazard ratios 
for the comparison of overweight with referent were less than 1.0, although the confidence 
intervals also cross 1.0 (young Black men, HR = 0.93 (95 % CI, 0.49, 1.76); young Black 
women, HR = 0.94 (0.52, 1.69)).         
     The goal of healthy people 2010 for a reduction in obesity to 15 % among the U.S. adult 
population is similar to our goal here of a 30 % reduction in the proportion obese.  Table 14 (MS 
2, Table 3) shows the proportion obese before and after a hypothetical intervention resulting in a 
30 % reduction in the proportion obese (shifting all who lost weight from the obese category to 
normal weight).   In most subgroups, a hypothetical 30 % reduction in obesity results in a 
prevalence of 15-19 % obesity in the population of interest.  Black women were the exception 
since there would be a prevalence of 33-34% of obesity for Black women even after a 30 %.  The 
median GIF (with 95 % simulation intervals) from 10,000 bootstrapped datasets for a 30 % 
reduction in obesity range from 4% to 11% for the eight subgroups.  The 2.5 % tail of the 
distribution of median GIF is negative for older Black men.  The overall median GIF for the 
scenario of a 30 % reduction in the proportion obese (scenario 6 from Table 15 (MS. 2, Table 4)) 
was 6.7 % (95 % intervals = 5.4, 8.0).  This can be interpreted to mean that 6.7% of incident 
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heart failure could be prevented in this population with a 30% reduction in obesity, assuming 
weight loss down to the normal weight category.     
     The overall median GIF with 95 % simulation intervals for 10 different scenarios of weight 
reduction are shown in Table 15 (MS. 2, Table 4) and Figure 10 (MS. 2, Figure 2).  The most 
aggressive weight reduction scenario assumed here, other than complete elimination as required 
in calculation of the attributable fraction, is a 30% reduction of obese and overweight down to 
the normal weight category (scenario 8, see Table 15 (MS. 2, Table 4)).  We predict that scenario 
8 would result in the prevention of 8.5 % (95 % intervals = 6.1%, 10.7%) of incident heart failure 
cases.  The last two scenarios represent the attributable fraction which assumes complete 
elimination of obesity and overweight in the case of the 10th scenario, whereas the 9th scenario 
assumes complete elimination of obesity only.  The attributable fraction (scenario 10) is 
approximately 3 times larger than our most aggressive scenario of weight reduction presented 
here (scenario 8).  There is only a small change in the GIF when those who are obese and have 
lost weight are shifted to normal weight (scenarios 2 and 6), rather than overweight (scenarios 1 
and 5).  This implies that weight loss among those who are obese down to the overweight group 
would have a similar population-level impact on heart failure incidence as weight loss down to 
the normal weight group.  
 
4. Discussion 
     We examined the possible public health impact on heart failure incidence given multiple 
hypothetical and feasible reductions in obesity and/or overweight, and found that the practical 
level of impact appears small, but may be potentially important.  We found that a 30 % reduction 
in obesity with presumed weight loss to the normal weight category, the goal most similar to 
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Healthy People 2010 goal of 15 % obese, would hypothetically result in 6.7 % fewer cases of 
incident heart failure.  It is estimated there will be 660,000 incident heart failure events in 2008.  
The average cost per hospital discharge for HF (estimated from 2003) was $6,577(Rosamond, 
Flegal et al. 2008).  To extrapolate our findings to these estimates, a 6.7 % reduction in heart 
failure would have resulted in 44,220 fewer incident heart failure cases with an estimated 
$477,674,356 cost savings for that year.  Due to the high prevalence of heart failure and frequent 
need for re-hospitalization, such an impact would offer important reduction in disease burden 
and healthcare utilization.  Although not accounted for in these calculations, population-wide 
weight reduction would also have a preventive effect on common heart failure risk factors, such 
as hypertension(Levy, Larson et al. 1996) and diabetes(Masoudi and Inzucchi 2007), resulting in 
further reductions in healthcare cost and utilization.   
     Another goal from healthy people 2010 is an increase in the percentage of normal weight up 
to 60 %(US Department of Health and Human Services 2000).  Even with a 30 % reduction in 
overweight and obese, we estimate we still will not have achieved this goal (data not shown); 
instead the percentage of normal weight after a 30 % reduction in obesity and overweight would 
be between 43–54 % per subgroup, except for among White women in which it would be 61 - 
65%.  More widespread weight reduction would be needed to accomplish this goal among race 
and gender groups other than White women.  
     Our findings for the generalized impact fraction are relatively small compared to our much 
higher estimate for the attributable fraction of 28 %.  As compared to the attributable fraction, 
the generalized impact fraction is a measure of preventable burden of disease that can be based 
on multiple hypothetical changes in the exposure distribution.  In fact, although not shown here, 
the generalized impact fraction can be used to predict the effect of a given shift in the 
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distribution of a continuous exposure measurement.  To date, the generalized impact fraction has 
not been used elsewhere to describe the preventable burden of heart failure due to obesity.  
However, two other studies have calculated the attributable fraction.  First, the Framingham 
Heart Study estimated the attributable fraction for heart failure was 14 % for overweight women, 
13.9 % for obese women, 8.8 % for overweight men and 10.9 % for obese men(Kenchaiah, 
Evans et al. 2002).  They used an equation for the attributable fraction appropriate when the 
relative risk has been adjusted for confounders.  The Framingham population has a lower 
prevalence of obesity compared to the ARIC study and they adjusted for causal intermediates 
which lowers the magnitude of the effect estimate.  Secondly, the First National Health and 
Nutrition Examination Survey (NHANES I) calculated the attributable fraction of heart failure 
for overweight (5.6 % in men; 9.6 % in women), however they dichotomized BMI at 27.8 kg/m2 
for men and 27.3 kg/m2 for women(He, Ogden et al. 2001).  In both studies, confidence intervals 
for attributable fraction were not estimated.  These estimates of attributable fraction are lower 
than those estimated here.  This is due to differences in the prevalence of obesity and overweight 
in the populations, and the magnitude of the relative estimate of effect. 
     There are several assumptions of the generalized impact fraction and the attributable 
fraction(Morgenstern and Bursic 1982).  The relative risk, or in this case hazard ratio, must be a 
valid estimate for a causal relationship between exposure and disease for the desired target 
population, and not biased by confounding or misclassification.  In this case, we have 
extrapolated from our study population, the ARIC cohort, to the U.S. population, our target.  
Also, we assume that those who are hypothetically shifted (obese) to a different risk group 
(normal weight) post-intervention, now have the same risk that their new risk group had pre-
intervention.  We have assumed those who lose weight will have the same risk of heart failure as 
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those who were normal weight without intervention.  When this condition is not met then the 
generalized impact fraction may overestimate the impact of the intervention.  Also, it is assumed 
there are not secular trends in risk of disease that are not due to the intervention; and there are 
not secular trends in intermediary diseases, such as diabetes for obesity, that would affect the 
relationship between the exposure and disease.  There are secular trends showing increasing 
incidence of heart failure, obesity, and diabetes(Rosamond, Flegal et al. 2008), which is one 
reason that prevention of disease has become vital.  Although all of these criteria are not easily 
met, as in this case, these are the same assumptions made when estimating the often used 
attributable fraction.     
    Limitations of this analysis and the generalized impact fraction in general, include that unlike 
the attributable fraction, one must stratify by important confounders rather use an adjusted 
relative measure of effect such that small sample sizes can be a problem.  Although in the current 
study, there were few confounders identified using a 10 % change in estimate criterion.  Inherent 
in estimating the generalized impact fraction, one must consider a counterfactual 
approach(Rodgers 2002), and in so doing we wanted to use feasible goals for population-wide 
weight reduction.  It is difficult to determine feasible goals for population-wide weight reduction; 
however, we considered a spectrum of weight loss with the goals recommended in the Healthy 
People 2010 report as our most optimistic goal.    
     In 1982, Morgenstern and Bursic illustrate the use of the generalized impact fraction with an 
example of the impact of a hypothetical weight loss programs on the incidence of coronary heart 
disease(Morgenstern and Bursic 1982).  Similarly, we estimated the effect of a feasible reduction 
in obesity on the burden of heart failure.  These examples show how this important measure, the 
generalized impact fraction, should be routinely used in practice for risk factors that are unlikely 
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to be completely eradicated.  For common risk factors such as obesity and overweight, the 
impact of intervention may reveal important changes in the burden of disease even when risk 
factor-disease associations are relatively weak.  Reduction in the incidence of heart failure of 
6.7%, the predicted impact of a 30% reduction in the prevalence of obesity, would result in an 
impressive reduction in the number of incident for heart failure events.  We propose studies 
should consider estimation of the generalized impact fraction instead of the attributable fraction, 
in order to avoid estimates of population impact based on unachievable goals, such as eradication 
of obesity.  Such evaluations are vital to prioritize and inform future prevention programs 
regarding the possible impact of their efforts.    
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Stratum A, White women, <55 years 
Dataset x from 10,000 (N = 3,079) 
for stratum A 
 
Stratum B, White women, ≥ 55 yrs 
Dataset x (N = 2,580) from 10,000 
bootstrapped datasets for stratum B 
Stratum C, Black women, < 55 yrs 
Dataset x (N = 1,423) from 10,000 
bootstrapped datasets for stratum C 
Stratum D, Black women, ≥ 55 yrs 
Dataset x (N = 927) from 10,000 
bootstrapped datasets for stratum D 
Stratum E, White men, < 55 years 
Dataset x (N = 2,476) from 10,000 
bootstrapped datasets for stratum E 
 
Stratum F, White men, ≥ 55 years 
Dataset x (N = 2,659) from 10,000 
bootstrapped datasets for stratum F 
Stratum G, Black men, < 55 years 
Dataset x (N = 830) from 10,000 
bootstrapped datasets for stratum G 
Stratum H, Black women, ≥ 55 yrs 
Dataset x (N = 668) from 10,000 
bootstrapped datasets for stratum H 
 Stratum A, White women, < 55 years 
From dataset x, the following were obtained: 
Poverwt,A,x, Pobese,A,x, HRoverwt,A,x, HRobese,A,x, Ncases,A,x 
 
GIFA,x = GIF for dataset x 
from stratum A for a given 
scenario of weight reduction 
 
 Stratum B, White women, ≥ 55 years 
From dataset x, the following were obtained:  
Poverwt,B,x, Pobese,B,x, HRoverwt,B,x, HRobese,B,x, Ncases,B,x 
 
Stratum C, Black women, < 55 years 
From dataset x, the following were obtained:  
Poverwt,C,x, Pobese,C,x, HRoverwt,C,x, HRobese,C,x, Ncases,C,x 
 
Stratum D, Black women, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,D,x, Pobese,D,x, HRoverwt,D,x, HRobese,D,x, Ncases,D,x 
 
Stratum E, White men, < 55 years 
From dataset x, the following were obtained:  
Poverwt,E,,x, Pobese,E,x, HRoverwt,E,x, HRobese,E,,Ncases,E,x 
Stratum F, White men, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,F,,x, Pobese,F,x, HRoverwt,F,x, HRobese,F,,Ncases,F,x 
Stratum G, Black men, < 55 years  
From dataset x, the following were obtained: 
Poverwt,G,,x, Pobese,G,x, HRoverwt,G,x, HRobese,G,,Ncases,G,x 
Stratum H, Black men, ≥ 55 years  
From dataset x, the following were obtained:  
Poverwt,H,,x, Pobese,H,x, HRoverwt,H,x, HRobese,H,,Ncases,H,x 
GIFB,x = GIF for dataset x 
from stratum B for a given 
scenario of weight reduction 
 
GIFC,x = GIF for dataset x 
from stratum C for a given 
scenario of weight reduction 
 
GIFD,x = GIF for dataset x 
from stratum D for a given 
scenario of weight reduction 
 
GIFE,x = GIF for dataset x 
from stratum E for a given 
scenario of weight reduction 
 
GIFF,x = GIF for dataset x 
from stratum F for a given 
scenario of weight reduction  
GIFG,x = GIF for dataset x 
from stratum G for a given 
scenario of weight reduction 
 
GIFH,x = GIF for dataset x 
from stratum H for a given 
scenario of weight reduction 
 
Figure 9.  (MS. 2, Figure 1) Diagram of intermediate steps in the estimation of the distribution of the generalized impact fraction (GIF) using 
bootstrapped datasets (sampled with replacement), x = dataset number out of 10,000 bootstrapped datasets.  Each dataset contains the same 
name number (N) in each stratum as found in the original data.  Poverwt= proportion overweight, Pobese = proportion obese, HRoverwt = 
unadjusted hazard ratio for obese, HRobese = unadjusted hazard ratio for overweight, and Ncases = number of incident heart failure cases 
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Table 12.  (MS. 2, Table 1)  Characteristics of the population (N = 14,642) at baseline by category of 
BMI, ARIC, 1987-1989 
Characteristics  Normal weight  
BMI < 25 kg/m2 
(N = 4,968) 
Overweight 
BMI 25-30 kg/m2 
(N = 5,787) 
Obese  
BMI > 30 kg/m2 
(N = 3,887) 
Body mass index, kg/m2, mean (SD) 22.5 (1.8) 27 (1.4) 34 (4.3) 
Age, years, mean (SD) 54 (6) 54 (6) 54 (6) 
Men, % 37 56 39 
Black, % 18 25 39 
Center, %    
     Jackson, MS 15 22 36 
     Forsyth County, NC 34 25 17 
     Minneapolis, MN 27 28 21 
     Washington County, MD 24 25 26 
Educational level, %    
     Less than high school 18 23 30 
     High school graduate 34 32 32 
     Greater than high school 48 46 38 
Smoking status, %    
     Never smoker 39 40 48 
     Former smoker 28 36 33 
     Current smoker 34 24 19 
Alcohol use, %    
     Never drinker 21 23 34 
     Former drinker 16 18 21 
     Current drinker 63 59 45 
Diabetes, % 5 10 21 
Hypertension, % 21 32 49 
History of coronary heart disease, % 3 5 5 
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Table 13.  (MS. 2, Table 2)  Total number of participants, number of heart failure events, follow-up time, proportion in each BMI category, and 
unadjusted hazard ratios for incident heart failure, stratified by race, gender and age, ARIC 1987-2003 
 HF  
events,  
N 
Person 
years of  
Follow-up 
Heart failure 
IR per 1,000  
person-years 
Proportion 
 normal 
weight 
Proportion 
overweight 
Proportion 
obese 
Unadjusted 
HR for 
overweight 
(95 % CI) 
Unadjusted 
HR 
for obese 
(95 % CI) 
White women,  
     age < 55 years, N= 3,079 
119 45,887 2.59 0.50 0.29 0.21 1.52 (0.92, 2.51) 4.14 (2.70, 6.36) 
White women,  
     age ≥ 55 years, N=2,580 
240 36,717 6.54 0.45 0.32 0.23 1.56 (1.31, 2.14) 2.58 (1.89, 3.53) 
Black women,  
     age < 55 years, N=1,423 
123 20,247 6.07 0.18 0.35 0.47 0.94 (0.52, 1.69) 1.63 (0.96, 2.76) 
Black women,  
     age ≥ 55 years, N = 927 
169 12,039 14.04 0.18 0.34 0.48 1.04 (0.62, 1.72) 1.75 (1.10, 2.77) 
White men,  
     age  < 55 years, N= 2,476 
151 36,034 4.19 0.27 0.51 0.22 1.65 (1.03, 2.64) 2.64 (2.01, 3.25) 
White men,  
     age  ≥ 55 years, N=2,659 
408 35,202 11.59 0.27 0.51 0.22 1.09 (0.85, 1.40) 1.98 (1.51, 2.59) 
Black men,  
     age < 55 years, N=830 
75 11,611 6.46 0.28 0.44 0.28 0.93 (0.49, 1.73) 2.10 (1.16, 3.80) 
Black men,  
     age ≥ 55 years, N=669 
120 7,881 15.23 0.34 0.39 0.26 1.12 (0.72, 1.76) 1.58 (1.00, 2.49) 
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Table 14.  (MS. 2, Table 3)  Median proportion in each BMI category along with median GIF from 10,000 bootstrapped 
datasets, after 2 scenarios of weight reduction, a 30 % reduction in obesity to normal weight, and a 30 % reduction in 
obesity and overweight with reduction to normal weight, stratified by race, gender and age, ARIC 1987-2003 
 Median  
Proportion 
Overweight 
Median  
Proportion 
Obese 
Median Proportion 
Obese* 
(after a 30 % 
Reduction) 
Median 
GIF*, % 
(95 % intervals) 
Median 
GIF**, % 
(95 % intervals) 
White women, age < 55 years 0.21 0.21 0.15 11 (8, 15) 13.5 (8.6, 18.3) 
White women, age ≥ 55 years 0.23 0.23 0.16 7 (5, 10) 10.5 (6.7, 14.4) 
Black women, age < 55 years 0.47 0.47 0.33 7 (0.5, 13) 6.7 (-4.4, 16.4) 
Black women, age ≥ 55 years 0.48 0.48 0.34 8 (2, 13) 8.2 (-1.1, 16.1) 
White men, age < 55 years 0.22 0.22 0.16 8 (5, 11) 13.6 (7.2, 20.0) 
White men, age ≥ 55 years 0.21 0.21 0.15 5 (3, 7) 6.1 (1.6, 10.4) 
Black men, age < 55 years 0.27 0.27 0.19 7 (2, 13) 6.6 (-4.4, 16.0) 
Black men, age ≥ 55 years 0.26 0.26 0.18 4 (-0.1, 8) 5.0 (-2.6, 11.9) 
*30 % reduction in obesity, shift all to normal weight 
**30 % reduction in obesity and overweight, shift all to normal weight 
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Table 15.  (MS. 2, Table 4) The median generalized impact fraction and attributable fraction (with 
2.5 % and 97.5 % simulation intervals) from 10,000 bootstrap datasets using the case-load weighted-
sum method, given 10 scenarios of reduced prevalence of obesity and overweight, ARIC, 1987-2003 
Hypothetical scenarios of weight reduction Median GIF (X 100) 
(95 % simulation intervals) 
Scenario 1:  15 % reduction in obesity, 
                     shift obese to overweight 
2.9 (2.3, 3.5) 
Scenario 2:  15 % reduction in obesity,  
                     shift obese to normal weight 
3.4 (2.7, 4.0) 
Scenario 3:  15 % reduction in obesity and overweight,  
                      shift both down one category 
3.7 (3.0, 4.5) 
Scenario 4:  15 % reduction in obesity and overweight,  
                      shift both to normal weight 
4.2 (3.0, 5.4) 
Scenario 5:  30 % reduction in obesity, 
                     shift obese to overweight 
5.7 (4.6, 7.0) 
Scenario 6:  30 % reduction in obesity,  
                     shift obese to normal weight 
6.7 (5.4, 8.0) 
Scenario 7:  30 % reduction in obesity and overweight,  
                      shift both down one category 
7.4 (6.0, 9.0) 
Scenario 8:  30 % reduction in obesity and overweight,  
                      shift both to normal weight 
8.5 (6.1, 10.7) 
Scenario 9:  Complete elimination of obesity,  
                      shift to normal weight 
22.0 (18.0, 27.0) 
Scenario 10:  Complete elimination of obesity and overweight,  
                       shift to normal weight 
28.0 (20.0, 36.0) 
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Figure 10.  (MS. 2, Figure 2) The median generalized impact fraction and attributable fraction (with 2.5 
% and 97.5 % simulation intervals) from 10,000 bootstrap datasets using the case-load weighted-sum 
method, given 10 scenarios of reduced prevalence of obesity and overweight, ARIC, 1987-2003 
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CHAPTER V 
 
CONCLUSIONS 
 
A.  Recapitulation of overall specific aims  
     Our overall goal was to characterize the association between 3 different anthropometric 
measures to define obesity and overweight and their association with incident heart failure, 
stratified by race and gender.  To better interpret our findings, we also determined the 
probable effect of outcome misclassification on our results.  To put our findings in a public 
health context, we determined the preventable burden of heart failure due to overweight and 
obesity.  Briefly these are recapitulated below in specific aims 1 and 2 which are addressed in 
manuscript 1, and specific aim 3 which is addressed in manuscript 2.   
 
Specific Aim 1   
Assess obesity/overweight as risk factors for the development of incident hospitalized heart 
failure.  Assess race as a potential effect modifier.  Compare three anthropometrical measures 
(e.g. BMI, waist circumference, and waist/hip ratio) as to their association with incident 
hospitalized heart failure. 
Research question:  Is there a positive association for obesity and overweight, as defined by 
each anthropometric measure (BMI, WHR and waist circumference), with incident heart 
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failure?  Does this association vary by race- and gender-group? Is one measure superior to 
the other two in the prediction of incident heart failure?       
 
Specific Aim 2   
Assess the probable magnitude and direction of systematic error due to misclassification of 
the outcome of hospitalized heart failure for the association of obesity with incident 
hospitalized heart failure.  This aim was achieved by performing a semi-automated 
probabilistic sensitivity analysis to estimate the degree of bias due to disease 
misclassification.    
Research question: What is the estimated magnitude and direction of bias due to outcome 
misclassification in this analysis?  
 
Specific Aim 3 
Assess the burden of incident heart failure that could be prevented if there were a reduction 
in the proportion of obesity and/or overweight persons in the population.  This aim was 
accomplished through the use of generalized impact fractions, a generalization of the 
attributable fraction.  The results for the generalized impact fraction were compared to the 
more commonly used attributable fraction.   
Research question:  What is the reduced burden of incident heart failure that would be 
expected if there were a feasible reduction in the proportion of overweight and obese persons 
in the population?  By how much does the attributable fraction differ from the generalized 
impact fraction in its estimate of preventable heart failure burden due to obesity?   
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B. Discussion of results 
    We found there was a positive association for obesity as defined by all three measures for 
incident HF.  Even with stratification by race and gender, the adjusted hazard ratios for the 
comparison of the highest category of each measure (obese) to the lowest were similar and 
well above 1.0 for all three anthropometric measures (For example, HR with 95 % CI for 3rd 
vs. 1st tertile of waist-hip ratio:  2.55 (1.88, 3.44) for white women; 3.10 (2.13, 4.51) for 
black women, 2.69 (2.10, 3.45) for white men, and 2.45 (1.75, 3.43) for black men.  Hazard 
ratios for the middle category for all three anthropometric measures tended to be 
intermediate, thus suggesting a graded response between body size and heart failure (For 
example, HR with 95 % CI for 2nd vs. 1st tertile of waist-hip ratio:  1.49 (1.08, 2.08) for white 
women; 2.10 (1.40, 3.15) for black women, 1.47 (1.11, 1.95) for white men, and 1.36 (0.92, 
2.01) for black men). These associations were of similar magnitude for all four race and 
gender groups studied here.  We further defined anthropometric categories by cross-
classifying BMI categories by high or low waist-hip ratio.  Age-adjusted heart failure 
incidence rates for BMI (normal weight, overweight and obese), stratified by high and low 
WHR show an increasing trend across these categories, with particularly a high heart failure 
incident rate (10.1 per 1,000 person-years) in those who have a high BMI and WHR.  Other 
forms and combinations of these three anthropometrics were explored although not included 
in manuscript 1, largely due to limitations in sample size.  These included further 
stratification of BMI into 6 categories, as defined by the six clinical action levels by the 
National Institutes of Health(1998).  There were small numbers for certain groups (for 
example, BMI < 18.5 kg/m2), even when men and women were combined.  This analysis (see 
shown Figure 20), shows an increasing linear trend for overweight group, and the 3 levels of 
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obesity with a peak hazard ratio for those with BMI > 40 (HR= 4.76, 95 % CI = 3.68, 6.15); 
however the underweight group (BMI < 18.5 kg/m2) actually shows a higher risk compared 
to the referent group (BMI 18.5 – 25 kg/m2), although imprecise due to small sample size for 
this group (HR = 1.77, 95 % CI = 1.05, 2.98).  Similarly, we divided BMI, waist 
circumference and WHR into quintiles (see Table 30), in which we show there is an 
increasing linear trend for all three measures.  The adjusted HR for incident HF for the 
highest group with BMI > 40 as compared to the referent group is 4.76 (95 % CI = 3.68, 
6.15).   
     We considered cross-classification of BMI by high and low waist circumference (see 
Figure 21), as these are clinical categories created by the National Institute of Health 
(NIH)(NIH 1998).  The cut-point that defines high or low waist circumference is 102 cm for 
men and 88 cm for women; since these two measures are highly correlated (r = 0.88) there 
were small sample sizes for the discordant groups (especially those with normal weight by 
BMI and high waist circumference and those with obesity by BMI and low waist 
circumference). Even with men and women combined, the confidence intervals were 
imprecise for these discordant groups.  For those in the category of obese BMI (≥ 30 kg/m2) 
and high waist circumference (adjusted HR = 2.62, 95 % CI = 2.25, 3.06), the findings are 
similar to the hazard ratio reported in manuscript 1 for the comparison of obese BMI and 
high WHR (adjusted HR = 3.18 95 % CI = 2.66, 3.81).       
     We used several methods to evaluate the effect of potential confounders.  Utilizing a 
change-in-estimate approach, we found that only a few of our potential confounders met a 10 
% change criterion.  For women, change-in-estimate criterion were met by two variables for 
BMI (smoking and race and center), whereas only age met the criterion for WHR, and none 
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of the variables met the criterion for waist circumference.  For men, age and smoking meet 
criterion for BMI, whereas none of the covariates meet criterion for waist circumference or 
WHR.  For all three exposures and in both men and women, there is minimal change in the 
confidence limit ratio with a reduced as compared to full model (precision).  Also, 
calculation of the “MSE”, as described in the methods section, indicated that the 
precision/validity trade-off favored adjustment for the excluded variable in all cases.  
Therefore, we chose to present the models inclusive of all potential confounders for 
consistency across models. 
    We also assessed the effect on model fit of the inclusion of significant covariate 
interactions in the final model, as shown in Table 28 of the appendix.  Likelihood ratio tests 
(LRT) were used to compare nested models (significance criterion of p < 0.05).  Calculation 
of change-in-estimate and “mean square error” were also considered here.  For both men and 
women and across all three exposures, when significant covariate interaction terms are 
included in the model, the HR and their associated confidence intervals changed minimally; 
for simplicity of interpretation, covariate interaction terms were excluded from the final 
model.  We conclude that our findings were fairly robust to changes in model form.     
     With time-dependent ROC analysis, we did not find that any one anthropometric measure, 
or even the cross-classified measures of BMI and WHR, as superior in the prediction of 
incident heart failure.  Stratification by race and gender did not change our inferences in this 
respect.                 
     Calculation of the GIF in manuscript 2 was enlightening as to the actual impact of an 
aggressive reduction in obesity and overweight.  The overall GIF number appears small; 
however, when applied to the actual impact on healthcare utilization and cost, then there 
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seems to be a large impact, since HF is a common condition.  A 30% hypothetical reduction 
in both obesity and overweight would prevent 8.5 % (95 % intervals = 6.1%, 10.7%) of 
incident heart failure cases, whereas a 30 % reduction in obesity only would prevent 6.7 % 
(95 % intervals = 5.4 %, 8.0 %) of incident heart failure.  However, a 6.7 % reduction in 
heart failure would result in an estimated 72,628 fewer heart failure hospitalizations with 
approximately $477,674,356 cost savings per year.  The attributable fraction (22 % (95 % 
intervals = 18 %, 27 %)), which assumes complete elimination of obesity and overweight, is 
approximately 3 times larger than the highest amount of weight reduction (30 %) assumed 
feasible here.           
  
C. Degree to which doctoral goals have been met 
     This dissertation is the product of my work as the lead investigator in the design, analysis 
and writing, under the primary supervision of my dissertation chair, Wayne Rosamond, PhD, 
MS.  Suggestions provided by this dissertation committee, and other co-authors have been 
incorporated.  This dissertation topic and its scope were approved at the time of my 
dissertation proposal defense and further at an interim dissertation meeting.  I believe that the 
expected goals of doctoral research work will have been met with these dissertation 
committee meetings, the preparation and submission of this document the graduate school, 
submission for publication of manuscript 1 to the ARIC publications committee, and the final 
dissertation defense itself.   
    There are four areas of expectations and standards for a doctoral dissertation specified in 
the “Academic Policies” manual for 2007-2008, by the department of epidemiology at UNC-
Chapel Hill; these areas include originality, depth, scholarship, and writing skills.  I’ll discuss 
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each area as to my achievement of these expectations, however it is the ultimately the 
decision of this dissertation committee to determine if these four expectations have been 
shown during my time in training here, as well as in my final doctoral dissertation document.  
There are several aspects of my dissertation that are original in substantive content and in 
creative application of existing and relatively new methods.  Substantively, the association of 
obesity with incident heart failure has not previously been evaluated stratified by race and 
gender.  The ability of these three measures to predict heart failure has not been previously 
compared with ROC analysis.  In addition, the second paper on the impact of reduction in 
obesity and overweight on the burden of heart failure is novel.  Methodologically, we use 
several techniques that are original in their application to this topic area including multiple-
bias modeling, time-dependent ROC analysis (with adjustment for optimism), and calculation 
of the generalized impact fraction.  These methods are also technically sophisticated and add 
considerable depth and scholarship to the analysis.  Depth and scholarship are the second and 
third expectations for a doctoral dissertation.  Depth is shown in the review of the literature 
on this topic, as well as the methods used to explore the best form for the main exposures and 
covariates, evaluation of potential confounders and effect measure modifiers.  Similarly, 
scholarship is shown in the synthesis of all of this work succinctly into the two enclosed 
manuscripts.    
     The fourth expectation of a doctoral dissertation is that it shows competence in scientific 
writing.  I have worked on my writing skills during my 5 years at UNC, with both required 
and optional courses.  I attended an elective 5-day seminar by George Gopen JD, PhD, 
offered by the UNC office of postdoctoral services called “Writing from the Reader’s 
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Perspective”.  In addition to this dissertation as an example of my scientific writing skills, I 
have also published two additional articles (as the first author) in peer-reviewed journals.   
    In summary, during my training at UNC Chapel Hill, I have gained considerable 
substantive knowledge in the area of cardiovascular epidemiology, improved scientific 
writing skills, as well as knowledge in how to critically appraise the literature.  I have learned 
skills in advanced epidemiologic methods.  This document shows the synthesis of all of these 
learned skills.     
 
 
D. Strengths  
     Strengths of the analysis for manuscript 1 include the large sample size of this well 
characterized cohort and the extended period of follow-up.  Measures were obtained using 
standardized techniques.  Anthropometric variables were analyzed in both continuous form 
and using cut-points.  Results are presented stratified by race and gender.  Since there are 
three anthropometric measures available from the baseline visit, we were able to compare the 
predictive ability of the three measures using a newly described method for time-dependent 
ROC analysis.  Furthermore, we used a novel technique for multiple bias modeling which 
incorporates the bias due to outcome misclassification, into multivariate modeling with 
Monte Carlo techniques.  This study provides further example of how Monte Carlo Risk 
Assessment techniques can be used to succinctly summarize the effect of systematic error.    
     Strengths of the analysis for manuscript 2 are the re-introduction of the generalized impact 
fraction as an alternative to the attributable fraction for exposures that are unlikely to be 
eliminated, such as obesity.  We show how confidence intervals can be obtained from 
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bootstrapped datasets.  In addition, we use these findings to extrapolate the public health 
impact in terms of the estimated decrease in heart failure hospitalizations and healthcare 
costs.      
    As compared to the attributable fraction, the GIF is a measure of preventable burden of 
disease that can be based on multiple hypothetical changes in the exposure distribution.  The 
utility of the GIF shown here should encourage others in its use.  As example of it’s limited 
use compared to the attributable fraction, in the New England Journal of Medicine, there is 
only one paper(Semenza, Rubin et al. 1996) using impact fractions between 1995 and 
11/2007, and yet there are 79 papers which mention the attributable risk or fraction between 
1993 and 2007.  Despite this relatively high number for the use of the attributable fraction, it 
is even considered underutilized(Nakayama 2000).  The limited application of the 
generalized impact fraction is likely due to lack of familiarity by most researchers; papers 
such as this one may provide an impetus for its increased use in the practice of epidemiology.    
 
E. Limitations 
   Limitations of these two studies include the definition of heart failure.  We included 
hospitalized and fatal heart failure, as we did not have data on outpatient heart failure; 
however, community surveillance reports have indicated that 74 % of outpatient heart failure 
cases are hospitalized within 1.7 years(Roger, Weston et al. 2004).  Furthermore, we do not 
know the etiology of the heart failure (i.e., ischemic, viral, or idiopathic) events or have 
echocardiographic data to define the type of heart failure (diastolic versus systolic).  Heart 
failure events were defined solely by ICD codes and were not validated by committee 
adjudication.  Because HF is a clinical syndrome without clear objective diagnostic criteria, 
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we were concerned with the possibility of misclassification of the discharge code based 
definition.  To address this potential limitation, we performed a sensitivity analysis to explore 
the effect of outcome misclassification on our findings.  We found that outcome 
misclassification would bias our results toward the null, given the parameters for sensitivity 
and specificity that we provided.     
      Limitations of the analysis (from manuscript 2) using the generalized impact fraction, 
include that unlike the attributable fraction, one must stratify by important confounders rather 
use an adjusted relative measure of effect such that small sample sizes can be a problem.  
There was not adequate sample size to stratify by all potential confounders that were adjusted 
for in manuscript 1 (age, race, gender, education, smoking, alcohol use); therefore we 
stratified based on age, race and gender only.  There were few confounders identified using a 
10 % change-in-estimate criterion.  Therefore, I suspect that further stratification with a 
larger sample would not have had much of an impact on the results for GIF.  An additional 
issue with stratification for multiple variables is that it makes the creation of bootstrapped 
datasets time-consuming, as each cross-classified group (race by gender by age group) must 
be bootstrapped independently.           
     Inherent in estimating the generalized impact fraction, one must consider a counterfactual 
approach(Rodgers 2002), and in so doing we wanted to use feasible goals for population-
wide reduction in obesity and overweight.  It is difficult to determine feasible goals for 
population-wide weight reduction; however, we considered a spectrum of weight loss with 
the goals recommended in the Healthy People 2010 report as our most optimistic goal.  
Clinical trial studies on interventions for weight loss have provided the mean number of 
kilograms lost(Franz, VanWormer et al. 2007), but these studies do not provide the actual 
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number we sought for our calculation of the GIF, which is the feasible proportion of obese 
whom could lose weight to shift categories to the normal weight group.   
   
F. Future Directions 
    Further improvements to the multiple-bias modeling sensitivity analysis used here would 
be to expand this technique to work with outcome misclassification in Cox proportional 
hazards models.  In this case, one would have to create a distribution to re-define person-time 
for those whom the outcome is reclassified.   
     Assessment of the potential impact of exposure reduction on disease incidence, such as 
done here with the generalized impact fraction, could be extended to include simulation 
techniques.  For example, bootstrapped datasets could be created with reduced prevalence of 
obesity (by subgroup) from which a distribution of heart failure incident rates could be 
calculated from this altered population as compared to the original population. 
     Future research in the association of obesity with heart failure should consider whether 
one type of adiposity, either visceral or subcutaneous, is more predictive of heart failure.  
Unfortunately, definitive measurements to distinguish visceral and subcutaneous fat require 
expensive imaging with computed tomography.  In addition, it would be interesting to assess 
the type of heart failure (diastolic or systolic dysfunction) most often associated with obesity.  
Currently, obesity is thought to most often result in diastolic dysfunction.  The ARIC study 
has begun detailed abstraction of medical records for all heart failure hospitalizations, along 
with physician validation; such data will aid in the determination of the type of heart failure 
associated with obesity.  The Multi-Ethnic Study of Atherosclerosis (MESA) study recently 
began in 2000-2002 will eventually have enough follow-up time for incident heart failure 
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outcomes, along with measures of chest computed tomography and cardiac MRI.  In 
addition, other studies should consider the age of onset of obesity and/or the amount of time 
obese as it relates to the age of onset of incident heart failure.  The epidemic of childhood 
obesity and metabolic complications may contribute to an earlier age of onset for heart 
failure.     
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A. IRB certification 
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I received approval from the ARIC study for this work.  I have also completed the 
collaborative institutional training initiative (CITI) program in research ethics.     
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B. Supplemental Results, Manuscript 1 
Figure 11.  (MS. 1, supplemental results) Distribution of measures of BMI, among men and women (red 
dotted line represents category cutpoints), ARIC 1987-1989 
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Figure 12.  (MS. 1, supplemental results) Distribution of measures of waist circumference, among men 
and women (red dotted line represents tertile cutpoints), ARIC 1987-1989 
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Figure 13.  (MS. 1, supplemental results) Distribution of measures of WHR, among men and women, (red 
dotted line represents tertile cutpoints), ARIC 1987-1989  
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Range of BMI for women is 14.2-65.9 
Range of waist circumference for women is 52-178 
Range of WHR for women is 0.49-1.29 
 
 
Table 17.  (MS. 1, supplemental results) Distribution of each anthropometric measure within 
category of each, for men, ARIC 1987-1989 
 
Mean Median Standard 
Error 
Interquartile 
Range 
BMI, kg/m2     
    <25, N = 1,865 23.0 23.3 0.04 2.1 
    25-30, N = 3,261 27.3 27.2 0.02 2.3 
    ≥ 30, N = 1,533 33.2 32.2 0.09 3.2 
Waist Circumference, cm     
    1st Tertile < 95, N = 2,349 88.1 89.0 0.11 7.0 
    2nd Tertile 95 - < 103, N = 2,099 98.4 98.0 0.05 4.0 
    3rd Tertile > 103, N = 2,211 110.7 108.0 0.17 9.0 
Waist Hip Ratio     
    1st Tertile < 0.94, N = 2,228 0.90 0.91 0.0007 0.04 
    2nd Tertile 0.94 - <0.98, N = 1,900 0.96 0.96 0.0003 0.02 
    3rd Tertile ≥ 0.98, N = 2,531 1.02 1.01 0.0006 0.04 
Range of BMI for men is 15.4-65.9 
Range of waist circumference for men is 52-178 
Range of WHR for men is 0.55-1.39 
 
 
 
 
 
 
 
Table 16.  (MS. 1, supplemental results) Distribution of each anthropometric measure within 
category of each, for women, ARIC 1987-1989 
 
Mean Median Standard 
Error 
Interquartile 
Range 
BMI, kg/m2     
    <25, N = 3,113 22.3 22.5 0.03 2.7 
    25-30, N = 2,545 27.3 27.2 0.03 2.5 
    ≥ 30, N = 2,373 35.1 33.8 0.10 5.7 
Waist Circumference, cm     
    1st Tertile < 87, N = 2,643 79.0 80.0 0.10 8.0 
    2nd Tertile 87 - <100, N = 2,668 92.8 93.0 0.07 6.0 
    3rd Tertile > 100, N = 2,720 112.1 109.0 0.21 13.0 
Waist Hip Ratio     
    1st Tertile <0.86, N = 2,762 0.80 0.81 0.0008 0.06 
    2nd Tertile 0.86 - <0.93, N= 2,449 0.89 0.89 0.0004 0.03 
    3rd Tertile ≥ 0.93, N = 2,820 0.98 0.97 0.0007 0.05 
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Table 18.  (MS. 1, supplemental results) Comparison of characteristics at baseline by category of BMI, waist hip ratio and waist 
circumference, ARIC, 1987-1989,  for women 
 BMI Waist Circumference Waist-hip ratio 
 < 25 25-30 ≥ 30 T1 T2 T3 T1 T2 T3 
Age, years, mean (SD) 54(6) 54(6) 54(6) 53(6) 54(6) 54 (6) 52(5) 54(6) 55(6) 
Black, % 14 32 47 18 28 42 26 28 35 
Center, %          
     Jackson 12 28 43 17 25 37 24 24 30 
     Forsyth 34 23 16 30 26 19 26 28 22 
     Minnesota 30 25 16 34 24 15 34 23 17 
     Maryland 24 24 25 19 25 29 17 25 31 
Education, %          
     < high school  14 23 33 13 22 33 13 22 32 
    HS graduate  39 37 35 38 38 36 37 38 36 
    > high school  47 40 32 50 40 32 50 40 32 
Smoking status, %          
    Never      46 55 61 48 54 58 53 53 53 
    Former  23 22 21 23 22 22 23 26 25 
    Current  31 24 18 29 24 20 23 26 25 
Alcohol use, %          
   Never  26 36 46 27 35 44 31 34 41 
   Former  13 16 20 12 14 21 11 17 20 
   Occasional     23 21 17 23 22 17 23 21 18 
   Light  29 23 15 30 23 16 29 22 17 
   Heavy  8 5 3 8 6 3 6 6 5 
CHD, % 1.1 1.9 1.9 1.0 1.7 2.2 0.6 1.8 2.5 
     MI, % 1.0 1.7 1.7 0.9 1.5 1.9 0.6 1.5 2.2 
Diabetes, % 4 10 22 3 7 22 3 7 21 
Hypertension, % 19 11 50 18 31 48 21 30 46 
LVH by ECG, % 1.3 2.1 3.4 1.3 2.0 3.2 1.2 2.5 2.9 
Lipids, mg/dl, mean (SD)          
   Total  214 (40) 222 (45) 220 (44) 211 (40) 221 (44) 222 (45) 209 (40) 219 (43) 226 (45) 
   LDL-C  129(39) 141 (42) 141 (40) 126 (39) 140(41) 142 (40) 126(38) 138 (41) 145 (41) 
   HDL-C 64(18) 57 (16) 51 (14) 65 (18) 58 (16) 51(14) 64 (18) 57 (16) 52(15) 
   Triglycerides 104(55) 124 (83) 141 (92) 97 (50) 121 (74) 146 (95) 96(55) 117(65) 150 (97) 
Creatnine, g/dl, mean (SD) 0.99 (0.3) 1.02 (0.4) 1.04 (0.6) 0.99 (0.2) 1.01 (0.4) 1.03 (0.6) 0.99(0.2) 1.00 (0.3) 1.03 (0.6) 
Albumin, g/dl, mean (SD) 3.88 (0.3) 3.84 (0.3) 3.75 (0.3) 3.87 (0.3) 3.85 (0.3) 3.77 (0.3) 3.85 (0.3) 3.84 (0.3) 3.81 (0.3) 
FEV1, L/sec, mean (SD) 2.57 (0.3) 2.57 (0.3) 2.57 (0.3) 2.55 (0.3) 2.51 (0.3) 2.47 (0.3) 2.58(0.3) 2.52(0.3) 2.44(0.3) 
LDL-C = low density cholesterol; HDL-C = high density cholesterol 
 131 
Table 19.  (MS. 1, supplemental results) Comparison of characteristics at baseline by category of BMI, waist-hip ratio and waist circumference, 
ARIC, 1987-1989, for men,  
 BMI Waist Circumference Waist-hip ratio 
 < 25 25-30 ≥ 30 T1 T2 T3 T1 T2 T3 
Age, years, mean (SD) 55 (6) 54 (6) 54 (6) 54 (6) 55 (6) 55 (6) 54 (5) 54 (6) 55 (6) 
Black, % 25 20 27 30 18 20 35 20 15 
Center, %          
     Jackson 21 17 23 26 16 17 30 17 12 
     Forsyth 32 26 23 26 27 26 26 27 26 
     Minnesota 23 30 29 26 28 29 26 28 29 
     Maryland 24 26 28 23 28 28 18 27 33 
Education, %          
     < high school  26 22 25 25 22 24 21 23 26 
    HS graduate  26 27 27 26 28 27 25 28 28 
    > high school  49 51 48 49 50 48 54 49 45 
Smoking status, %          
    Never      26 29 29 30 29 25 33 28 24 
    Former  35 46 50 36 46 51 38 45 49 
    Current  40 24 21 34 25 23 29 27 27 
Alcohol use, %          
   Never  13 12 14 13 12 13 15 13 11 
   Former  22 21 25 22 21 24 21 22 24 
   Occasional     12 13 14 13 12 14 13 13 13 
   Light  41 44 38 42 44 40 43 42 41 
   Heavy  11 9 9 10 10 10 9 10 11 
CHD, % 6.3 6.8 8.7 6.1 7.2 8.1 5.3 6.7 9.0 
     MI, % 5.2 5.6 7.3 5.0 6.0 6.8 4.6 5.5 7.4 
Diabetes, % 6 10 21 6 10 18 6 10 18 
Hypertension, % 25 31 47 26 31 42 27 31 40 
LVH by ECG, % 1.6 2.1 2.4 1.5 2.7 1.9 1.6 2.4 2.1 
Lipids, mg/dl, mean (SD)          
   Total  206 (39) 213 (39) 213 (41) 208 (39) 213 (40) 213 (40) 207 (39) 212 (40) 212 (40) 
   LDL-C  134 (38) 142 (36) 141 (37) 136 (38) 142 (36) 140 (36) 136 (38) 141 (37) 141 (36) 
   HDL-C 50 (17) 43 (12) 40 (11) 50 (16) 43 (12) 40 (11) 50 (16) 44 (13) 41 (11) 
   Triglycerides 111 (67) 143 (89) 171  (134) 111 (65) 144 (91) 168 (124) 108 (58) 143 (98) 166 (118) 
Creatnine, g/dl, mean (SD) 1.19 (0.2) 1.24 (0.4) 1.23 (0.2) 1.21 (0.2) 1.24 (0.5) 1.22 (0.2) 1.22 (0.3) 1.22 (0.4) 1.22 (0.2) 
Albumin, g/dl, mean (SD) 3.92 (0.3) 3.94 (0.3) 3.90 (0.3) 3.93 (0.3) 3.93 (0.3) 3.91 (0.3) 3.93 (0.3) 3.94 (0.3) 3.91 (0.3) 
FEV1, L/sec, mean (SD) 3.66 (0.4) 3.68 (0.4) 3.64 (0.4) 3.58 (0.4) 3.69 (0.4) 2.73 (0.4) 3.64 (0.4) 3.69 (0.4) 3.67 (0.4) 
LDL-C = low density cholesterol; HDL-C = high density cholesterol 
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Table 20.  (MS. 1, supplemental results) Person-Time contribution in years (%) by covariates and category of each exposure, for women (only 
those non-missing for all covariates included), ARIC, 1987-2003 
 BMI < 25 
44,714 P-Y 
BMI 25-30 
36,094 P-Y 
BMI ≥ 30 
32,432 P-Y 
WC -T1 
38,045 P-Y 
WC - T2 
38,177 P-Y 
WC - T3 
37,018  
P-Y 
WHR - T1 
40,010 P-
Y 
WHR - T2 
34,760 P-Y 
WHR - T3 
38,470 P-Y 
Race and center          
  Whites, 
Minnesota  
13,734  
(31 %) 
9,119 
(25 %) 
5,487 
(17 %) 
13,088 
(34 %) 
9,357 
(25 %) 
5,897 
(16 %) 
13,500 
(34 %) 
8,142 
(23 %) 
6,699 
(17 %) 
   Whites, 
Forsyth 
14,745 
(33 %) 
6,975 
(19 %) 
3,892 
(12 %) 
10,939 
(29 %) 
8,991 
(24 %) 
5,683 
(15 %) 
9,750 
(24 %) 
8,680 
(25 %) 
7,183 
(19 %) 
   Blacks, Forsyth  762 
(2 %) 
1,308 
(4 %) 
1,146 
(4 %) 
583 
(2 %) 
1,109 
(3 %) 
1,524 
(4 %) 
726 
(2 %) 
955 
(3 %) 
1,534 
(4 %) 
   Blacks, 
Jackson 
4,877 
(11 %) 
9,841 
(27 %) 
13,665 
(42 %) 
6,068 
(16 %) 
9,332 
(24 %) 
12,984 
(35 %) 
9,265 
(23 %) 
8,228 
(24 %) 
10,890 
(28 %) 
   Whites, 
Maryland 
10,596 
(24 %) 
8,850 
(25 %) 
8,241 
(25 %) 
7,368 
(19 %) 
9,389 
(25 %) 
10,931 
(30 %) 
6,769 
(17 %)  
8,754 
(25 %)  
12,164 
(32 %) 
Education          
     < HS educ. 5,838 
(13 %) 
8,041 
(22 %) 
10,137 
(31 %)  
4,533 
(12 %) 
7,965 
(21 %) 
11,518 
(31 %)  
5,061 
(13 %) 
7,324 
(21 %)  
11,632 
(30 %) 
    HS grad. 17,447 
(39 %) 
13,507 
(37 %) 
11,484 
(35 %) 
14,391 
(38 %) 
14,655 
(38 %) 
13,392 
(36 %) 
14,830 
(37 %) 
13,317 
(38 %) 
14,291 
(37 %) 
    > HS educat. 21,429 
(48 %) 
14,546 
(40%)  
10,811 
(33 %) 
19,121 
(50 %) 
15,558 
(41 %) 
12,108 
(33 %) 
20,119 
(50 %) 
14,119 
(41 %) 
12,547 
(33 %) 
Smoking status          
    Never smoker     21,230 
(47 %)  
20,072 
(56 %) 
20,133 
(62 %) 
18,557 
(49 %) 
21,075 
(55 %) 
21,802 
(59 %) 
21,692 
(54 %) 
18,826 
(54 %) 
20,917 
(33 %) 
Former smoker 10,537 
(24 %) 
7,893 
(22 %) 
6,919 
(21 %) 
8,861 
(23 %) 
8,378 
(22 %) 
8,110 
(22 %) 
9,332 
(23 %) 
7,447 
(21 %)  
8,570 
(22 %) 
   Current smoker 12,947 
(29 %) 
8,129 
(23 %) 
5,380 
(17 %) 
10,626 
(28 %) 
8,724 
(23 %) 
7,106 
(19 %)  
8,986 
(22 %) 
8,487 
(24 %) 
8,983 
(23 %) 
Alcohol use          
  Never drinker 11,592 
(26 %) 
12,971 
(36 %) 
14,967 
(46 %)  
10,140 
(27 %) 
13,298 
(35 %) 
16,092 
(43 %) 
12,272 
(31 %) 
11,845 
(34 %) 
15,413 
(40 %)  
  Former drinker 5,637 
(13 %) 
5,384 
(15 %)  
6,038 
(19 %) 
4,540 
(12 %) 
5,327 
(14 %) 
7,193 
(19 %) 
4,412 
(11 %) 
5,528 
(16 %) 
7,119 
(19 %)  
  Occasional 
drinker  
10,578 
(24 %) 
7,663 
(21 %) 
5,675 
(17 %)  
8,848 
(23 %) 
8,637 
(23 %) 
6,431 
(17 %) 
9,457 
(24 %) 
7,344 
(21 %) 
7,116 
(18 %) 
  Light/mod 
drinker 
13,228 
(30 %) 
8,259 
(23 %)  
4,853 
(15 %)  
11,623 
(31 %) 
8,685 
(23 %) 
6,032 
(16 %) 
11,498 
(29 %) 
7,861 
(23 %) 
6,980 
(18 %) 
  Heavy drinker 3,679(8%) 1,817(5%) 899(3%) 2,894(8%) 2,230(6%) 1,270(3%) 2,371(6%) 2,181(6%) 1,815(5%) 
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Table 21.  (MS. 1, supplemental results) Person-Time contribution in years (%) by covariates and category of each exposure, for men (only those 
non-missing for all covariates included), ARIC, 1987-2003 
 BMI < 25 
24,846 
P-Y 
BMI 25-30 
44,380 
P-Y 
BMI ≥ 30 
19,797 
P-Y 
WC -T1 
31,813 
P-Y 
WC - T2 
28,443 
P-Y 
WC - T3 
28,768 
P-Y 
WHR - T1 
30,683 
P-Y 
WHR - T2 
25,804 
P-Y 
WHR - 
T3 
32,537  
P-Y 
Race by Center          
Whites, 
Minnesota  
5,905 
(24 %) 
13,667 
(31 %) 
5,882 
(59 %) 
8,709 
(27 %) 
8,226 
(29 %) 
8,520 
(30 %) 
8,430 
(27 %)  
7,402 
(29 %) 
9,623 
(30 %) 
   Whites, Forsyth 7,191 
(29 %) 
11,031 
(25 %) 
3,362 
(17 %) 
7,237 
(23 %) 
7,270 
(26 %) 
7,077 
(25 %) 
7,065 
(23 %) 
6,589 
(26 %) 
7,930 
(24 %) 
   Blacks,Forsyth  823(3 %) 875(2 %) 581(3 %) 991(3 %) 593(2 %) 695(2 %) 1,043(3 %) 520(2 %) 715(2 %) 
   Blacks, Jackson 4,656 
(19 %) 
7,330 
(17 %) 
4,508 
(23 %) 
7,545 
(24 %) 
4,385 
(15 %) 
4,565 
(16 %) 
8,784 
(29 %)  
4,098 
(16 %) 
3,613 
(11 %) 
   Whites,  
Maryland 
6,273 
(25 %) 
11,476 
(26%)  
5,463 
(28 %)  
7,331 
(23 %) 
7,969 
(28 %) 
7,911 
(27 %) 
5,362 
(17 %) 
7,194 
(28 %)  
10,656 
(33 %) 
Education          
     < HS education 5,640 
(23 %) 
9,223 
(21 %) 
4,548 
(23 %) 
7,184 
(23 %) 
5,726 
(20 %) 
6,500 
(23 %)  
5,897 
(19 %)  
5,628 
(22 %) 
7,885 
(24 %) 
    High school grad. 6,479 
(26 %) 
12,044 
(27 %) 
5,319 
(27 %) 
8,158 
(26 %) 
7,926 
(28 %) 
7,757 
(27 %) 
7,477 
(24 %) 
7,188 
(28 %)  
9,177 
(28 %)  
    > HS education 12,728 
(51 %) 
23,114 
(52 %) 
9,930 
(50 %) 
16,470 
(52 %) 
14,791 
(52 %) 
11,511 
(40 %) 
17,309 
(56 %) 
12,988 
(50 %) 
15,475 
(48 %) 
Smoking status          
    Never smoker      7,153 
(29 %) 
13,555 
(31 %)  
5,886 
(30 %)  
10,336 
(32 %) 
8,729 
(31 %) 
7,529 
(26 %) 
10,655 
(35 %) 
7,743 
(30 %) 
8,196 
(25 %) 
    Former smoker 9,054 
(36 %) 
20,766 
(47 %) 
9,905 
(50 %)  
11,718 
(37 %) 
13,225 
(46 %) 
14,782 
(51 %) 
11,878 
(39 %)  
11,789 
(46 %)  
16,058 
(50 %) 
    Current smoker 8,640 
(35 %) 
10,059 
(23%)  
4,006 
(20 %) 
9,759 
(31 %) 
6,489 
(23 %) 
6,457 
(22 %) 
8,151 
(27 %) 
6,272 
(24 %) 
8,282 
(25 %)  
Alcohol use          
   Never drinker 3,242 
(13 %) 
5,558 
(13 %) 
2,837 
(14 %) 
4,265 
(13 %)  
3,637 
(13 %) 
3,736 
(13 %) 
4,490 
(15 %) 
3,482 
(13 %) 
3,666 
(11 %) 
   Former drinker 5,221 
(21 %) 
8,840 
(20 %) 
4,687 
(24 %) 
6,689 
(21 %)  
5,705 
(20 %) 
6,354 
(22 %) 
6,053 
(20 %) 
5,524 
(21 %) 
7,171 
(22 %) 
   Occasional drinker    3,110 
(13 %) 
5,691 
(13 %) 
2,791 
(14 %) 
4,103 
(13 %) 
3,480 
(12 %) 
4,008 
(14 %) 
3,880 
(13 %)  
3,361 
(13 %) 
4,351 
(13 %)  
   Light/mod drinker 10,581 
(43 %) 
20,081 
(45%)  
7,662 
(39 %) 
13,811 
(43 %) 
12,801 
(45 %) 
11,712 
(41 %) 
13,754 
(45 %) 
10,914 
(42 %) 
13,656 
(42 %) 
Heavy drinker 2,693(11%) 4,210(9%) 1,820(9%) 2,946(9%) 2,820(10%) 2,957(10 %) 2,506(8%) 2,523(10%) 3,693(1%) 
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Figure 14.  (MS. 1, supplemental results) Plot of cumulative incidence for heart failure (person-years) by category of BMI (black line =  
normal weight, red line = overweight, green line = obese), stratified by race and gender, ARIC, 1987-2003 
 
   A. White men        B. Black men 
 
    
   C. White women      D. Black women 
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Figure 15.  (MS. 1, supplemental results) Plot of cumulative incidence for heart failure (Person-years) by tertile of waist circumference  
(black line = first tertile, red line = second tertile, green line = third tertile), stratified by race and gender, ARIC, 1987-2003 
 
   A. White men       B. Black men 
 
 
   C. White women      D. Black women 
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Figure 16.  (MS. 1, supplemental results) Plots of cumulative incidence for heart failure (person-years) by tertile of waist-hip ratio  
(black line = first tertile, red line = second tertile, green line = third tertile), stratified by race and gender, ARIC, 1987-2003 
 
   A. White men        B. Black men 
 
 
   C. White women      D. Black women 
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Table 22.  (MS. 1, supplemental results) Assessment of proportional hazards assumption using log negative log survival plot and time 
interaction terms for all 3 exposures, as indicator and continuous variables, ARIC, 1987-2003 
 Log negative log plot Time interaction term PHA Decision? 
 Obese (3rd)  vs. referent (1) Overweight (2) vs. referent (1)   
BMI 
     Women 
     Men 
 
1 cross @ 2451  
No cross 
 
Overlap then parallel (181)2  
Overlap 
 
P = 0.4 
P = 0.1 
 
No violation 
No violation 
Waist-hip ratio              
     Women 
     Men 
 
No cross 
No cross 
 
No cross 
1 cross @ 4033 
 
P = 0.09 
P = 0.1 
 
No violation 
No violation 
Waist circumference 
     Women 
     Men 
 
Cross @1104 
No cross 
 
Overlap then parallel (181)5 
Overlap then parallel (403)6 
 
P = 0.5 
P = 0.03 
 
No violation 
No violation 
1 
--8 events before cross 
2 
–9 events occur before lines become parallel 
3 
--4 events before cross 
4 
--3 events before cross 
5  
--6 events before cross 
6 
--8 events before cross 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 138 
Table 23.  (MS. 1, supplemental results) Results of modeling using a backward-selection change-in-estimate approach for categorized 
anthropometric measures, comparing highest to referent, for women, ARIC 1987-2003 
 BMI Waist Circumference Waist Hip Ratio 
 Adjusted HR 
(95 % CI) 
CLR CIE MSE Adjusted HR  
(95 % CI) 
CLR CIE  MSE  
 
Adjusted HR 
(95 % CI) 
CLR CIE MSE  
Full model 1 2.52  
(2.03, 3.12) 
1.54 -- 0.0120 2.70  
(2.15, 3.39) 
1.58 -- 0.0136 2.76  
(2.18, 3.49) 
1.60 -- 0.0144 
- Age  2.42  
(1.95, 2.99) 
1.53 0.04  2.96  
(2.36, 3.72) 
1.58 0.09  3.34  
(2.65, 4.22) 
1.59 0.19* 0.05 
- Alcohol  2.66  
(2.15, 3.29) 
1.53 0.02  2.84  
(2.26, 3.56) 
1.58 0.05  2.85  
(2.25, 3.60) 
1.60 0.03  
- Smoking 2.18  
(1.76, 2.70) 
1.53 0.14* 0.03 2.46  
(1.96, 3.09) 
1.58 0.09  2.79  
(2.20, 3.53) 
1.60 0.01  
- Education 2.66  
(2.15, 3.29) 
1.53 0.02  2.86  
(2.28, 3.58) 
1.57 0.06  2.92  
(2.31, 3.69) 
1.60 0.06  
- Race/center 2.87  
(2.33, 3.53) 
1.52 0.13* 0.028 2.95  
(2.36, 3.69) 
1.56 0.09  2.79  
(2.21, 3.52) 
1.59 0  
*criterion met for change in estimate 
CIE = change in estimate = | ln(crude HR/adjusted HR) |, MSE (full) = variance (lnHRfull); MSE (reduced) = variance (lnHRred) + CIE2 
Full model, age in years centered at 45, alcohol (never, former, current occasional, current mod/light, and current heavy), smoking (never, former, ever), 
education (< high school, high school, > high school), race_center indicator variables 
If MSE full is < MSE reduced then precision/validity trade off favors adjustment 
 
Table 24.  (MS. 1, supplemental results) Results of modeling using a backward-selection change-in-estimate approach for 
continuous measures per SD change for each anthropometric variable, for women, ARIC 1987-2003 
 BMI Waist Circumference Waist Hip Ratio 
 Adjusted HR  
(95 % CI) 
CLR CIE Adjusted HR  
(95 % CI) 
CLR CIE  Adjusted HR  
(95 % CI) 
CLR CIE 
Full model 1 1.47 (1.37, 1.58) 1.15 -- 1.54 (1.43, 1.65) 1.15 -- 1.62 (1.48, 1.76) 1.19 -- 
- Age  1.41 (1.31, 1.51) 1.15 0.04 1.54 (1.43, 1.65) 1.15 0.006 1.74 (1.60, 1.89) 1.18 0.07 
- Alcohol  1.49 (1.39, 1.60) 1.15 0.01 1.57 (1.46, 1.69) 1.16 0.02 1.63 (1.50, 1.78) 1.19 0.006 
- Smoking 1.37 (1.27, 1.47) 1.16 0.07 1.47 (1.36, 1.58) 1.16 0.05 1.62 (1.49, 1.76) 1.18 0 
- Education 1.50 (1.40, 1.61) 1.15 0.02 1.57 (1.46, 1.69) 1.16 0.03 1.65 (1.51, 1.79) 1.19 0.02 
- Race/center 1.53 (1.43, 1.64) 1.15 0.04 1.59 (1.48, 1.71) 1.16 0.06 1.63 (1.50, 1.77) 1.18 0.02 
For Table 23 and Table 24, complete case analysis, n= 7967 or 64 deleted after deletion of blacks not from Jackson or Forsyth and  
any missing variables 
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Table 25.  (MS. 1, supplemental results) Results of modeling using a backward-selection change-in-estimate approach for categorized 
anthropometric measures, comparing highest to referent, for men, ARIC 1987-2003 
 BMI Waist Circumference Waist Hip Ratio 
 Adjusted 
HR  
(95 % CI) 
CLR CIE MSE 
 
Adjusted 
HR  
(95 % CI) 
CLR CIE MSE  
 
Adjusted HR  
(95 % CI) 
CLR CIE MSE  
Full model 2.43  
(1.98, 2.98) 
1.51 -- 0.011 2.26  
(1.88, 2.73) 
1.45 -- 0.009 2.58  
(2.12, 3.14) 
1.48 -- 0.010 
- Age (cont) 2.17  
(1.78, 2.66) 
1.49 0.11* 0.022 2.23  
(1.85, 2.69) 
1.45 0.01  2.78  
(2.29, 3.39) 
1.48 0.07  
- Alcohol  2.46  
(2.01, 3.01) 
1.50 0.008  2.27  
(1.89, 2.74) 
1.45 0.004  2.57  
(2.11, 3.13) 
1.48 0.004  
- Smoking 2.16  
(1.77, 2.64) 
1.49 0.12* 0.025 2.15  
(1.79, 2.59) 
1.45 0.05  2.59  
(2.13, 3.15) 
1.48 0.008  
- Education 2.45  
(2.00, 3.00) 
1.5 0.01  2.28  
(1.89, 2.75) 
1.46 0.009  2.65  
(2.18, 3.23) 
1.48 0.03  
- Race/center 2.41  
(1.97, 2.95) 
1.5 0.01  2.22  
(1.84, 2.68) 
1.46 0.02  2.43  
(2.00, 2.94) 
1.47 0.07  
   *criterion met for change in estimate,   CIE = change in estimate = | ln(crude HR/adjusted HR) | 
   Full model, age in years, alcohol (never, former, current occasional, current mod/light, and current heavy), smoking (never, former, ever), education (<        
high school, high school, > high school), race_center indicator variables 
If MSE full is < MSE reduced then precision/validity trade off favors adjustment 
 
Table 26.  (MS. 1, supplemental results) Results of modeling using a backward-selection change-in-estimate approach for 
continuous measures per SD change for each anthropometric variable, for men, ARIC 1987-2003 
 BMI Waist Circumference Waist Hip Ratio 
 Adjusted HR 
(95 % CI) 
CLR CIE Adjusted HR 
(95 % CI) 
CLR CIE  Adjusted HR 
(95 % CI) 
CLR CIE 
Full model 1 1.45 (1.36, 1.56) 1.15 -- 1.50 (1.40, 1.60) 1.14 -- 1.50 (1.41, 1.60) 1.13 -- 
- Age  1.37 (1.29, 1.45) 1.12 0.06 1.45 (1.36, 1.54) 1.13 0.006 1.54 (1.44, 1.64) 1.14 0.03 
- Alcohol  1.46 (1.37, 1.56) 1.14 0.007 1.51 (1.42, 1.61) 1.13 0.007 1.50 (1.41, 1.60) 1.13 0 
- Smoking 1.40 (1.32, 1.49) 1.13 0.04 1.46 (1.37, 1.56) 1.14 0.03 1.49 (1.40, 1.59) 1.14 0.007 
- Education 1.46 (1.36, 1.55) 1.14 0.007 1.50 (1.41, 1.60) 1.13 0 1.51 (1.42, 1.65) 1.16 0.007 
- Race/center 1.46 (1.37, 1.55) 1.13 0.007 1.50 (1.41, 1.60) 1.13 0 1.47 (1.37, 1.56) 1.14 0.02 
    For Table 25 and Table 26, complete case analysis, n= 6603 or 56 deleted after deletion of blacks not from Jackson or Forsyth and  
    any missing variables 
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Table 27 (MS. 1, supplemental results) Assessment for additive interaction using interaction contrast ratios (ICR) for 
race, stratified by gender 
 MEN 
ICR*  
WOMEN 
ICR*  
BMI   
   Overweight vs. normal -0.27 -0.65  
   Obese vs. normal - 0.19  -0.32  
WHR 
  
   2nd tert vs. 1st tert 0.22 1.66  
   3rd tert vs. 1st tert 1.09 2.55  
WC 
  
   2nd tert vs. 1st tert -0.51 0.3 
   3rd tert vs. 1st tert 0.49 1.05 
*all 95 % confidence intervals included 0
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Table 28.  (MS. 1, supplemental results) Assessment for improved model fit with covariate interactions for the association of categorized BMI, 
waist circumference and WHR with incident heart failure, ARIC, 1987-2003 
 -2 log 
likelihood 
Likelihood Ratio 
Test, P value 
HR (95 % CI) CLR CIE MSE 
BMI -Women       
     ME:  Main effects  10706.916  2.52 (2.03, 3.12) 1.54 -  
     M1:  ME + smoke_dum1*age (P = 0.005), educ_dum1*age 10695.141 0.003 (M1 vs.ME) 
 
2.48 (2.00, 3.08) 1.54 0.016 0.0123 
     M2:  ME + smoke_dum1*age (P = 0.006) 10698.871 0.005 (M2 vs.ME) 
0.05 (M2 vs.M1) 
2.50 (2.01, 3.09) 1.54 0.008 0.0120 
BMI - Men        
     ME:  Main effects  12056.961  2.43 (1.98, 2.98) 1.51 - 0.0107 
     M1:  ME + smoke_dum1*etoh_dum1, educ_dum1*age 12055.395 0.5 (M1 vs.ME) 2.43 (1.98, 2.98) 1.51 0  
Waist Circumference - Women       
     ME:  Main effects 10681.349  2.70 (2.15, 3.39) 1.58 - 0.0137 
     M1:  ME + Smoke_dum1*age (P = 0.006), 
educ_dum1*age 
10669.844 0.003 (M1 vs.ME) 2.67 (2.13, 3.36) 1.58 0.01 0.0136 
     M2:  ME + Smoke_dum1*age (P = 0.006) 10673.536 0.005 (M2 vs.ME) 
0.06 (M2 vs.M1) 
2.68 (2.13, 3.36) 1.58 0.007  
Waist Circumference – Men       
    ME:  Main effects 12062.006  2.26 (1.88, 2.73) 1.45 - 0.0091 
    M1:  ME + smoke_dum1*etoh_dum1 (P = 0.03),     
smoke_dum2*etoh_dum1 (P = 0.04), educ_dum1*age 
12056.275 0.1 (M1 vs.ME) 2.26 (1.87, 2.72) 1.45 0 0.0091 
M2:  ME + smoke_dum1*etoh_dum1 (P = 0.04),             
smoke_dum2*etoh_dum1 (P = 0.05) 
12057.324 0.1 (M2 vs.ME) 
0.3 (M2 vs.M1) 
2.26 (1.87, 2.72) 1.45 0  
WHR - Women       
   ME:  Main effects 10703.239  2.76 (2.18, 3.49) 1.60 - 0.0144 
   M1:  ME + smoke_dum1*age (P = 0.006), educ_dum2*age 10694.958 0.02 (M1 vs.ME)  2.74 (2.17, 3.47) 1.60 0.007 0.0145 
   M2:  ME + smoke_dum1*age (P = 0.005) 10695.174 0.02 (M2 vs.ME) 
0.6 (M2 vs.M1) 
2.74 (2.16, 3.46) 1.60 0.007  
WHR - Men       
   ME:  Main effects 12028.931  2.58 (2.12, 3.14) 1.48  0.010 
   M1:  ME + smoke_dum1*etoh_dum1,  
smoke_dum2*etoh_dum1, educ_dum2*age (P = 0.0007) 
12013.411 0.002 (M1 vs.ME) 
 
2.55 (2.09, 3.10) 1.48 0.01 0.010 
   M2: ME + educ_dum2*age (P = 0.0006) 12017.258 0.0006 (M2vs.ME) 
0.2 (M2 vs.M1) 
2.56 (2.10, 3.12) 1.49 0.008 0.010 
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Figure 17.  (MS. 1, supplemental results) Fully adjusted hazard ratios (with 95 % CI) for incident heart 
failure by category of obesity and overweight as measured by BMI, waist circumference and WHR, for 
women 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 143 
 
Figure 18.  (MS. 1, supplemental results) Fully adjusted hazard ratios (with 95 % CI) for incident heart 
failure by category of obesity and overweight as measured by BMI, waist circumference and WHR, for 
men   
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Table 29.  (MS. 1, supplemental results) Unadjusted and adjusted* hazard ratios (with 95 % 
CI) for incident heart failure by continuous measures of BMI, waist circumference and waist 
hip ratio, stratified by gender, ARIC, 1987-2003 
 Women 
HR (95 % CI) 
Men 
HR (95 % CI) 
BMI, 1 unit change, unadjusted 1.07 (1.06, 1.09) 1.08 (1.06, 1.09) 
BMI, 1 unit change, adjusted 
 
1.07 (1.05, 1.08) 1.09 (1.08, 1.11) 
BMI, 1 SD change, unadjusted 1.53 (1.44, 1.63) 1.35 (1.27, 1.44) 
BMI, 1 SD change, fully adjusted 1.47 (1.37, 1.57) 1.45 (1.36, 1.54) 
   
Waist Circumference, 1 SD change, unadjusted 1.68 (1.58, 1.80) 1.44 (1.36, 1.53) 
Waist Circumference, 1 SD change, fully adjusted 1.54 (1.43, 1.65) 1.50 (1.40, 1.60) 
   
WHR, 1 SD change, unadjusted 1.89 (1.75, 2.04) 1.54 (1.45, 1.63) 
WHR, 1 SD change, fully adjusted 1.62 (1.48, 1.76) 1.50 (1.41, 1.60) 
    SD for BMI in women = 6.0, SD for BMI in men = 4.2 
    SD for waist circumference in women = 15.4, SD for waist circumference in men = 10.9 
    SD for WHR in women = 0.08, SD for WHR in men = 0.05 
    All models including center have blacks not from Jackson or Forsyth excluded (n = 22 women, n= 26 men) 
    Adjusted for age, smoking, alcohol use, education and race and center 
    Complete case analysis for unadjusted models too 
    Same results estimate whether centered BMI or not 
 
Figure 19.  (MS. 1, supplemental results) Fully adjusted models for incident heart failure by standard 
deviation change in anthropometric measures of BMI, waist circumference and WHR, by gender 
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Figure 20.  (MS. 1, supplemental results) Fully adjusted hazard ratios (with 95 % CI) for incident heart 
failure by action level categories of BMI, men and women combined, ARIC, 1987-2003 
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Table 30.  (MS. 1, supplemental results) Adjusted* hazard ratios (with 95 % CI) for incident heart 
failure by BMI, waist circumference and waist-hip ratio, each evenly divided into 5 groups 
(quintiles) to assess for a linear trend, stratified by gender, ARIC, 1987-2003 
 Women 
HR (95 % CI) 
P for  
trend 
Men 
HR (95 % CI) 
P 
for trend 
BMI  <0.0001  <0.0001 
1st quintile 1.00  1.00  
2nd quintile 0.99 (0.72, 1.39)  1.33 (1.02, 1.72)  
3rd quintile 1.30 (0.96, 1.77)  1.30 (1.00, 1.69)  
4th quintile 1.77 (1.32, 2.37)  1.59 (1.24, 2.03)  
5th quintile 2.82 (2.11, 3.76)  2.77 (2.20, 3.49)  
     
Waist Circumference  <0.0001  <0.0001 
1st quintile 1.00  1.00  
2nd quintile 1.20 (0.79, 1.59)  1.28 (0.95, 1.73)  
3rd quintile 1.08 (0.76, 1.54)  1.70 (1.29, 2.30)  
4th quintile 1.73 (1.26, 2.38)  1.95 (1.49, 2.55)  
5th quintile 3.05 (2.25, 4.15)  2.86 (2.22, 3.67)  
     
WHR  <0.0001  <0.0001 
1st quintile 1.00  1.00  
2nd quintile 1.39 (0.97, 1.99)  1.79 (1.32, 2.43)  
3rd quintile 1.76 (1.25, 2.49)  1.89 (1.39, 2.55)  
4th quintile 2.11 (1.51, 2.94)  2.75 (2.06, 3.67)  
5th quintile 3.40 (2.47, 4.68)  3.94 (2.98, 5.20)  
*Adjusted for age, smoking, alcohol use, education and race and center 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 147 
 
 
Table 31.  (MS. 1, supplemental results) Adjusted* hazard ratios (with 95 % CI) for 
incident heart failure by categories of BMI, waist circumference and waist hip ratio, 
stratified by gender, with the first three years of follow-up excluded, ARIC, 1987-2003 
 Women 
HR (95 % CI) 
Men 
HR (95 % CI) 
BMI, Overweight vs. normal weight 1.39 (1.09, 1.77) 1.31 (1.07, 1.61) 
BMI, Obese vs. normal weight  2.70 (2.15, 3.39) 2.49 (2.01, 3.08) 
   
Waist Circumference, 2nd Tertile vs. 1st tertile 1.28 (0.98, 1.67) 1.61 (1.31, 1.99) 
Waist Circumference, 3rd Tertile vs. 1st tertile 2.86 (2.24, 3.64) 2.30 (1.89, 2.80) 
   
WHR, 2nd Tertile vs. 1st tertile 1.84 (1.41, 2.42) 2.62 (2.13, 3.22) 
WHR, 3rd Tertile vs. 1st tertile 2.89 (2.25, 3.72) 1.46 (1.15, 1.85) 
   *Adjusted for age, smoking, alcohol use, education and race and center 
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Figure 21.  (MS. 1, supplemental results) Fully adjusted hazard ratios (with 95 % CI) for incident heart 
failure by category of waist circumference within category of BMI, men and women combined, ARIC, 
1987-2003 
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Figure 22.  (MS. 1, supplemental results) Receiver operating curve (ROC) comparing BMI, WHR and 
WC for the prediction of incident heart failure, ARIC, 1987-2003 
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Table 32.  (MS. 1, supplemental results) Summary of area under receiver operating curve at year 10 
(AUC10), adjusted for optimism, for BMI, WHR and waist circumference, and BMI stratified by 
high and low WHR, and accompanying Hosmer-Lemeshow statistic (H-L), stratified by gender 
 BMI WHR Waist 
circumference 
BMI, stratified 
by WHR 
All women 
AUC (10)1, H-L 
AUC (10)2, H-L 
 
0.78910, 20.5 
0.79, 18.5 
 
0.79171, 5.84 
0.79, 5.3 
 
0.7913, 13.4 
0.79, 13.6 
 
0.7935, 21.1 
All men 
AUC (10)1, H-L 
AUC (10)2, H-L 
 
0.7375, 28.7 
0.74, 16.6 
 
0.7384, 17.4 
0.74, 11.6 
 
0.7335, 26.6 
0.73, 20.7 
 
0.7416, 21 
1Model 1:  In addition to anthropometric measure, adjusted for smoking status, drinking, age, educational  
status, and race 
2Model 2:  Model 1 + race and center 
Conclusions were there was no difference in inferences based on AUC(10) with inclusion of race and center 
variable. 
 
 
 
Table 33. (MS. 1, supplemental results) Summary of area under receiver operating curve at year 
10 (AUC10) for BMI, WHR and waist circumference, stratified by race and gender 
 AUC (10)1,  
for BMI 
AUC (10) 1,  
for WHR 
AUC (10) 1,  
for WC 
     Black women 0.75 0.77 0.76 
     White women 0.79 0.79 0.79 
     Black men 0.69 0.71 0.70 
     White men 0.75 0.75 0.74 
  In addition to anthropometric measure, adjusted for smoking status, drinking, age, educational status 
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Figure 23.  (MS. 1, supplemental results) Adjusted* hazard ratios (with 95 % CI) for incident heart 
failure by BMI, waist circumference and waist hip ratio, stratified by gender, ARIC, 1987-2003 
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Table 34 (MS. 1, supplemental results) Comparison of adjusted* odds ratios (95 % CI) from logistic 
models with adjusted* hazard ratios (with 95 % CI) from  Cox proportional hazards models for incident 
heart failure by categories of BMI, waist circumference (WC) and waist hip ratio (WHR), stratified by 
gender, ARIC, 1987-2003 
 WOMEN MEN 
 HR (95 % CI) OR (95 % CI)             HR (95 % CI) OR (95 % CI)             
BMI, Overweight vs. normal  1.39 (1.09, 1.77) 1.46 (1.15, 1.85) 1.31 (1.07, 1.61) 1.39 (1.13, 1.71) 
BMI, Obese vs. normal  2.70 (2.15, 3.39) 2.78 (2.21, 3.50) 2.49 (2.01, 3.08) 2.77 (2.21, 3.47) 
     
WC, 2nd Tertile vs. 1st tertile 1.28 (0.98, 1.67) 1.34 (1.03, 1.74) 1.61 (1.31, 1.99) 1.71 (1.38, 2.12) 
WC, 3rd Tertile vs. 1st tertile 2.86 (2.24, 3.64) 2.96 (2.33, 3.77) 2.30 (1.89, 2.80) 2.45 (2.00, 3.00) 
     
WHR, 2nd Tertile vs. 1st tertile 1.84 (1.41, 2.42) 1.78 (1.36, 2.32) 1.46 (1.15, 1.85) 1.45 (1.14, 1.85) 
WHR, 3rd Tertile vs. 1st tertile 2.89 (2.25, 3.72) 2.92 (2.28, 3.73) 2.62 (2.13, 3.22) 2.75 (2.23, 3.40) 
*adjusted for smoking status, drinking, age, educational status, and race and center 
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Table 35.  (MS. 1, supplemental results) Summary of the odds ratios from the cumulative 
probability distributions from the sensitivity analysis of the effect of nondifferential 
misclassification of the outcome (heart failure) on the association of obesity as defined by BMI 
with incident heart failure 
 median OR  
with 95 %  
uncertainty 
intervals 
Width of 
intervals 
Nondifferential outcome misclassification   
  Conventional analysis (random error only) 2.89 (2.47, 3.42) 1.39 
  Sensitivity analysis (systematic error only) 4.54 (3.06, 14.63) 4.79 
  Total error analysis (systematic + random error) 4.54 (2.93, 14.83) 5.05 
   Sensitivity:  min=0.6, mode 1 = 0.7, mode2 = 0.85, max. = 1 
   Specificity:  min = 0.94, mode 1 = 0.96, mode 2 = 0.96, max = 1 
 
 
 
Figure 24.  (MS. 1, supplemental results) Graphical summary of the odds ratios from the cumulative 
probability distributions from the sensitivity analysis of the effect of nondifferential misclassification  
of the outcome (heart failure) on the association of obesity as defined by BMI with incident heart  
failure 
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C. Supplemental Results, Manuscript 2 
 
Figure 25. (MS. 2, supplemental results) Percentage of normal weight, overweight and obese as defined 
by category of BMI, waist circumference and waist hip ratio, stratified by gender 
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Table 36. (MS. 2, supplemental results) The median generalized impact fraction and attributable 
fraction (with 2.5 % and 97.5 % simulation intervals) from 10,000 bootstrap datasets using the 
case-load weighted-sum method, given 10 scenarios of reduced prevalence of obesity and 
overweight, ARIC, 1987-2003 
Hypothetical scenarios of weight reduction Median GIF, % 
(95 % simulation intervals) 
Reduction in obesity, shift to normal weight 
Scenario 1: 5 % reduction in obesity 1.1 (0.9, 1.3) 
Scenario 2: 10 % reduction in obesity 2.2 (1.8, 2.7) 
Scenario 3:  15 % reduction in obesity 3.4 (2.7, 4.0) 
Scenario 4:  20 % reduction in obesity 4.5 (3.6, 5.3) 
Scenario 5:  25 % reduction in obesity 5.6 (4.5, 6.7) 
Scenario 6:  30 % reduction in obesity 6.7 (5.4, 8.0) 
Reduction in obesity and overweight, shift both to normal weight 
Scenario 1:  5 % reduction in obesity and overweight 1.4 (1.0, 1.8) 
Scenario 2:  10 % reduction in obesity and overweight 2.8 (2.0, 3.6) 
Scenario 3:  15 % reduction in obesity and overweight 4.2 (3.0, 5.4) 
Scenario 4:  20 % reduction in obesity and overweight 5.6 (4.1, 7.1) 
Scenario 5:  25 % reduction in obesity and overweight 7.1 (5.1, 8.9) 
Scenario 6:  30 % reduction in obesity and overweight 8.5 (6.1, 10.7) 
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Figure 26.  (MS. 2, supplemental results)  Graph of the median generalized impact fraction for 5 %  
up to 30 % weight reduction with weight loss down to normal weight for obese (black) and for obese  
and overweight (red) 
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